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1Chapter 1 
General introduction to 
biological membranes
8Cell membranes
The cell membrane plays a vital role in any species from all three domains of life 
– Eukarya, Eubacteria, and Archaea. This two dimensional arrangement of lipids 
and proteins separates the internal contents of the cell from the outside medium. 
Moreover, the membrane pursues the multiple reactions needed to keep the cell 
alive, incl. energy and signal transduction, solute transport and enzymatic catalysis. 
The formation of the lipid bilayer has its origin in the amphipathicity of the lipid 
molecules (1). Eukaryotic cell membranes contain hundreds of different lipids, which 
are distributed asymmetrically over the two leaflets of the bilayer. To synthesize 
those lipids cells use about 5 % of their genes and invest a substantial amount of 
energy resources (2). It is thought that the complexity of the membrane serves to 
buffer the external perturbations and ensures matching of the spaces at the protein-
lipid interfaces to avoid ion and solute leakage (1).
Lipids are classified in different categories: e.g. glycerophospholipids, sphingolipids, 
and sterols. Compared to most prokaryotes, eukaryotic cells contain two extra lipid 
categories, i.e. sterols and sphingolipids. These lipids are also known to be key players 
in the trafficking of membrane vesicles in eukaryotes. In fact, the sterol composition 
increases along the secretory pathway, i.e. from 5% in the endoplasmic reticulum 
(ER) to more than 40 % in the plasma membrane (PM), and intermediate amounts 
in the Golgi complex (2). Cholesterol, the sterol of mammalian cells, increases the 
stiffness and the thickness of the membrane. These characteristics are important since 
the transmembrane domains (TMDs) of plasma membrane proteins of yeast and 
vertebrates are predicted to be somewhat longer than those of proteins resident in the 
ER and Golgi complex (3). Thus, cholesterol is able to induce protein sorting in those 
bilayers where the thickness and stiffness differ. Even more, it has been shown in 
yeast that ergosterol and sphingolipids play a role in the trans-Golgi network (TGN) 
sorting machinery by enriching for so-called ‘rafts’ lipids, which results in a higher 
lipid order in the secretory vesicles compared to the late Golgi membrane (4). All 
together there is a lot of evidence that cholesterol and ergosterol are responsible for 
the organization of membrane proteins in the biosynthetic secretory pathway. 
Membrane organization: ‘Rafts’
Cell membranes are not only complex in composition but also in the organization 
of the lipid and protein molecules. Initially, it was thought that the proteins were 
the key factors of membrane functionality, with the lipids serving as a 2D fluid 
mosaic in which the proteins were embedded (5). Later, the lateral segregation of 
sphingolipids and cholesterol together with some proteins in the plasma membrane 
of epithelial cells was observed. Those protein-lipid platforms could be isolated by 
solubilization of the cell membrane with cold detergent (Triton X-100), resulting in 
the so-called Detergent Resistant Membranes (DRMs). Herewith, the ‘raft’ concept 
as a functional organization of the membrane was introduced (6), even though 
the existence of lipid domains in cell membranes was suggested in several earlier 
studies (7). In parallel, the lateral segregation of lipids (and proteins) has also 
been studied in model membranes, giant unilamellar vesicles (GUVs), containing 
glycerophospholipids, sphingolipids and cholesterol. In those three-component 
mixtures the lipids separate in two relevant phases: liquid-ordered (Lo) phase, 
enriched in sphingolipids, cholesterol or saturated phospholipids, and the liquid-
disordered (Ld) phase containing most of the unsaturated glycerophospholipids (8, 9). The domains are dynamic and dependent on the lipid composition and 
temperature (10, 11). The coexistence of two different lipid domains has also been 
seen in Giant Plasma Membrane Vesicles (GPMVs), lipids isolated from rat kidney 
membranes at low temperatures or at physiological temperatures in the presence 
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of cholera toxin; the latter induces clustering of ganglioside GM1 (12-14). However, 
the demonstration of membrane rafts in biological membranes is difficult due to 
their small size, and the introduction of artifacts upon detergent extraction and GM1 
clustering (15). Consequently, the lipid raft concept has been highly debated (16, 17). 
Finally, with the development of new microscopy techniques, there is now some 
consensus on the nature of rafts and membrane organization (18). Membrane rafts are 
defined as dynamic, nanoscale, sterol-sphingolipid-enriched, ordered assemblies of 
proteins and lipids. Those assemblies can merge into larger raft domains by specific 
lipid-lipid, protein-lipid and protein-protein oligomerizing interactions (Figure 1) 
(19). The nanoscale rafts are supported by NMR measurements in GMPVs, which 
indicated an increased relaxation time in the lipid chain resonance at temperatures 
around the phase miscibility transition. GPMVs contain two liquid phases at low 
temperatures (comparable to Lo and Ld) and one liquid phase at high temperatures. 
However, slightly above the transition temperature, heterogeneity can be observed 
that corresponds to < 50 nm-sized membrane regions (20). This implies that cell 
membranes reside close to a critical point where small membrane compartments 
exist at a very low energetic cost. 
Opposite to the protein enrichment in rafts (seen in DRMs), polytopic membrane 
proteins and transmembrane peptides have been shown to partition into the Ld phase in model membranes (21, 22), whereas palmitoylated single membrane spanners 
have been observed in membrane rafts (23). However, palmitoylation is not the only 
factor to associate proteins with rafts, also length of the transmembrane segments 
and amino acid sequence plays a role (1). 
Figure 1. Raft-based heterogeneity in cell membranes. (A) Raft platforms formed, in response 
to external signals, from nanoscale assemblies of sterols, sphingolipids, glycolipids and 
proteins in the plasma membrane. (B) Micrometre-sized raft ‚phases’ induced at equilibrium 
usualy seen in GUVs. Figure modified with permission from K. Simons (19).
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Interaction of small molecules with membranes: Amphipathic 
pore-forming peptides
Cell membranes are complex in composition and dynamic in nature, and the 
interaction of small hydrophobic or amphipathic molecules with the lipid bilayer can 
have important consequences for the stability and barrier function of the membrane. 
Important examples are the antimicrobial peptides (AMPs) (24). They are produced 
by living organisms of all types in order to protect themselves against microbes (25). 
In fact, the gene-encoded antimicrobial peptides serve as part of their innate immune 
system (26, 27). Despite the huge variety of AMPs, they share similar features such 
as a cationic nature and amphipathicity. Their diversity in sequence classifies them 
in different structural groups: α-helical, β-sheet, extended and looped (28, 29). Figure 
2 shows two examples of AMPs, with different structure, studied in this thesis, the 
cyclic BPC194 and the linear Alamethicin. 
Figure 2. Illustrations of BPC194, form the MD simulations of Chapter 2, and Alamethicin, from the crystal structure 
by R. Fox and F. M. Richards (30). Scale bar represents 1 nm.
What is still under debate is whether their main target is the cell membrane or some 
metabolic function after accessing the cytoplasm (24). However, the interaction of 
AMPs with cell membranes and the impact on the function of biological membranes 
makes them important targets of study, and several modes of membrane disruption 
have been demonstrated. In the ‘barrel-stave’ model, peptides associate and align 
perpendicular to the bilayer forming the pore (31). In the ‘carpet model’, peptides are 
attracted and then oriented parallel to the membrane surface (32). Once a threshold 
concentration is reached peptides disrupt the bilayer in a detergent-like fashion by 
forming micelles. In this case, specific peptide-peptide interactions are not required. 
In the ‘toroidal-pore model’, like in the barrel-stave, peptides align perpendicular to 
membrane but the lipids in the vicinity of the peptides do not align parallel to the 
peptides (33). Membrane curvature is induced in such a way that the lumen of the 
pore is formed by both, peptides and the phospholipid head groups. The ‘disordered-
toroidal pore model’ is a recent modification of the regular toroidal-pore model (34, 
35). Peptides adopt a less-rigid conformation/orientation, and the pore lumen is 
11
1
General introduction to biological membranes
only aligned by the phospholipids. There are other peptides, named cell-penetrating 
peptides (CPPs), which are able to translocate across the cell membrane with very low 
toxicity. They can serve as drug carriers by mediating cellular uptake of proteins and 
other molecules like drugs. Methods have been described to assess the interaction of 
peptides with membranes, both in vitro and in vivo, which facilitates the classification 
of CPPs (36) and AMPs (37-39). Even more, to predict the active concentration ranges 
in vivo and to aid the design of new antibiotics, correlations have been made between 
the minimum inhibitory concentration of AMPs in vivo, and their partition constants 
and threshold concentrations in model membranes (40). 
There is increasing evidence that the classification of antimicrobial peptides on the 
basis of a single mode of action is often not correct, as the interaction of AMPs with 
the cell membrane is complex and the different models are not mutually exclusive. 
Also, the distinction AMPs and CPPs is not unambiguous, and the classification 
is often biased by the type of experiment(s) or molecular dynamics simulation 
done to characterize the molecules (34, 35, 41, 42). There is experimental evidence 
that peptides can undergo a dual mode of action to disrupt the membranes. For 
example, the G13A mutant of the N-terminal 20 residue-peptide of the influenza 
hemagglutinin promotes contents leakage but also fuses membranes as a way of 
entering the host cell (43). The antimicrobial cryptdin-4 found in mice induces hemi-
fusion and contents leakage in model membranes (44). The prototypic CPP derived 
from the human immunodeficient virus (HIV)-1 TAT protein residues 48-60, known 
as TAT, causes leaky fusion of liposomes with a lipid composition mimicking that 
of late endosome (45). The human salivary antimicrobial peptide Histatin 5 causes 
temporary damage to the plasma membrane of the parasites and acts as a CPP and 
is translocated to the cytoplasm (46). A recent in vivo study revealed how the human 
antimicrobial, LL-37, acts on Gram-negative bacteria Escherichia coli. The action 
mechanism involves two stages. Initially, the peptide binds and quickly saturates the 
outer membrane, containing the lipopolysaccharide and O-antigen. Subsequently, it 
enters the periplasmic space and shortly after this step the cell growth is arrested. 
Well after the cell growth is inhibited the peptide reaches and permeabilizes the 
cytoplasmic membrane (39). This work also shows that in vitro methods may not 
reveal the full complexity of the action mechanism of AMPs. Importantly, the 
complex and multiple interactions of the AMPs with cells may be the cause for the 
difficulty of target cells to develop resistance. As a result, an increased interest in the 
understanding of the mechanism of action of those peptides has emerged in the past 
decade. Their selectivity for bacterial versus mammalian cells makes AMPs important 
pharmacological agents to treat infections against drug-resistant pathogens and, 
thus, a good alternative to the conventional antibiotics.
Interaction of small molecules with membranes: reducing 
versus non-reducing sugars
Saccharides are synthesized in large amounts when yeast or plant cells enter into 
an anhydrobiotic state, where the amount of water in the organism is reduced and 
the metabolism is slowed or stopped (47, 48). Upon entering this state, a common 
physiological response of the cells is the synthesis of high amounts of sugars such as 
sucrose and trehalose. Membranes are stabilized by these sugars, but the molecular 
mechanism behind it is not fully understood. 
In model membranes it has been shown how sugars are bound by hydrogen 
bonding with the lipid head groups. However, the only sugars found in nature 
that are synthesized by the organisms undergoing dehydration are the two non-
reducing sugars sucrose and trehalose. For that reason those two have been studied 
extensively in dryed membrane systems (49-55). It has been suggested that these 
12
sugars intercalate in between the lipid/water interface, resulting in the spreading of 
the lipids, thinning of the bilayer and decreasing of the transition phase temperature 
(Tm) during dehydration. The reason for the decrease in the Tm is the ability of the sugars to keep the lipid molecules separated from each other when the amount of 
water molecules is extremely low, which avoids a tight packing of the acyl chains and 
the transition from the liquid to the gel phase of the membrane. Several mechanisms 
have been described to explain this phenomenon, such as the replacement of water 
molecules by the sugars at the lipid/water interface, formation of amorphous 
glasses to protect the membrane, the concentration of water molecules close to the 
membranes preserving its native properties or the exclusion of the sugars from the 
surface reducing the compressive stress in the membrane upon dehydration (51, 52, 
55-60).
There are also some studies on fully hydrated systems and here the mechanisms 
via which sugars stabilize membranes have been explained in the following way. 
At low amounts of sugars, the saccharides bind the lipids and replace the water 
molecules of the lipid/water interface resulting in an increase of the membrane area. 
However, at high sugar concentrations the sugars are expelled from the membrane 
due to the domination of the kosmotropic effect of the sugars. Consequently, the 
sugar concentration in the bulk solution is higher than in the hydration zone of 
the lipids. However, the sugar molecules that were already bound at lower sugar 
concentrations are still in the membrane causing the same changes in membrane area 
as at low concentrations (55, 59, 61, 62).
To study the membrane organization, the whole system needs to be hydrated to 
mimic the in vivo membrane environment. To study the membrane organization 
and formation of lipid rafts, GUVs or GPMVs are often used as model systems even 
though they lack the complexity of native plasma membranes. For instance, artificial 
membranes are not asymmetric in composition of the two bilayer leaflets, they are 
not connected to active processes within the cell, and they exclude interactions of 
membrane proteins skeletal components. These are all factors that can influence 
the distribution of membrane components and likely contribute to the fact that 
macroscopic phase separation is readily observed in model systems but not in living 
cells (63). However, to study specific parameters of biological membranes, GUVs 
and GPMVs serve as perfect simplified membrane model systems. For example, the 
physical basis underlying the diffusion of proteins and lipids in membranes could 
only be delineated in GUVs (64). Similarly, the effect of small antimicrobial peptides 
and other molecules like saccharides on membranes can be addressed with greater 
detail in GUVs than would be possible in vivo.
Design of novel membrane pores: Applications in synthetic 
biology
Ion transport across membranes of the cells and organelles is an important process to 
provide organisms with co-factors, to generate ion gradients, to regulate cell volume 
and others. To fulfill this function ion pumps and ion channels are embedded in 
the cell membrane. The ion transporters are driven by ATP or electrochemical ion 
gradients, and they pump ions against their concentration gradient (65). In general, 
they are specific for one or a few ions, e.g. the P-type Na+/K+-ATPase. The ion 
channels either display a high ion selectivity, e.g. the voltage-gated ion channels of 
our central nervous system, or are ion or solute indifferent, e.g. the mechanosensitive 
channels involved in cell volume regulation (66). Ion channels allow the passive 
transport of ions down the concentration gradient (65). Ion channels have served 
as models to create new and easy to control synthetic channels. The applications 
include the use of small synthetic ion channels in drug (antibiotics) release (drug 
13
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delivery systems), and the engineering of in vitro catalysts, detectors and sensors (67). 
However, it is not trivial to work with channels outside their native environment, 
the cell membrane, and their insertion into the membrane is a complicated protein-
mediated process. Moreover, the functions of membrane proteins are highly regulated 
by the surrounding lipids and/or they have co-evolved with other proteins. A way 
to overcome this limitation is the use of simpler channels, such as peptide-based 
pores that auto insert into the membrane and have less specific lipid demands. 
However, their structures and functions are often ill defined, which is a challenge 
for subsequent engineering (68). After all there are some peptide-based pores that 
have been engineered, such as alamethicin, gramicidin A, melittin, and amphiphilic 
peptides made of leucine-serine or leucine-arginine-alanine repeats (69). Arguably, 
alamethicin is the best-characterized and “most-modified” antimicrobial peptide, 
containing 2-aminoisobutyric acid in addition to natural amino acids. Alamethicin is 
thought to form ‘barrel-stave’ type pores (see also previous section). This 20-residue 
α-helical peptide assembles perpendicular to the bilayer with the hydrophilic 
residues aligning the pore and the hydrophobic amino acids shielding the aliphatic 
lipid chains (70-75). The peptide has been tethered covalently with different kinds 
of linkers to create preferred oligomeric states (76, 77). It has also been linked to 
other molecules to control the assembly by extramembrane segments (78, 79), protein 
ligand interactions (80, 81) or by metals (82). 
DNA as a template has been used to control chemical reactions (83), to perform 
asymmetric catalysis (84, 85), to modulate protein activity (86) and even to create 
entire channels with high analyte selectivity (87). The high selectivity of base-pairing 
gives a very robust control over the assembly process, which is attractive in the 
design of synthetic channels. Therefore, DNA might serve as a useful building block 
to regulate and give control to new synthetic channels.
Saccharomyces cerevisiae as model system
A key achievement in the evolution of eukaryotic cells has been the 
compartmentalization of cellular processes within membrane-enclosed organelles. 
The increased complexity of higher organisms relates to the need to differentiate cell 
types, to perform inter- and intracellular signaling and to compartmentalize specific 
functions. Saccharomyces cerevisiae serves as a model organism for eukaryotic cells 
with around 30 % of the total proteome being membrane proteins, very similar to that 
of other eukaryotes, bacteria and archaea (88). Moreover, yeast is easily susceptible 
to genetic, biochemical and microscopic studies. Yeast possesses a great variety of 
lipids. Compared to the PM of mammalian cells with about 30-40 % cholesterol and 
10-20 % sphingomyelin, yeast has about 30 % sphingolipids (from which 80 to 100 
% are in the PM), which may function as the mammalian sphingomyelin; most of 
the phosphosphingolipids in yeast have a inositol headgroup. In addition, yeast 
possesses ergosterol, instead of cholesterol, in amounts comparable to those of the 
glycerophospholipids (89, 90). Ergosterol together with complex sphingolipids have 
been shown to form functional rafts, and they have been isolated as detergent-insoluble 
glycolipid-enriched complexes (DIGs) or DRMs (91, 92). Together with ergosterol 
and sphingolipids some polytopic proteins have been co-purified such as the plasma 
membrane H+-ATPase Pma1p, the glycosylphosphatidylinositol (GPI) anchor Gas1p, 
the general amino acid permease Gap1p, the hexose transport facilitator Hxt1p, the 
H+/uracil symporter Fur4p and the H+/Tryptophan symporter permease Tat2p (91-
96). The importance of ergosterol and sphingolipids in the formation of rafts in the 
yeast PM is evident from the fact that all these proteins require either ergosterol 
or sphingolipids or both to get properly targeted to the PM. For example, Pma1p 
and Gas1p are no longer associated with lipid rafts in cells lacking ergosterol or in 
lcb1-100 cells, which are unable to synthesize sphingolipids. Sphingolipids are also 
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required for the oligomerization of Pma1p in the ER, which is crucial for the delivery 
of the protein to the cell surface (97). Arginine uptake via the H+/Arginine symporter 
Can1p was decreased 3-fold in cells with decreased ergosterol (erg24 and erg6) and the 
protein was degraded in the vacuolar lumen in lcb1-100 cells (98). Another example 
is Tat2p, an integral membrane that is no longer delivered to the PM in the absence 
of ergosterol (94, 99). 
Several micro compartments have been described for yeast, frequently denominated 
lipid rafts due to their lipid/protein segregation but they seem to function differently 
from the mammalian cells rafts (100). On the basis of the lateral segregation of 
membrane proteins, three main compartments have been described for yeast. The 
membrane compartment occupied by Can1p (MCC), the membrane compartment 
occupied by Pma1p (MCP), and the membrane compartment occupied by the 
rapamycin kinase complex 2, TORC2 (MCT). Cells contain 50-80 of the patch-like MCC 
domains, furrow-like invaginations in the cell surface, with dimension of around 300 
nm long and 50 nm deep. MCPs are described as a network percolated by the MCCs 
and MCTs (98, 101-104). The MCC domain has been shown to accommodate several 
proteins apart from Can1p, namely the tetraspan proteins of unknown function 
Nce102p, Sur7p, Ynl194p, Ydl222p, Ylr414p and Ygr131p (101, 105, 106), and the 
transport proteins Fur4p and Tat2p (96, 107). Even though, the function of the Sur7p 
family proteins is not fully understood, the sphingolipid composition and sporulation 
of yeast were altered in cells lacking Sur7p, Ynl194p and Ydl222p (105). There are also 
indications that Sur7p interacts with the cell wall since digestion of the wall caused 
the Sur7p patches to disappear. However, there is some controversy on this topic since 
Malinska et al. showed the maintenance of the Sur7p patches after cell wall digestion 
(101). The extracellular regions of Sur7p-family proteins have the highest sequence 
conservation and homologues are present in several fungi and higher plant but not 
in organisms lacking a cell wall (105). The actin cytoskeleton does not appeared to 
be directly involved in the maintenance of the patchy localization of MCC proteins 
as treatment of cells with lantrunculin A, which depolymerizes F-actin, showed no 
effect (98, 101, 107). The membrane potential has been shown to play an important 
role in the maintenance of the MCC domains. By dissipating the membrane potential 
with FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone), all proteins 
from the MCC domain, except Sur7p, and ergosterol lost their patchy localization at 
the cell periphery. Surprisingly, pretreatment of cells with filipin, to stain ergosterol, 
and then FCCP, to dissipate the membrane potential, locked Can1p in the MCCs 
(107). Filipin is also known to disrupt membrane rafts by sequestering the sterols to 
some extent (108). There are a number of proteins that are not localized in patches but 
distributed homogenously over the PM, incl. the hexose transport facilitator, Hxt1p 
and the yeast general amino acid permease, Gap1p (98, 109). Interestingly, Gap1p 
also requires sphingolipid biosynthesis for proper localization at the PM (109). The 
fact that both MCC and MCP contain raft lipids, sphingolipids and ergosterol, is 
consistent with the localization of Gap1p in both compartments.
In close vicinity to the PM and right underneath the MCC domain, reside the so-called 
‘eisosomes’ (from the Greek ‘eis’, meaning portal, and ‘soma’, meaning body) (110, 
111). Their constituents are all cytosolic proteins that interact with the MCC domain. 
They were initially described as endocytic sites with Pil1p as main fundamental 
component. Deletion of PIL1 leads to miss-localization of Lsp1p, another protein 
associated with eisosomes, and the MCC protein Sur7p. On the contrary, deletion 
of LSP1 or SUR7 did not have any effect on the localization of Pil1p. The eisosomes 
are surprisingly static and after photo-bleaching of Pil1p-GFP no recovery of 
fluorescence was observed (107, 110). Pkh-kinases were also found to co-localize 
with eisosomes, i.e. Lsp1p. Pkh-kinases, Pkh1 and Pkh2 are regulated by the Long-
Chain Bases (LCB), which form the metabolic precursors of sphingolipids. Mutations 
15
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in these kinases or in sphingolipid biosynthetic enzymes block endocytosis. Those 
LCBs regulate the assembly of Pil1p since higher levels of LCBs or ceramides increase 
the amounts of Pil1p in the plasma membrane and make the eisosome patches more 
elongated. Pkh-kinases are also responsible for the phosphorylation and localization 
of Pil1p in the eisosomes (112). The idea that eisosomes serve as endocytic points 
has been questioned by Grossmann and coworkers, who found that the proteins of 
the endocytic machinery are excluded from the MCC/eisosomes (106). They showed 
21 proteins co-localizing with the MCCs, nine of them being polytopic with 4 or 12 
TMDs; the other twelve, all cytosolic, were assigned to the eisosomes. However, 
deletion of PIL1 gene resulted in complete dissipation of all MCC markers analyzed 
(HUP1, Can1p, Sur7p and ergosterol). When deleting the PIL1 or NCE102 genes, 
thus dissipating the MCCs, the endocytosis of Can1p (and Fur4p) was increased 
either by adding an excess of substrate or protein synthesis inhibitor cycloheximide. 
The data suggest that proteins are protected when localized in the MCC/eisosome 
patches (106). This is in agreement with the fact that Pil1p down-regulates pathways 
involved in endocytosis (Pkc1-mitogen-activated protein and Ypk1). In other words, 
the eisosomes/MCCs would represent an area that is protected from endocytosis. 
This idea is reinforced by experiments from Brach et al., who showed that only 30 % 
of the total Can1p resides in the MCCs and the endo- and exocytosis occurs outside 
those domains (113). Recently, another study pointed out the fact that the reported 
compartmentalization of yeast PM is not so strict (114). They studied 46 PM proteins 
and none of them were fully co-localizing with each other. They concluded that the 
yeast PM might be organized in numerous partially overlapping domains. 
Protein dynamics in the plasma membrane of Saccharomyces 
cerevisiae
As mentioned heretofore, the total amount of sphingolipids and ergosterol increases 
along the secretory pathway (2), and these lipids also play an important role in the 
TGN-sorting machinery for the targeting of the proteins to the PM via secretory 
vesicles (4). Interestingly, the lateral diffusion of proteins and lipids in the yeast 
PM is very slow (115-118). This slow diffusion is a particular feature of the PM 
because the diffusion in internal membranes seems faster. The SNARE Sso1 protein 
in the PM of yeast has a diffusion constant of ~0.0025 µm2/s, which is two orders 
of magnitudes slower than in mammalian cells (0.1 µm2/s). The same protein was 
targeted to the vacuolar membrane by fusing it to the N-terminal domain of SNARE 
Pep2. The resulting diffusion in the vacuolar membrane was much higher, similar to 
that in mammalian membranes. However, the fraction of the chimera that localized 
to the PM of yeast had again an anomalously slow diffusion. The diffusion of the 
two PM proteins analyzed, Sso1 and Snc1, did not depend on the presence of the 
cell wall or the actin cytoskeleton, but it was 2-fold faster in the erg6 mutant (115). 
Besides membrane proteins, lipid probes have also been shown to diffuse slowly 
at the PM of yeast. The cell wall had no influence on the diffusion, but removal of 
surface proteins by trypsinization of spheroplasting of cells resulted in a significant 
increase of the diffusion coefficients (117). A difference in diffusion speed of PM 
and vacuolar membrane residents was observed for the lipid-anchored Ras2, albeit 
with only a 4-fold slower diffusion in the PM (119). In addition, the diffusion of 
membrane reporters in the ER was found to be 5-6 times faster than in the inner 
nuclear membrane (120, 121). One of the causes for the slow mobility in the PM could 
be the high fraction of sphingolipids and ergosterol as compared to the organellar 
membranes or vesicles in the secretory pathway. 
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The exceptionally slow diffusion of membrane proteins together with the endocytic 
cycling of proteins has been proposed as means to maintain the membrane polarity 
(115, 122, 123). Maintenance of membrane polarity is a fundamental feature of the 
yeast cell cycle. Two signaling pathways can regulate the polarized distributions: 
immobilization via scaffolds (e.g. cytoskeleton) or through dynamic recycling of 
membrane proteins (123). The dynamic maintenance of the polarity is strongly 
influenced by the lateral diffusion of membrane proteins. In fact, polarity is achieved 
by balancing of three different mechanisms. First, the delivery of membrane proteins 
via vesicle transport. Second, the lateral diffusion of membrane proteins. Third, the 
redistribution from the PM to the cytoplasm via endocytosis (124). It has been shown 
that the delivery of proteins via vesicle trafficking, 50-80 nm in size (97, 125), and the 
recycling via endocytosis occur at restricted sites that are non-randomly distributed 
over the PM In fact, those sites are excluded from the cortical ER and are also free 
of MCC/eisosome domains. The MCC invaginations are thought be responsible for 
the local perforations of the cortical ER (126). Taken collectively, the PM is a complex 
structure with tight regulation of the spatial and functional organization of its 
constituents. 
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We report the molecular basis for the differences in activity of cyclic and linear antimicrobial peptides. We 
iteratively performed atomistic molecular dynamics simulations and biophysical measurements to probe 
the interaction of a cyclic antimicrobial peptide and its inactive linear analogue with model membranes. 
We establish that, relative to the linear peptide, the cyclic one binds stronger to negatively-charged 
membranes. We show that only the cyclic peptide folds at the membrane interface and adopts a beta-sheet 
structure characterized by two turns. Subsequently, the cyclic peptide penetrates deeper into the bilayer 
while the linear peptide remains essentially at the surface. Finally, based on our comparative study, we 
propose a model characterizing the mode of action of cyclic antimicrobial peptides. The results provide 
a chemical rationale for enhanced activity in certain cyclic antimicrobial peptides and can be used as a 
guideline for design of novel antimicrobial peptides.
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Introduction
Antimicrobial peptides (AMPs) are currently in the spotlight as potential candidates to 
overcome bacterial resistance to conventional antibiotics. These peptides are natural 
weapons produced by a variety of organisms, including insects, animals and plants 
(127, 128). While displaying a wide spread in primary structures, most antimicrobial 
peptides exhibit common basic features (129-131). The linear α-helical peptides 
have been shown to be unstructured in water and adopt a secondary structure 
upon association with the membrane (132, 133). Though acquiring structure upon 
membrane binding is an important feature of these AMPs, short peptides lacking 
a well-defined secondary structure are also active (134). Cyclic AMPs are amongst 
the most effective antimicrobial agents (25, 135) and some members of the family 
have been shown to adopt a structure even in water (136). One of the best studied 
examples is gramicidin S, whose structure in aqueous media, an anti-parallel β-sheet 
characterized by two turns, is important for its activity (137). Comparative studies 
between related peptides with differing activities, though not yet been undertaken, 
would help us rationalize the essential structural properties vital for function and 
will help us design more potent antimicrobial peptides.
Besides acquiring structure at the membrane interface, the partitioning behavior of the 
peptides, i.e. the membrane-aqueous medium partition coefficient and the membrane 
penetration depth also contribute to their efficacy and action and selectivity (138). In 
fact, the local concentrations of AMPs in the membrane can be up to 10,000 times 
higher than in the aqueous phase (40), therefore the understanding of partitioning 
behaviour is of importance to unravel mechanisms of action of these peptides. Again, 
undertaking comparative studies would help us distinguish between essential and 
non-essential differences in partitioning and help to extract only the critical features.
The focus of our work is a cyclic peptide, BPC194 [c(KKLKKFKKLQ)], which, 
from a library of de novo designed cyclic decapeptides, proved most active against 
plant pathogens such as Erwinia amylovora, Pseudomonas syringae and Xanthomonas 
vesicatoria (139, 140); its linear analogue is poorly active. Here, we present a combined 
MD and biophysical study of the cyclic peptide interacting with anionic lipid bilayers 
to understand its mechanism of action. The linear analogue, BPC193 has been studied 
to contrast the behavior of the two related peptides and extract the molecular basis 
for antimicrobial activity. We show how the cyclic and linear peptides differ both in 
their partitioning behavior and their folding state upon interaction with membranes. 




The 9-fluorenylmethoxycarbonyl (Fmoc)-protected amino acid derivatives, coupling 
reagents, and 4-methylbenzhydrylamine (MBHA) resin hydrochloride (0.4 mmol/g) 
were obtained from Iris Biotech (Marktredwitz, Germany). Trifluoroacetic acid (TFA), 
N,N-dimethylformamide (DMF), N-methyl-2-pyrrolidinone (NMP), Pd(PPh3)4, 
sodium N,N-diethyldithiocarbamate, triisopropylsilane (TIS), tetrahydrofuran 
and CHCl3 were from Sigma-Aldrich Corporation (Madrid, Spain). Piperidine, 
N-methylmorpholine (NMM), and N,Ndiisopropylethylamine (DIEA) were 
purchased from Fluka (Buchs, Switzerland). Acetic acid (AcOH), diethyl ether 
and CH2Cl2 were from Panreac (Castellar del Vallès, Spain). Solvents for reverse-
phase high-performance liquid chromatography (RP-HPLC) were obtained from 
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Scharlau (Sentmenat, Spain). H2O was de-ionized and filtered using a COT Millipore 
Q-gradient. The 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) and 
2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris-HCl) were from Roche Diagnostics 
GmbH (Germany), sodium chloride, sodium fluoride and Triton-X100 were from 
Merck (Germany). Phospholipids 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine 
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol (DOPG) and 1,2-dioleoyl-
sn-glycero-3-phosphatidyl-ethanolamine (DOPE) were from Avanti Polar Lipids.
Peptide synthesis
Decapeptides investigated in this study (Table 1) varied in the type of aromatic 
aminoacid at position 6 and included cyclic analogues: BPC194, BPC294 and BPC418, 
together with their linear counterparts: BPC193, BPC293 and BPC417. Peptides were 
synthesized from a MBHA resin by carrying out solid-phase synthesis of linear 
sequences followed by on-resin cyclization. A three-dimensional orthogonal Fmoc/
tButyl/Allyl strategy was used (141). Side-chain protection for Lys and Trp was as 
tert-butyl carbamate (Boc) and as tert-butyl (tBu) for Tyr. Fmoc-Glu-OAl residue 
was used as trifunctional amino acid to allow peptide anchoring onto the resin, 
which resulted in a Gln after peptide cleavage from the support. The MBHA resin 
(0.4 mmol/g, 200-400 mesh) was swollen with CH2Cl2 (1 × 20 min), DMF (1 × 20 
min), piperidine/DMF (3:7, 1 × 5 min), DMF (6 × 1 min), and CH2Cl2 (3 × 1 min). 
Then, the resin was treated with Fmoc-Rink linker (5 equiv), N-[(1H-benzotriazol-
1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate 
(HBTU) and DIEA (10 equiv) with overnight stirring. The Fmoc group was removed 
by treating the resin with a mixture of piperidine/DMF (3:7, 2 + 8 min). Couplings 
were conducted using the corresponding Fmoc-protected amino acid (4 equiv), 
which was dissolved in DMF and preactivated for 5 min with HBTU (3.8 equiv), 
1-hydroxybenzotriazole (HOBt) (4 equiv) and DIEA (7.8 equiv). The mixture was 
added to the resin and shaken for 1 h at room temperature. The completion of the 
reactions was checked by the Kaiser test. Peptide elongation was performed by 
repeated cycles of Fmoc group removal and coupling. After each deprotection and 
coupling step, the resin was washed with DMF (5 × 1 min). Once the chain assembly 
was completed, the C-terminal allyl ester was cleaved by treatment with Pd(PPh3)4 (3 
equiv.) in CHCl3/AcOH/NMM (92.5:5:2.5, 1 mL) with stirring under nitrogen for 3 h 
at room temperature, followed by washings with tetrahydrofuran (3 × 2 min), DMF 
(3 × 2 min), DIEA/CH2Cl2 (1:19, 3 × 2 min), sodium N,N-diethyldithiocarbamate 
(0.03 M in DMF, 3 × 15 min), DMF (10 × 1 min) and CH2Cl2 (3 × 2 min). After final 
Fmoc removal, the resin was divided: One portion of the resin was used to obtain 
the linear peptides. The rest of the resin was subjected to cyclization by treatment 
with benzotriazol-1-yl-N-oxytris(pyrrolidino)phosphonium hexafluorophosphate 
(PyBOP) (5 equiv), HOBt (5 equiv), and DIEA (10 equiv) in NMP at 25 ºC for 24 h. 
After this time, the resin was washed with NMP (6 × 1 min), CH2Cl2 (3 × 1 min), and 
diethyl ether (3 × 1 min), and air-dried. Cleavage of the corresponding linear and 
cyclic peptides was performed by treatment with TFA/H2O/TIS (95:2.5:2.5) for 2 h 
at room temperature, and the cleavage cocktail was evaporated to dryness under a 
stream of nitrogen. Following diethyl ether extraction, peptides were dissolved in 
H2O, lyophilized and analyzed by analytical HPLC performed at 1.0 ml/min using 
a Kromasil (4.6 × 40 mm; 3.5 μm particle size) C18 reverse-phase column. Linear 
gradients of 0.1% aqueous TFA and 0.1% TFA in CH3CN were run from 0.98:0.02 
to 0:1 over 7 min with UV detection at 220 nm. All peptides synthesized showed 




Liposomes for calcein dequenching. Liposomes were prepared as described previously 
(142). Briefly, liposomes at a final concentration of 1mM of lipid molecules were 
prepared by rehydration of a dried lipid film with 100 mM calcein-NaOH in 10 mM 
HEPES, pH 7.0. The vesicles were then subjected to five cycles of flash freezing in liquid 
nitrogen and rapid thawing at 50°C. Subsequently, the liposomes were sonicated (5 
× 10 sec. pulses at 75% amplitude with a Sonics Vibra Cell VCX 130 sonicator) to 
obtain unilamellar vesicles. Liposomes were separated from the non-encapsulated 
dye by size exclusion chromatography (Sephadex G-75, GE Healthcare). The column 
was equilibrated and eluted with 10 mM HEPES, pH 7.0, plus 150 mM NaCl, further 
refered as buffer A.
Liposomes for Circular Dichroism (CD). Liposomes were prepared similarly as 
described for the calcein dequenching experiments except that the dried lipid film 
was rehydrated with 10 mM sodium phosphate, pH 7.0, plus 150 mM NaF to a final 
concentration of 25 mM lipids. Sodium chloride was replaced by sodium fluoride 
to reduce the noise levels at wavelengths < 200 nm, which is caused by chloride 
ions. Furthermore, liposomes were extruded through a 30 nm polycarbonate filter 
(Whatman International Ltd, UK), instead of sonication, to obtain a more homogenous 
sample.
Liposomes for binding and tryptophan environment assays. Liposomes were prepared by 
rehydration of DOPG phospholipid films in buffer A to a final concentration of 25 
mM and subsequently extruded through a 200 nm polycarbonate filter. 
Calcein dequenching
The calcein dequenching assay was performed as reported previously (142). A 20 
μl sample of liposomes (1mM of lipid), obtained as described in section 2.1.3.1 
of Materials and Methods, was placed in 3 ml of buffer A, which yielded a final 
concentration of 6.7 μM of lipid in the cuvette. The membrane permeabilizing activity 
of the peptide was followed by measuring the increase in fluorescence (calcein 
dequenching), resulting from vesicle leakage after peptide addition addition (0-52 
μM). Fluorescence emission was monitored at 520 ± 5 nm (excitation at 485 ± 2 nm) 
in a Cary Eclipse Fluorescence Spectrophotometer (Varian Inc.). The release of the 
calcein was calculated as a percentage of the total amount present in the liposomes: 
% Release = (I−I0)/(I100−I0) × 100
where I is the measured fluorescence intensity at a given time, I0 is the initial 
background fluorescence intensity and I100 is the fluorescence intensity upon 
complete lysis of the liposomes, which was elicited by adding Triton X-100 (0.06% 
final concentration).
Circular dichroism
Far-UV circular dichroism spectra were recorded on a Jasco J-815 CD spectrometer 
(Jasco, UK) between 190 and 250 nm at room temperature and scanning every 1 
nm, using a quartz cell of 1 mm path length. The peptide at 0.15 mM was titrated 
with small aliquots (1 to 10 μL) of DOPG liposomes at a concentration of 25 mM. 
2,2,2-Trifluoroethanol (TFE, Janssen Chimica) was used as a secondary structure 
inducer. The spectra were corrected for the absorption of buffer and vesicles. 
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Peptide environment probed with tryptophan fluorescence
The tryptophan analogues (BPC417 and BPC418) were placed in a quartz cuvette in 
buffer A at 2 μM and their fluorescence was monitored with a Fluorlog-3 (Jobin Yvon) 
spectrofluorimeter at an excitation wavelength of 285 ± 5 nm and emission scanning 
from 295 to 400 nm. Different amounts of DOPG vesicles were introduced into the 
cuvette (at final lipid concentrations of 2.28, 28 and 275 μM, corresponding to P:L 
ratios of 0.88, 0.071 and 0.0073, respectively). Subsequently, NaCl was titrated into 
the cuvette to a final concentration of 350 mM. The emission spectra were corrected 
with the corresponding buffer spectra (including DOPG and salt) and fitted to a 
skewed Gaussian curve (143) to obtain the fluorescence emission maximum, λmax.
Peptide binding by ultracentrifugation
Increasing amounts of DOPG liposomes (0-753 μM) were added to 0.5 ml of 6 μM 
peptide in buffer A up to a P:L ratio of 1:114 and incubated for 20 min at room 
temperature. The samples were spun down by ultracentrifugation (1 h at 270,000 × 
g) and supernatants were separated from the pellets. A control experiment with an 
encapsulated dye in the same vesicles was carried out and under those conditions 
the vesicles were quantitatively spun down. To correct for the differences in quantum 
yield of the tryptophan fluorescence in different environments (hydrophilic buffer 
A vs. hydrophobic membrane environment), 2% (w/v) of sodium dodecyl sulfate 
(SDS) was added to the supernatant fraction and the fluorescence was measured. A 
correction was made for the background signal using a reference solution of buffer 
A, liposomes and SDS without the peptide. The percentage of binding was calculated 
using the equation:
% Binding = 100 − (I0/I × 100)
where, I0 is the fluorescence intensity of the supernatant sample with peptide without liposomes and I is the fluorescence intensity of the samples with liposomes. The 
obtained data were fitted to a general binding equation to obtain the dissociation 
constant (Kd):
% Binding = (Bmax × Clipid)/(Kd + Clipid)
where, Clipid is the concentration of lipid and Bmax is the maximum value for binding. 
For this purpose a simple binding equilibrium was assumed where peptide 
interacts [P] with the membrane [M] to form a peptide-membrane complex [PM]. 
This approach is equivalent to what was described by Matos and coworkers (144). 
The affinity of peptide membrane interaction can also be expressed as partitioning 
coefficients (145). The relationship between the two models is discussed in the work 
of Matos et al. (144).
Molecular Dynamics Simulations
System set-up
Simulations were performed with BPC194 [c(KKLKKFKKLQ)], and the linear 
analogue BPC193 [H-KKLKKFKKLQ-OH]. For the cyclic peptide, a peptide bond 
was created between the N-terminal lysine residue and the C-terminal glutamine 
residue. The initial structure of the peptides was modeled using the leap module of 
AMBER 9 (146).
Peptide in aqueous environment
A number of systems were prepared with either one cyclic or one linear peptide 
solvated by water. The cyclic peptide was initially unstructured in all simulations but 
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different starting conformations of the linear analogue were tested: α-helix, bend and 
random-coil. An overview of all simulations performed is shown in Table 2 (Wa-Wk), 
and the details are presented in Table 3. All systems were simulated in a cubic box 
of length 4~5 nm and about 3000 water molecules. In a few simulations, counterions 
(Cl-) were added to neutralize the system.
Peptide-membrane systems
A number of simulations were performed with peptides in a solvated DPPG 
(1,2-dipalmitoyl-sn-glycero-3-phosphatidylglycerol) membrane system. Simulations 
were performed with molar peptide: lipid (P:L) ratios of 1:128, 2:60, 4:128 and 9:128 
(and 6000-8000 water molecules) for both BPC194 and BPC193 (see Table 2 for an 
overview and Table 3 for details). Initially, the peptides were placed in the water 
phase close to the membrane surface, with distances between the peptide and 
membrane ranging from 1.5 to 2.3 nm. The cyclic peptide was initially unstructured 
and different conformations were tested for the linear peptide. Multiple simulations 
were run from different initial random velocity distributions for each of the P:L ratios. 
The simulations were carried out in the presence and absence of counter ions, and 
using different electrostatic schemes.
Simulations parameters
The GROMACS software package (147) was used to perform all MD simulations. 
The GROMOS force-field 43a2 (148) was used to describe the peptide and peptide–
solvent interactions. Simulations in water were also run using GROMOS force-field 
53a6 (149). The force-field for DPPG lipids was optimized from DPPC (150) and 
POPG lipids (151), compatible with the GROMOS96 parameters. The choline head-
groups were replaced by glycerol from the POPG force-field, and the tail parameters 
were taken from the DPPC force-field. The parameters were then optimized to 
achieve an area per lipid consistent with experiment (152). The equilibrated DPPG 
bilayer had a thickness of 3.54 ± 0.05 nm and an area per lipid of 0.69 ± 0.01 nm2. 
All force-fields were parameterized for use with a group-based twin range cut-off 
scheme (using cutoffs of 1.0/1.4 nm and a pair-list update frequency of once per 10 
steps), including a reaction field (153, 154) correction with a dielectric constant of 78 
to account for the truncation of long-range electrostatic interactions. To test the effect 
of long-range electrostatic interactions, in some simulations the RF was replaced 
by the particle-mesh Ewald (PME) method. The water was modeled using the SPC 
model (155). A time step of 2 fs was used. Bond lengths were constrained using the 
LINCS algorithm (156). The simulations were performed in the NP|PZT ensemble 
using periodic boundary conditions. The temperature was weakly coupled (coupling 
time 0.1 ps) to T = 320 K using the Berendsen thermostat (157). The pressure was also 
weakly coupled (coupling time of 1.0 ps and compressibility of 4.5 × 10-5), using 
a semi isotropic coupling scheme in which the lateral (P|) and perpendicular (PZ) 
pressures were coupled independently at 1 bar, corresponding to a tension-free state 
of the membrane. The simulation setup is similar to that used in previous studies 
of peptide-membrane interactions (34, 35). For a general review on MD studies of 
peptide-membrane interactions see the work of Mátyus et al. (158).
Analysis
The secondary structure of the peptides was calculated with the DSSP code (159). For 
the cyclic peptide, the bonded N-terminus (K1) and C-terminus (Q10), present in the 
turn region, were neglected while calculating the secondary structure. The structural 
properties were then calculated from the average number of residues involved in 
each secondary structural feature along the simulation. The total “β-structure” is 
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reported as the sum of β-sheet and β-bridge (one hydrogen bond less than β-sheet) 
and the “non-structured”, as the sum of coil, bend and turn. 
To analyze the alignment of the lysine residues, the distance between the planes 
formed by the Cα, Cγ and Nζ atoms of the spatially-symmetric lysine residues K1-K8, 
K2-K7 and K4-K5 were calculated.
Results
The cyclic peptide permeabilizes the membrane and has a preference for 
anionic lipids
The cyclic peptide BPC194 has a high antimicrobial activity (MIC values ranged from 
3.1-12 μM) and low hemolytic activity (not exceeding 17% at 375 μM) (139). A calcein 
dequenching assay was performed to determine the membrane permeabilizing 
activity of the cyclic peptide, BPC194, two cyclic analogues (BPC294 with Tyr and 
BPC418 with Trp instead of Phe at position 6) and the corresponding linear analogues 
BPC193, BPC293, BPC417 (Table 1).
Table 1. Names and sequences of the peptides used in this study.
Figure 1 summarizes the results obtained for the cyclic analog BPC194 and shows 
that it caused the leakage of calcein from vesicles comprising of anionic lipids. The 
leakage reached 100% in DOPG membranes though it did not exceed 5% in DOPC, 
even at high P:L ratios (Fig. 1A). Experiments with liposomes composed of mixtures 
of DOPG, DOPC and/or DOPE confirmed that the cyclic peptide (BPC194) has a 
preference for anionic lipids since the leakage increases with the content of DOPG 
lipids in the vesicles (Fig. 1B). Poration propensity of BPC194 in anionic lipids was 
independent of the vesicle size (Fig. 2)
Figure 1. Vesicle permeabilizing properties of peptides. Leakage of calcein as a function of peptide concentration 
is shown. (A) Circles: the action of BPC194 on DOPG and DOPC vesicles (filled and hollow symbols, 
respectively). Squares: data obtained with BPC193 with DOPG and DOPC vesicles (small filled and big 
hollow symbols, respectively). (B) Calcein dequenching results for BPC194 using liposomes of different 
lipid composition: DOPC, DOPG/DOPE 1:1 (mol/mol) and DOPG/DOPC 1:1 (mol/mol) and DOPG. The 
end-points of leakage at a peptide concentration of 52 μM and a lipid concentration of 6.7 μM are shown. 
Error bars indicate deviation between individual experiments (n = 3).
Cyclic Linear
Code Sequence Code Sequence
BPC194 c(KKLKKFKKLQ) BPC193 H-KKLKKFKKLQ-OH
BPC294 c(KKLKKYKKLQ) BPC293 H-KKLKKYKKLQ-OH
BPC418 c(KKLKKWKKLQ) BPC417 H-KKLKKWKKLQ-OH
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All three cyclic analogues caused the leakage of calcein for anionic membranes (Fig. 
3). These results are line with the in vivo data (139) and are consistent with the fact 
that bacterial membranes are generally more rich in negatively-charged lipids than 
the outer leaflet of the plasma membrane of higher eukaryotes, e.g. mammalian 
cells (40). The calcein leakage from vesicles was negligible for the linear analogues, 
irrespective of the lipid composition. The low antimicrobial activity of the linear 
peptide is consistent with the lack of membrane permeation in model membrane 
systems. Below, we focus on the interaction of the cyclic and linear analogues 
with anionic lipids to understand the remarkable differences in their membrane 
permeabilizing properties.
Figure 2. Vesicle permeabilizing propensity of BPC194 
with SUVs and LUVs. The percentage of leakage of DOPG 
vesicles is represented as a function of P/L ratio (lipid 
concentration constant at 10.6 μM). BPC194 has similar 
poration propensity with small unilamellar vesicles, SUVs 
(80 nm in size; full circles) and 200 nm large unilamellar 
vesicles, LUVs (open circles). 
Figure 3. Vesicle permeabilizing properties of the cyclic 
analogues BPC194, BPC294 and BPC418. The percentage 
of leakage of calcein from DOPG liposomes is represented 
as a function of peptide concentration at a final lipid 
concentration of 10.6 μM. Triangles, dotted line represent 
data for BPC194; circles, dashed line: BPC294; and squares, 
solid line: BPC418. In all cases the cyclic peptides had 
similar membrane-permeabilizing properties.
Both the linear and cyclic peptides bind to PG membranes 
To test whether the low activity of the linear peptides stems from their inability to 
bind to anionic membranes, we analyzed their membrane binding properties by 
MD simulations and fluorescence experiments. In the MD simulations, the peptides 
(BPC193 and BPC194) were placed in the water phase close to the surface of a DPPG 
bilayer at P:L ratios of 1:128, 4:128 and 9:128. Both peptides bound to the membrane 
rather fast and on similar (nanosecond) time scales (Figs. 4A and 4B). To validate 
the simulation data, the fluorescence of the tryptophan in BPC417 and BPC418 was 
used to monitor the interaction of the linear and cyclic peptides with the membranes. 
BPC417 and BPC418 bound to DOPG membranes albeit with different affinities (Fig. 
4C). BPC418 bound to the membrane with a Kd, of 7 +/- 2 μM (under these conditions 
the overall P:L ratio = 0.84). BPC417 bound with a Kd for DOPG of 96 +/- 10 μM 
(P:L ratio = 0.0625). From the data presented in Fig. 4C, one can derive P:L ratios at 
which the amount of cyclic and linear peptide bound is equal and compare these 
conditions with those in Fig. 1A. Even at equal amounts of peptide interacting with 
the membrane, the cyclic peptide is orders of magnitude more effective in membrane 
permeabilization than the linear one. For instance, when the cyclic and the linear 
peptide are ~ 60% bound (P:L ratio of around 0.6 and 0.06, respectively) the cyclic 
peptide causes ~ 50% of dye leakage, while the linear analog is not active.
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Both linear and cyclic peptides are structure-less in aqueous solution
To analyze the structure of the peptides in aqueous solution, atomistic MD 
simulations as well as CD measurements were performed. In the simulations, the 
cyclic and the linear peptide showed no defined secondary structure in aqueous 
solution and appeared mainly in a non-structured conformation (Figs. 5A and 5B). On 
average, only 13 and 16% β-structure was adopted by the cyclic and linear peptide, 
respectively (Table 2). Although we found that 50 ns of simulation were not sufficient 
for the peptides to completely sample their configurational space, the simulation 
data taken as a whole points to an unstructured conformation for both peptides in 
solution. The lack of secondary structure in the MD simulations was confirmed by 
CD measurements (Figs. 5I and 5J).
Figure 4. Binding of cyclic and 
linear peptides to PG membranes. 
(A) Time course of the simulation 
1Ca of BPC194 (pink) interacting 
with DPPG membranes. (B) Time 
course of the simulation 1Lb of 
BPC193 (purple). In both A and B, 
the head-group phosphorus atoms 
are shown in yellow, the lipid tails 
in grey and side-chains have been 
removed for clarity. (C) Percentage 
binding of BPC418 (solid black 
circles) and BPC417 (solid black 
squares) at 6 μM concentration to 
DOPG membranes assessed by 
ultracentrifugation and employing 
the fluorescence of tryptophan. Error 
bars denote the deviation between 
individual experiments (n = 4); the 
top X-axis: P:L ratios corresponding 
to lipid concentrations indicated at 
the bottom axis. Dashed line: the fit 
of the data used to obtain the Kd.
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Figure 5. Structure of peptides in water and upon membrane binding. Secondary structure plot in water as 
determined by the DSSP code and representative snapshot of BPC194 (A) and BPC193 (B). The colors 
associated with the secondary structural elements are red (β-sheet), yellow (turn), green (bend), black 
(β-bridge) and white (coil). In both snapshots, Lys residues are shown in orange, Phe and Leu in white and 
Gln in light pink. (C-E) Cyclic peptide DSSP plots of the simulations at P:L ratios of 1:128, 4:128 and 9:128, 
respectively. (F-H) Linear peptide DSSP plot of representative simulations at P:L ratios 1:128, 4:128 and 
9:128, respectively. (I) CD spectra of the cyclic BPC194 in aqueous buffer (black line) and in the presence of 
DOPG vesicles (red line) at a P:L ratio of 0.38. (J) CD spectra of the linear peptide BPC193 in buffer, in the 
presence of DOPG membranes (at P:L ratio 0.38) or a secondary structure inducer TFE (black, red and blue 
line, respectively). Peptides 0.15 mM, lipids 0.4 mM, TFE – 25% (vol/vol).
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Table 2. Overview of secondary structure and binding characteristics in all simulations performed on the 
cyclic (BPC194) and linear (BPC193) peptides. Results are averaged over all peptides present in the system, 
and over all independent simulations. The average binding depth as well as the maximum binding depth 
observed for a particular peptide is given. The standard errors reported are calculated from the standard 
deviation, between all peptides in all simulations. aCenter of mass of the peptide. bCenter of mass of the 
phenyl ring of the phenylalanine residue.





Peptide Deptha Phe Depthb
Av. Max Av. Max
Cyclic
Water Wa-Wc 3 87 ± 5 13 ± 5 - - - -
1:128 1Ca-1Cg 7 79 ± 3 21 ± 3 -0.34 ± 0.38 -1.16 -0.52 ± 0.65 -1.75
4:128 4Ca-4Cc 3 67 ± 4 33 ± 4 -0.08 ± 0.23 -0.99 -0.03 ± 0.29 -0.86
9:128 9Ca-9Cj 10 68 ± 2 32 ± 2 -0.24 ± 0.25 -1.2 -0.57 ± 0.20 -1.4
Linear
Water Wd-Wk 8 84 ± 4 16 ± 4 - - - -
1:128 1La-1Lb 2 100 ± 0 0 ± 0 -0.18 ± 0.25 -0.78 -0.10 ± 0.41 -0.85
2:60 2La-2Lb 2 - - - - - -
4:128 4La-4Lb 2 100 ± 0 0 ± 0 -0.10 ± 0.18 -0.75 0.50 ± 0.23 -0.46
9:128 9La-9Lg 7 99 ± 0 1 ± 0 0.41 ± 0.19 -0.62 0.52 ± 0.19 -1.37
Cyclic peptide adopts β-structure upon binding to membranes 
Upon interaction of BPC194 with the DPPG membrane surface, a secondary structure 
was induced within nanoseconds in the simulations (Fig. 5C-E). The average fraction 
of β-structure increased from 13% to 32% (Table 2). The increase in β-structure was 
most pronounced at the higher P:L ratios of 4:128 and 9:128. Visual inspection of 
the MD simulations of BPC194 showed that the β-structure formation gives rise 
to an amphipathic-like structure with a spatially-symmetric arrangement of two 
pairs of lysine residues: K1-K8 and K2-K7 on opposite strands. When the peptide 
adopted a β-structure, these lysine pairs aligned in a parallel manner and gave rise 
to a high charge density (Figs. 6A and 6B). When the intra-strand hydrogen bonds 
were weakened and the β-structure was lost, the lysine residues could point away 
from each other (Fig. 6C). On average, the distances between the lysine pairs at the 
membrane interface were reduced from 1 nm (in aqueous medium) to about 0.7 nm. 
Upon addition of DOPG membranes, a substantial change in ellipticity of BPC194 
was observed (Fig 5I); similar behavior was seen for the tryptophan (BPC418) and 
tyrosine containing (BPC294) cyclic peptides but not for the linear analogues (Fig. 
7). The CD spectra of the cyclic peptides in the presence of DOPG are reminiscent of 
β-sheet and β-turn structures reported for other (cyclic) peptides (160-162). However 
a quantitative deconvolution of the spectra is difficult as CD spectra simulators are 
designed for large proteins rather than cyclic small peptides. Unfortunately, it is not 
possible to perform solution-state NMR measurements on the membrane-associated 
states of the peptides, since the molecular mass of the vesicles to which the peptides 
are associated is so large that any NMR signal of the peptide would be broadened 
beyond detection.
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Figure 6. Different binding modes of the cyclic peptide. The lysine residues are depicted in grey, the head-
group phosphorus atoms are represented as spheres and the acyl tails in grey. (A-B) In certain binding 
modes during the simulation, the lysine residues aligned with inter-strand hydrogen bonds (dashed grey). 
(C) In others, the lysines snorkelled out independently and the inter-strand distances increased.
Figure 7. Secondary structure of cyclic peptide analogues. CD spectra of BPC294 (A), BPC418 (B) and BPC194 
(C) in aqueous buffer (black line) and in the presence of DOPG liposomes (grey line) at P:L ratios of 1.5, 
0.3 and 0.3, respectively. The peptide concentration was 0.15 mM, the lipid concentration 0.1 mM (A) and 
0.4 mM (B and C). The spectra of BPC418 suffered from high scattering due to fusing vesicles and were 
acquired at lower lipid concentrations. The CD spectra of small cyclic peptides are difficult to deconvolute 
because of the contributions of different turns and aromatic residues, and the lack of experimental 
structural data such as X-ray and NMR. On the basis of our MD simulations and the fact that the recorded 
spectra are reminiscent of β-sheet and β-turn, we conclude that the peptides upon interaction with DOPG 
vesicles undergo folding.
The inactive linear peptide remains structure-less at the membrane surface
In contrast to the cyclic peptide, the linear analogue remained fully unstructured 
(Figs. 5F-H) with no intra-molecular hydrogen bonding at the DPPG membrane 
interface at P:L ratios of 1:128 and 4:128 (Table 2). At the highest P:L ratios (9:128) 
a few intermolecular interaction were observed, resulting in peptide clusters. This 
gave rise to some β-sheet characteristics on the interacting peptides, originating 
mainly from interactions of the peptide backbone and the glutamine side-chain. The 
CD measurements were entirely consistent with the MD simulations (Figs 5J). 
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The cyclic and linear peptides differ in membrane penetration
BPC194 was able to penetrate deeper into the phospholipid membrane than its linear 
counterpart. In the MD simulations, the distances between the phosphorus atoms of 
the outer leaflet and the centre of mass of the peptide were calculated and are plotted 
in Figs. 8A-D. The cyclic peptide BPC194 was able to insert below the level of the 
phosphorus atoms (see Table 2). Though a single peptide (P:L 1:128) appeared on 
average to bind deeper (-0.34 nm) compared to systems with P:L ratios of 4:128, 9:128 
(-0.08 nm and -0.24 nm), the maximum insertion for individual peptides was at P:L 
ratio of 9:128 (-1.20 nm). Visual inspection of the trajectories showed that large values 
of insertion of the cyclic peptide were associated with high local perturbations, which 
led to poration of the membrane (163).The fluctuations in the outer leaflet, calculated 
as the deviation of the phosphorus atoms of the head-groups from their center of 
mass were ± 0.44 nm for the cyclic peptide. In contrast to the cyclic peptide, the linear 
analogue BPC193 did not embed very deep. The maximum insertion observed was 
-0.62 nm below the level of the phosphorus atoms and was not accompanied by large 
bilayer perturbations. Furthermore, low perturbations were seen in comparison to 
the cyclic peptide and the outer-leaflet fluctuations were ± 0.29 nm for the linear 
peptide.
Next, we examined the environment of the tryptophan from fluorescence emission 
spectra. The peptide that was initially in buffer was exposed to DOPG vesicles, 
which resulted in a blue-shift of the fluorescence emission peak (λmax) of ~14 and ~10 
nm for the cyclic and linear peptides, respectively (see Figs 8E and 8F; at these P:L 
ratios essentially all peptides are bound). The larger blue-shift for the cyclic peptide 
points to a more hydrophobic environment and thus to a deeper insertion into the 
membrane. Increasing the ionic strength resulted in a shift of the λmax of the linear 
peptide back to what it was in the aqueous medium, which is indicative of reversible 
binding. The salt effect was not observed for the cyclic peptide, and even at the highest 
P:L ratio of 0.88 (where about 50% was bound (Fig. 4C) and the membranes were 
saturated with peptide), the backshift of λmax was only marginal (Fig. 8G). Thus, the 
salt effects are also consistent with a deeper insertion of the cyclic peptide, BPC418, 
as compared to the linear one. It has been reported that certain peptides (e.g pep-1) 
(164) can translocate through the membrane without causing leakage/poration. We 
believe that the shallow and reversible membrane-embedding of BPC193 (incl. MD 
simulations and much less pronounced fluorescence blue-shift of the linear peptide 
as compared to the cyclic counterpart) argue against such possibility for the linear 
peptides. 
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Figure 8. Depth of insertion of cyclic and linear peptides to PG membranes and peptide environment changes. (A-D) 
MD simulations of peptides. Distance between the centre of mass of the peptides BPC193 (A) and BPC194 
(B) and the phosphorus atoms of the DPPG bilayer at different P:L ratios: 1:128 (solid line), 4:128 (dashed 
line) and 9:128 (dotted line). At higher P:L ratios, the distances plotted are the averages of all peptides 
in the system. (C-D) Distance between the phenylalanine residue and head-group phosphorus atoms. 
The zero value was taken as the interface boundary (horizontal solid line). (E-G) Peptide environment 
assessed by Trp fluorescence. Wavelengths of tryptophan fluorescence emission maxima (λmax) of BPC418 
(circles, solid line) and BPC417 (squares, dashed line) in buffer (first data point), upon addition of DOPG 
membranes (arrow), and following titration with NaCl up to 350 mM. The peptide concentration was 2 
μM; DOPG was added at different concentrations, yielding (E) P:L = 0.0073, (F) P:L = 0.071 and (G) P:L = 
0.88.
Discussion
Molecular mechanism of pore formation
Based on our results, we propose here a molecular-detailed model outlining the 
differences in mode of action of the cyclic and linear peptides (schematically presented 
in Fig. 9). Both peptides when present in the aqueous phase are mainly unstructured 
and have a propensity to bind to (anionic) membrane surfaces. From this point on, 
the behavior of the two peptides diverges. The cyclic peptide has a larger tendency to 
fold, enabling it to insert deeper into the membrane interface. Through cooperative 
interactions, some of these membrane-embedded and folded cyclic peptides cause 
large perturbations in the bilayer. The linear peptide assumes a more extended 
conformation and is unable to perturb the membrane substantially. Finally, the 
cyclic peptide is able to porate the vesicles and cause dye leakage while the linear 
is unable to do so. The model highlights the structural and partitioning differences 
of two related peptides with the same sequence but varying antimicrobial activity 
and thereby point to the critical features required for high antimicrobial activity. The 
mechanistic model proposed here resembles the one described for gramicidin S in 
the sense that the cyclic peptide interacts with the membrane, adsorbs to the bilayer 
surface, folds and gets inserted into the hydrophobic core of the membrane (165). 
However, for BPC194 the poration has been confirmed experimentally and evaluated 
31
2
Structural basis for the enhanced activity of cyclic antimicrobial peptides: The case of BPC194
with molecular detail by MD simulations (163). The results of our study provide 
important clues for rational design of novel cyclic antimicrobial peptides (work in 
progress).
Figure 9. A schematic view of the mechanism of action. Left: The cyclic peptide BPC194 (pink); right: the linear 
analogue BPC193 (purple). The five possible thermodynamic states (stable or metastable) are: aqueous-
unfolded, membrane-adsorbed, folded, inserted and porated. The equilibrium is shifted to the right for 
the cyclic peptide BPC194 and the porated state is the most favorable one. For the linear analogue BPC193, 
the membrane-adsorbed is the most favored state and the peptide remains unfolded at the surface of the 
membrane.
Folding and insertion of BPC194 at the membrane interface 
The cyclization of the peptides that were studied is not linked to gain of structure in 
solution. However, upon membrane binding the cyclic peptide assumes a β-structure 
structure unlike the linear one. For BPC194, the β-structure gives rise to a spatially-
symmetric arrangement of the lysine pairs, resulting in an amphipathic-like structure, 
a conformation that was seen also for gramicidin S (166). The linear peptide has 
larger conformational entropy, and folding of the backbone to a β-hairpin structure 
is less favorable than in the cyclic peptide. The structure formation and consequently 
a deeper insertion of the cyclic peptide was accompanied by local perturbations of 
the membrane-leaflet and could be linked to its higher charge density, compared to 
BPC193. The lower charge density of the linear peptide and the formation of peptide 
clusters may prevent the linear peptide from substantially perturbing or embedding 
into the membrane. A correlation between high charge density and poration has been 
previously seen for cyclic analogues of linear antimicrobial peptides (167).
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Folding of BPC194 is reminiscent of folding in linear β-hairpin peptides
A very important aspect of this work is the prediction of the peptide folded states at 
the membrane interface by MD simulations and supported by CD studies. Predicting 
the correct folds and folding pathways of (poly)peptides, even short ones, remains a 
challenge. Folding of peptides into β-hairpins has been used as a paradigm for protein 
folding and a large number of pathways such as zip-in, zip-out and middle-out have 
been proposed (168-170). Multiple, long simulations and enhanced sampling methods 
have often been used to probe the folding events. In contrast, in the simulations 
presented here, folding at the membrane surface is sampled within nanoseconds 
after the peptide binds to the membrane. While kinetics at membrane interfaces is 
usually slow, the ‘fast-folding’ observed here is due to the limited phase-space of 
the cyclic peptide. For BPC194, only three hydrogen bonds are present in the folded 
state and due to cyclization, the backbone atoms involved in these hydrogen bonds 
are close together even in the unfolded state. In water, the peptide is non-structured 
because the thermal fluctuations are enough to break these three backbone hydrogen 
bonds that are then compensated by the neighboring water molecules. However, at 
the membrane interface the backbone atoms (that are always spatially close) form 
the three hydrogen bonds because of lack of other hydrogen-bond partners and the 
lower polarity of the membrane leading to the peptide adopting the folded state very 
fast. The folding is reminiscent of the zip-in model described for linear β-hairpins, 
whereby the ends first approach each other and then the hydrogen bonds are formed.
Conclusions
In conclusion, there is now compelling evidence that cyclization of certain sequences 
of membrane-active peptides enhances their antimicrobial performance. In this 
paper, we analyze the molecular basis for activity in a cyclic antimicrobial peptide, 
BPC194 by comparing the mechanism of action of the active and inactive analogues. 
We show that the molecular basis for the enhanced activity resides most likely in 
the restriction of the number of conformations in the cyclic peptide. We show that 
it can adopt a favorable orientation towards the membrane and acquire an ordered 
structure that allows a high charge density and amphipathic arrangement. The latter 
allows the cyclic peptide to locate itself deeper in the membrane as well as to perturb 
it more than its linear counterpart. Thus, the alignment of lysine residues on opposite 
strands leads to a high charge density and an amphipathic arrangement. We propose 
that these structural and partitioning behavior determined here are related to the 
difference in poration propensity and thus the antimicrobial activity. 
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Table 3. Summary of details of all the simulations performed on the cyclic (BPC194) and linear (BPC193) 
peptides together with secondary structure content during the simulation. The averages and standard 

















Wa Cyclic Random 43a2 - RF 50 85 15
Wb Cyclic Random 43a2 6 Cl- PME 50 99 1
Wc Cyclic Random 53a6 6 Cl- PME 100 77 23
Average Cyclic - - - - - 87 ± 5 13 ± 5
Wd Linear α-helix 43a2 - RF 160 72 27
We Linear α-helix 53a6 6 Cl- PME 30 96 4
Wf Linear Bend 43a2 - RF 54 90 10
Wg Linear Bend 43a2 6 Cl- PME 50 92 8
Wh Linear Bend 53a6 6 Cl- PME 100 94 6
Wi Linear Extended 43a2 - RF 55 90 10
Wj Linear β-hairpin 53a6 6 Cl- RF 100 68 32
Wk Linear β-hairpin 53a6 6 Cl- PME 100 66 33
Average Linear - - - - - 84 ± 4 16 ± 4
1:128
1Ca Cyclic Random 43a2 - RF 80 91 9
1Cb Cyclic Random 43a2 - RF 50 90 10
1Cc Cyclic Random 43a2 - RF 50 70 30
1Cd Cyclic Random 43a2 - RF 50 87 13
1Ce Cyclic Chair 43a2 - RF 50 76 24
1Cf Cyclic Chair 43a2 - RF 50 73 27
1Cg Cyclic Chair 43a2 - RF 50 69 31
Average Cyclic - - - - - 79 ± 3 21 ± 3
1La Linear Bend 43a2 - RF 40 99 1
1Lb Linear Extended 43a2 - RF 100 100 1
Average Linear - - - - - 100 ± 0 100 ± 0
2:60
2La 2 linear α-Helix 43a2 - RF ~200 70 30
2Lb 2 linear α-Helix 43a2 - RF ~200 60 40
4:128
4Ca Cyclic Random 43a2 - RF 100 69 30
4Cb Cyclic Random 43a2 24 Cl- RF 100 63 37
4Cc Cyclic Random 43a2 24 Cl- PME 40 68 32
Average Cyclic - - - - - 67 ± 4 33 ± 4
4La Linear Extended 43a2 24 Cl- RF 100 ~100 ~0
4Lb Linear Extended 43a2 24 Cl- PME 40 100 0
Average Linear - - - - - 100 ± 0 0 ± 0
9:128
9Ca Cyclic Random 43a2 - RF 160 63 37
9Cb Cyclic Random 43a2 - RF 20 62 38
9Cc Cyclic Random 43a2 - RF 30 61 39
9Cd Cyclic Random 43a2 - RF 30 73 27
9Ce Cyclic Random 43a2 54 Cl- RF 90 70 30
9Cf Cyclic Random 43a2 54 Cl- RF 75 76 24
9Cg Cyclic Random 43a2 54 Cl- RF 75 65 35
9Ch Cyclic Random 43a2 54 Cl- PME 36 66 34
9Ci Cyclic Random 43a2 54 Cl- PME 32 72 28
9Cj Cyclic Random 43a2 54 Cl- PME 32 69 31
Average Cyclic - - - - - 68 ± 2 32 ± 2
9La Linear Extended 43a2 - RF 142 ~100 ~0
9Lb Linear Extended 43a2 - RF 100 99 1
9Lc Linear Extended 43a2 - RF 41 100 0
9Ld Linear Extended 43a2 - RF 35 98 2
9Le Linear Extended 43a2 54 Cl- RF 87 99 1
9Lf Linear Extended 43a2 54 Cl- RF 85 98 2
9Lg Linear Extended 43a2 54 Cl- PME 24 99 1
Average Linear - - - - - 99 ± 0 1 ± 0
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The mechanism of action of antimicrobial peptides is still poorly understood. To probe the biophysical 
characteristics that confer activity, we present here a molecular-dynamics and biophysical study of a cyclic 
antimicrobial peptide and its inactive linear analogue. In the simulations, the cyclic peptide caused large 
perturbations in the bilayer and cooperatively opened a disordered toroidal pore, 1-2 nm in diameter. 
Electrophysiology measurements confirm discrete poration events of size 1-2 nm by the cyclic peptide. We 
also show that lysine residues aligning parallel to each other in the cyclic but not linear peptide are crucial 
for function. By employing Dual-Color Fluorescence Burst Analysis (DCFBA), we show that both peptides 
are able to fuse/aggregate liposomes but only the cyclic peptide is able to porate them. The results provide 
detailed insight on the molecular basis of activity of cyclic antimicrobial peptides.
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Introduction
How antimicrobial peptides (AMPs) kill bacteria by interacting with the cell 
membrane is not fully understood. These peptides, often small and cationic, are 
secreted into the aqueous phase, usually in an unfolded state and bind quickly to the 
target membrane, where secondary structure may be induced (24, 127, 130, 131, 171-
174). At a certain threshold concentration antimicrobial peptides permeabilize the 
membrane, either by forming a discrete pore or by disrupting the bilayer structure 
(25, 28, 40, 127, 130, 132, 133, 167, 173, 175-179). For linear α-helical peptides the 
barrel-stave and toroidal-shaped model have been proposed as pore structures (29, 
33, 73, 127, 167, 171, 180). In addition, a disordered toroidal pore has been proposed 
for linear antimicrobial peptides from molecular dynamics (MD) simulations (34, 35, 
181).
Cyclic AMPs have emerged as good antimicrobial candidates due to their robust 
secondary structure and high activity (165, 182, 183). Gramicidin S, a cationic 
decapeptide, is one of the best studied cyclic AMPs (165, 182, 184-186) and has been 
shown to permeabilize bilayers but not to stabilize well-defined pores (187). MD 
simulations in DMSO solution (188) and with DMPC bilayers (189) have shown 
that gramicidin S has a relatively rigid backbone conformation, but no poration 
events were seen in the simulations. Arginine-rich cyclic peptides have been shown 
to assemble into nanotubes and extrude the bilayer in MD simulations (190). In 
general, the molecular details of the action of cyclic AMPs, such as whether these 
short peptides can open and stabilize pores, as well as the molecular basis for their 
increased activity is still unclear.
The focus of our work is a cyclic antimicrobial peptide, BPC194 that was chosen as 
the best candidate from a library of de novo synthesized cyclic peptides (139, 140). 
The cyclic peptide shows a high antimicrobial activity to different plant pathogenic 
bacteria (Erwinia amylovora, Pseudomonas syringae and Xanthomonas vesicatoria). 
Here, we present a combined MD and biophysical study of the cyclic peptide 
interacting with anionic lipid bilayers to understand its mechanism of action. The 
linear analogue BPC193, which is not active, has also been studied allowing us to 
reveal the functionally - important structural characteristics. We show that the only 
cyclic peptide is able to form pores in anionic membranes in line with its enhanced 
antimicrobial activity. The pore size was validated by three independent approaches 
- MD simulations, electrophysiology and DCFBA fluorescence imaging. We further 
extract the functionally - relevant structural properties and show the importance of 
charged residues in forming and stabilizing pores. Finally, an intermediate state was 
identified which is close to the real transition state during pore formation. 
Materials and methods
Molecular Dynamics Simulations
System set-up. MD simulations were performed for systems containing 9 peptides 
(BPC194 c(KKLKKFKKLQ); BPC193 KKLKKFKKLQ) and a fully solvated DPPG 
(dipalmitoyl-phosphatidylglycerol; anionic lipid) bilayer. The simulations were 
carried out at a peptide:lipid (P:L) ratio of 9:128 for both cyclic and the linear 
analogues together with 6000~8000 water molecules and 128 K+ as counter-ions for 
anionic lipids. The peptides were initially placed in the water phase at a distance 
of 1.5-2.3 nm from the membrane surface. The initial structure of the peptides was 
modeled using the leap module of AMBER 9 (146), as unstructured peptides with 
no intra-molecular hydrogen bonds. Multiple simulations were run from different 
initial random velocity distributions (Table 1).
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Set-up for transition state simulations. A snapshot at 109 ns was taken from the 
simulation 9Ca (Table 1), as an example of the transition state. From this system, ten 
simulations were performed with different initial velocity distributions. The transition 
state was also modified to substitute the cyclic peptide for the linear analogue. This 
substitution was made by cutting the peptide bond between N-terminal residue and 
the C-terminal residue, as well as adding the corresponding missing atoms. The 
system was simulated as a linear peptide but with the initial conformation of the cyclic 
peptide (so called hairpin conformation). Further, a harmonic potential was applied 
to the linear peptide to pull the N-terminal from C-terminal to obtain a random-coil 
conformation in the transition state. For the modified systems, a minimization was 
carried out followed by an equilibration with constraints on phosphorus atom and 
water molecules to keep the position of the transition state. Ten simulations were run 
for the hairpin conformation and two of the random-coil conformation by changing 
the starting random velocities.
Analysis. The secondary structure of the peptides was calculated by using the DSSP 
code (159). For the cyclic peptide, the N-terminal residue K1 and C-terminal residue 
Q10 that are present in the turn region, were neglected while calculating the secondary 
structure. The structural properties were then calculated from the average number 
of residues involved in each secondary structural feature along the simulation. The 
total b-structure is reported as the sum of b-sheet and b-bridge and the total non-
structured as the sum of coil bend and turn. The persistence of structure over time 
was calculated as the percentage of time the b-structure was present.
Simulation parameters. All MD simulations were performed with the GROMACS 
software package (147). The peptide and peptide–solvent interactions were 
described by the GROMOS force-field 43a2 (148). The force-field for DPPG lipids was 
optimized from DPPC (150) and POPG lipids (151), compatible with the GROMOS96 
parameters. The choline head-groups were replaced by glycerol from the POPG force-
field, and the tail parameters were taken from the DPPC force-field. The parameters 
were then optimized to achieve an area per lipid consistent with experiment (152). 
The equilibrated DPPG bilayer had a thickness of 3.54 ± 0.05 nm and an area per lipid 
of 0.69 ± 0.01 nm2. The force-fields have been parameterized for use with a group-
based twin range cut-off scheme (using cutoffs of 1.0/1.4 nm and a pair-list update 
frequency of once per 10 steps), including a reaction field (RF, (154)) correction with 
a dielectric constant of 78 to account for the truncation of long-range electrostatic 
interactions. The water was modeled using the SPC model (155). The simulations 
were performed using periodic boundary conditions and a time step of 2 fs was used. 
The temperature was weakly coupled (coupling time 0.1 ps) to T = 320 K, using the 
Berendsen thermostat (157). The pressure was weakly coupled (coupling time of 
1.0 ps and compressibility of 4.5 × 10-5), using a semi-isotropic coupling scheme in 
which the lateral (P|) and perpendicular (PZ) pressures are coupled independently at 1 bar, corresponding to a tension-free state of the membrane. The simulation setup is 
similar to that used in previous studies of peptide-membrane interactions (34, 35, 42). 
For a general review on MD studies of peptide-membrane interactions see the work 
of Mátyus et al. (158).
Biophysical Characterization
Electrophysiology measurements. A planar lipid bilayer setup was used as described 
below. The bilayer was formed by painting with 1 μl of a 20 mg/ml solution of 
DOPG lipid (1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol, Avanti Polar Lipids) in 
n-decane (Aldrich) across the 250 μm opening of a Delrin cup that separates two 
solution-filled compartments, designated cis and trans (191-193). Both compartments 
were filled with a buffer solution consisting of 10 mM HEPES (2-(4-(2-hydroxyethyl)-
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1-piperazinyl)-ethanesulfonic acid, (Roche Diagnostics GmbH), pH 7.0, containing 
150 mM NaCl (Merck), further referred to as buffer A. The planar bilayers were 
stable at the voltages applied during the experiment. The transmembrane current (Im) 
under different applied potentials (V) was monitored, using an integrating Bilayer 
Clamp Amplifier BC-535 (Warner Instruments). Currents were filtered through 
an 8-pole low-pass Bessel Filter LPF-8 (Warner Instruments) and digitized using 
Clampex 10.2 software (Axon Molecular Devices). Membrane conductance (Gm) 
events were identified as Gm = Im/V and analyzed with the Clampfit software (Axon Molecular Devices) (194). The peptides at 3 and 10 μM were added to the cis side of 
the planar lipid bilayer and stirred for 1 minute without applying voltage. In some 
cases a voltage of ± 40 mV was applied to pre-activate the peptide and decrease 
the time needed to observe activity. Subsequently, the conductance was recorded at 
different voltages ranging from 0 to ± 50 mV. A total of 10 traces were recorded each 
with freshly prepared DOPG membranes. The pore diameter was estimated by an 
extended version of the model proposed by Hille (66, 195) given by (196):
Eq. 1
where, d is the diameter of the pore, ρ is the resistivity of the buffer, g is the measured 
conductance and l is the length of the pore. The resistivity of the buffer A was assumed 
to be 80 Ωcm (66). The length of the pore equals the membrane thickness and was 
assumed to be 3.5 nm.
Dual-color fluorescence burst analysis. In the DCFBA experiment, liposomes were 
labeled with two, spectrally non-overlapping fluorescent probes (37). One probe was 
incorporated in the phospholipid bilayer, while the other filled the aqueous interior 
of the liposome. By using a dual-color laser-scanning microscope, we monitored 
membrane disrupting effects at the single liposome level. The results are presented in 
the DCFBA profiles as the population-distribution histogram of liposomes with a 
given internal marker concentration, Ci, given by:
Eq. 2
where, IL is the fluorescence of the lipid marker and ISM is the fluorescence of the 
internal size marker in each fluorescence burst (38).
The average fluorophore population, Pfluorav, is given by:
Eq. 3
where, Ifluor is the fluorescence intensity of each peak above a given threshold for 
every P:L ratio, I0fluor is Ifluor at P:L = 0, Npeaks is the number of peaks at every P:L ratio and N0peaks is Npeaks at P:L = 0. The relative population of the internal size marker, PSMrel, is given by:
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Eq. 4
where, PSMav is the average internal marker population and Pmembrav is the average 
membrane fluorophore population.
DCFBA assay. Liposomes were prepared as described by van den Bogaart (37). 
Briefly, DiD (1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarbo-cyanine perchlorate; 
Invitrogen) labeled-liposomes were prepared by rehydration of a dried lipid film 
in the presence of glutathione (GSH)-labeled Alexa Fluor 488 (AF488, Invitrogen) 
as a aqueous phase marker in buffer A. The DiD/DOPG molar ratio was 1:12,000. 
Subsequently, the liposomes were extruded 11 times through a 200 nm polycarbonate 
filter (AVESTIN, Canada). The liposomes were separated from the non-encapsulated 
fluorophores by centrifugation (20 min, 270,000 × g, 20ºC) and resuspended in 
buffer A to a final concentration of 5 mg/ml DOPG. Fluorescence burst analysis was 
carried out on a laser-scanning confocal microscope (197), as described by van den 
Bogaart (37, 133, 198). Different amounts of peptide were added to 64 μg/ml DOPG 
liposomal solutions, yielding final peptide-lipid ratios from 1/52 to 5/1. The samples 
were equilibrated for 10 minutes at room temperature after each addition of peptide. 
The fluorescence bursts were measured for 10 min. To estimate the size of the pore, 
a size marker was encapsulated inside the DiD-labeled vesicles, i.e., 10 kDa dextran 
labeled with fluorescein (Invitrogen).
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Results and discussion
The cyclic peptide causes large perturbations in DPPG bilayers
To probe the poration propensity of BPC194, we performed simulations of the 
peptides interacting with a DPPG bilayer at a P:L ratio of 9:128. DPPG bilayers 
were chosen since the peptide is antimicrobial (characterized by anionic lipids) with 
low hemolytic activity (characterized by zwitterionic lipids). The time course of a 
particular simulation (Table 1, 9Ca) is depicted in Figure 1A, but similar behavior 
was observed in the remaining simulations (Table 1, 9Cb-Cg). The peptides were 
initially placed in the water layer close to the bilayer (0 ns) and subsequently bound 
fast (~5 ns) to the membrane interface. During the simulation, most of the peptides 
remained bound at the interface though, a few peptides were able to cooperatively 
perturb the outer leaflet and consequently insert deeper (Figure 1A, 16-60 ns). In the 
perturbed state, the positively-charged residues of the peptides interacted with the 
closest head-group moieties and pulled them, together with some water molecules, 
into the core of the membrane. The peptide-free inner leaflet was also affected by 
the action of the cyclic peptide bound on the outer leaflet. This behavior was seen 
repetitively during the simulation and was usually followed by a relaxation of both 
leaflets. Occasionally, a much larger perturbation occurred (109 ns), characterized by 
a decrease in the local lipid-chain order (Figure 2A). At this point, the perturbation 
was caused by a cooperative effect of three peptides, one of which adopted a 
transmembrane-orientation with its glutamine residue close to the centre of the 
hydrophobic core. In this position, the glutamine residue interacted with some head-
group atoms of the inner leaflet. During this perturbation, a few water molecules 
were able to cross the membrane. However, the inner leaflet relaxed again and the 
orientation of the glutamine residue reverted back to the interface (Figure 1A, 115 
ns). Only smaller perturbations of the membrane were observed in the remainder of 
the simulation.
Table 1. Overview of the MD simulations performed.
Code System Electrostatic Regime Counter-ions Time (ns)
9Ca Cyclic RF - 160
9Cb Cyclic RF - 20
9Cc Cyclic RF - 30
9Cd Cyclic RF - 30
9Ce Cyclic RF 54 Cl- 90
9Cf Cyclic RF 54 Cl- 75
9Cg Cyclic RF 54 Cl- 75
9La Linear RF - 140
9Lb Linear RF - 100
9Lc Linear RF - 40
9Ld Linear RF - 35
9Le Linear RF 54 Cl- 90
9Lf Linear RF 54 Cl- 85
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The cyclic peptide can form a disordered toroidal pore
In our previous simulations of AMP action (34, 35), the first event during pore 
formation was the bridging of the two leaflets by a peptide. Although such an 
orientation of the peptides was seen in simulation 9Ca (Figure 1A, 109 ns), it did not 
lead to a porated state. Nevertheless, we expect this highly perturbed state to be an 
intermediate, mimicking the transition state toward pore formation. To sample the 
conformational space around this so-called “transition state”, ten simulations were 
set up; the velocities in the system were varied to provide a different direction on the 
potential energy surface that may lead to pore formation. Indeed, a pore was formed 
in six out of ten simulations; for details see Table 2 (C1-10). The mechanism of the pore 
formation is depicted in Figure 1B, using C9 as a representative of all simulations. 
The first time point (0 ns) was taken as the transition state from which the simulation 
was started (cf. Figure 1A, 109 ns). Water molecules readily inserted into the bilayer 
and finally after 1~2 ns, some water molecules crossed the bilayer to open a water 
channel. Head-group atoms of both leaflets moved inside the membrane core to line 
the water channel. From then on, the pore remained open and the lipid head-groups 
of both leaflets rearranged to form a disordered toroidal-shaped pore around 25 ns. 
The size of the water channel fluctuated both in time as well as along the direction 
of the pore axis, ranging between ~1 and 2 nm (see Figures 1B, 65 ns and Figure 
2B-C). The pores formed in our simulations could be characterized as disordered 
toroidal pores with the peptides residing in different positions and orientations. In 
all cases, the pore was stabilized by three peptides; a dimer and a monomer, with the 
remaining peptides lying close to the pore. No peptide translocation was seen in the 
nanosecond time regime of the simulations.
Table 2. Overview of the ten simulations starting from the transition state with the cyclic peptide (C1-C10) 
















C1 2-3 ns DTP Stabilization HG 20 ns ± 0.50 29.9 3 40
C2 4 ns DTP Stabilization HG 12 ns ± 0.50 34.5 3 40
C3 4 ns DTP Stabilization HG 17 ns ± 0.52 36.7 3 40
C4 - No pore Perturbations afterwards ± 0.46 34.2 - 40
C5 1 ns DTP Stabilization HG 20 ns ± 0.54 34.2 3 40
C6 - No pore Perturbations afterwards ± 0.40 34.1 - 40
C7 - No pore Perturbations afterwards ± 0.48 32.8 - 40
C8 - No pore Perturbations afterwards ± 0.43 33.1 - 40
C9 1-2 ns DTP Stabilization HG 10 ns ± 0.59 33.4 3 125
C10 1-2 ns DTP Stabilization HG 10 ns ± 0.55 36.6 3 170
L1 25 ns DTP Stabilization HG 45 ns ± 0.47 33.2 1 50
L2 - No pore Relaxation ± 0.39 21.9 - 50
L3 - No pore Large Perturbations ± 0.48 16.1 1 50
L4 - No pore Relaxation ± 0.41 20.7 - 40
L5 - No pore Relaxation ± 0.38 19.8 - 40
L6 - No pore Relaxation ± 0.40 22.3 - 40
L7 20-30 ns DTP Stabilization HG 60 ns ± 0.54 22.2 1 150
L8 - No pore Relaxation ± 0.43 18.7 - 40
L9 - No pore Relaxation ± 0.45 26.7 - 60
L10 3-4 DTP Stabilization HG 45 ns ± 0.48 17.0 1 150
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Figure 1. The cyclic peptides cause large fluctuations in the membrane upon binding and can form a disordered 
toroidal pore. (A) Time course of the simulation 9Ca. At 0 ns all peptides were placed close to the bilayer and 
they bound within 5 ns. The first perturbation of the inner leaflet was seen at 16 ns, when some lipids were 
pulled into the bilayer due to the action of the cyclic peptide. The highest perturbation was at 109 ns and 
involved three peptides, one of which adopts a transmembrane orientation. The inner leaflet relaxed at 
115 ns. (B) The snapshot of the transition state (Fig. 1, 109ns) was taken as the starting structure (0 ns). An 
increase of the number of water molecules inserting into the bilayer was followed by the opening of a water 
channel (1-2 ns) and insertion of lipid head-groups further inside to form a toroidal-shaped pore (10-25 
ns). A stable toroidal-shaped pore was seen at 65 ns. The head-groups are depicted in yellow spheres. The 
peptide backbone is shown in pink, lipid tails in grey and water molecules in cyan. To clarify the briding of 
the two leaflets from transition state and on, the lysine residues (orange) and the glutamine residue (light 
pink) are shown only for the peptide in a transmembrane orientation. (C) Current traces recorded after the 
addition of BPC194 peptide to DOPG membranes. (D) I-V curves plotted from seven independent current 
trace recordings of BPC194.
Figure 2. (A) Lipids involved in the large 
perturbation show a decrease in their lipid-order 
parameter. Lipid-tail order parameters of the 
Sn2 chain obtained from simulation C9a. The 
order parameters are plotted for pure DPPG 
(solid black line) as a reference, peptide-free 
leaflet (dashed line) and peptide-associated 
leaflet (solid red line), and the peptide-
associated leaflets are divided between LP 
(Large Perturbation, dashed-dotted line) 
and not LP (not Large Perturbation, dotted 
line). The left plot shows the first simulation 
amongst 0-60 ns, where the peptides interacts 
and bind to membrane surface, and right plot 
the insertion till the largest perturbation occur 
(60-190 ns). (B-C) Pore features. (B) An example 
of the disordered toroidal pore (simulations 
C9). The peptides not directly involved in the 
pore are not shown for clarity. (C) The top view 
of the pore. The phosphorus atoms are colored in yellow spheres, the peptide backbone in pink and the 
lysine side-chain in orange. The water molecules that are present in the channel are depicted in cyan.
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Electrophysiology revealed that pore formation is specific for cyclic 
peptides
To monitor the pore formation of BPC194 ion fluxes in a planar lipid bilayer setup 
were measured. An example of a current trace recorded upon addition of BPC194 
to the cis compartment of the planar lipid bilayer setup is shown in Figure 1C. A 
voltage-dependent conductance was observed implying that a pore or channel 
was formed/opened. These conductance events were stable during the course of 
the recording, pointing towards the formation of discrete pores. The average I-V 
curve of all independent recordings is plotted in Figure 1D. The pore has an average 
unitary pore conductance of 0.61 ± 0.12 nS. Since the I-V curve is symmetric the pores 
formed by BPC194 are not ion selective. The diameter of the pore was estimated (see 
Eq. 1 from Materials and methods) to range between 1.5-1.9 nm. At higher peptide 
concentrations, we also observed higher overall conductance that was a multiple 
of the unitary conductance, reflecting the higher probability of pore formation. The 
same increase in probability of pore formation was observed on applying voltages 
higher than ± 50 mV. However, these extra poration events were transient with 
shorter dwell times.
The linear peptide does not perturb or porate DPPG bilayers substantially
Simulations of the linear analogue interacting with DPPG bilayers were performed 
under conditions identical to the cyclic peptide (Table 1, 9La-Lf). A typical time 
course of the simulation is depicted in Figure 3A. Upon binding, the linear peptides 
somewhat perturb the membrane, albeit much less than the cyclic ones. Larger 
perturbations leading to a transition state were not seen in any of the simulations 
with the linear peptide. Though the average thickness of the bilayer is similar for 
the two peptides (3.7 ± 0.1 nm for the linear and 3.6 ± 0.1 nm for the cyclic peptide), 
the perturbations in the outer leaflet are substantially higher when the cyclic peptide 
is attached. The fluctuations in the outer leaflet, calculated as the deviation of the 
phosphorus atoms of the head-groups from their center of mass are ± 0.44 nm for the 
cyclic peptide in comparison to ± 0.29 nm for the linear peptide. These results were 
supported by the electrophysiology measurements, in which the linear analogue 
did not show pore formation or ion flux through the membrane at the same voltage 
regime in which the cyclic peptide formed pores (Figure 3B).
Structure-Function relationship of the cyclic peptide
To investigate the relation between secondary structure and the ability of the peptides 
to stabilize a pore, we clustered the peptides depending on how far they lie from the 
pore and the role they play in stabilizing it (Figures 3A and 3B). Three classes of 
peptides were distinguished: those within the rim of the pore (distance 0.3 nm from 
the center of the pore, region 1), those lying at the mouth of the pore (within 0.3-1.5 
nm, region 2) and those not involved in the pore (further away than 1.5 nm, region 
3; Table 3). Peptides in region 1 adopt a stable secondary structure (40% b-structure) 
in all simulations where a pore is formed (six simulations). Although the number 
of residues involved in secondary structure varied between the three peptides, all 
three showed the longest persistence of b-structure over time (97%). The peptides 
belonging to region 2 also exhibited a high b-structure (39% for peptides of this 
region), but the percentage fluctuated over time and the persistence of b-structure 
was 89%. Finally, the peptides in region 3 exhibited multiple folds and adopted 
different conformations showing only 18% b-structure for the individual peptides.
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Figure 3. The linear peptides do not induce 
fluctuations in the membrane. (A) Time 
course of the simulation L9a. Initially 
(0 ns), all linear peptides were placed 
close to the outer leaflet. Within 10 
ns all peptides bound and remained 
at the membrane interface. No large 
perturbations were seen along the 
simulation (25-140 ns). The head-
groups of DPPG are depicted in yellow 
spheres, the peptide backbone in violet 
and lipid tails in grey. (B) Current traces 
recorded after the addition of BPC193 
peptide to DOPG membranes.
Figure 4. Secondary structure related to the 
distance at the rim of the pore and its function. 
(A) DSSP plot of the secondary structure 
of all peptides for simulation C9, taking 
the transition state as the 0 ns time 
point. (B) Top view of the pore showing 
the positions of the nine peptides. The 
phosphorus atoms of the outer leaflet 
are depicted as yellow spheres and the 
backbone is colored in pink. Region 1 
peptides are those involved in the pore 
(within dashed black line). The peptides 
that remain at the rim of the pore (region 
2) are delimited by the red dashed line. 
The peptides furthest from the pore 
(region 3) are outside the circles. (D)
Parallel arrangement of lysine residues 
in the β-structure (D) An example of 
the aligned lysine residues stabilizing 
the lipid curvature in the porated state 
(side-view of the pore). (E) The average 
distance between lysine residues K1-
K8 and K2- K7 (plotted as a sum) for 
peptides in regions 1, 2 and 3. The time 
scale to the left of the grey line refers to 
simulation 9Ca (before transition state 
formation 0-109 ns). The time frame to 
the right is an average for all simulations 
(C1-10) where a pore was formed with 
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Table 3. Secondary structure and distance from the centre of the pore for the peptides belonging to the three regions. 
The values reported are an average calculated from all simulations where a pore was formed. The time of 
persistence of β-structure (see Materials and Methods) is also reported. The standard errors reported are 
calculated from the standard deviation, between all peptides in all simulations.
The apparent importance of the b-structure for stabilization of the pore can be 
rationalized by considering the relative orientation of the lysine residues. As 
illustrated in Figure 4C, the b-structure gives rise to a parallel arrangement of the 
lysine pairs (K1-K8 and K2-K7) on the two strands that, presumably, facilitates the 
interaction of the lysines with the lipid head-groups in the curved geometry of the 
pore (Figure 4D). The distances between the lysine pairs K1-K8 and K2-K7 (plotted as 
a sum of the two values) for the three regions of the peptides is shown in Figure 4E. 
When the peptides are bound to the membrane (0-109 ns, till grey line), the value 
fluctuates for all three clusters of peptides. However, once the transition state is 
reached and later when a pore is opened (beyond grey line), the distance between 
the lysine pairs in the peptides in region 1 remained low, consistent with their high 
persistence of secondary structure. The value for the peptides in region 2 was also 
low at the transition state but increases as the pore relaxes. The peptides in region 3, 
which were not involved in the pore, showed the largest distance between the lysine 
pairs along the simulations.
Transition state alchemy: Why the linear peptide cannot stabilize pores
To test whether the b-strand conformation is indeed linked to activity, we repeated 
the simulations from the transition state with the linear peptide by in-silico alchemy, 
i.e. removing the peptide bond between the first and last residue. The results of these 
simulations are summarized in Table 2 (L1-10). In seven of the ten simulations, the 
bilayer relaxed and the linear peptide moved back to the interface. In the remaining 
three simulations, a water channel eventually opened. The time course of one of the 
poration events (L7) is depicted in Figure 5. Although we observed that the linear 
peptide is also able to stabilize a water pore (starting from the perturbations caused by 
the cyclic peptide), the pore differs from the pore formed in the presence of the cyclic 
peptides: i) Only one of the three peptides involved in the transition state remained 
embedded near the central pore region; and ii) The lipid head-groups did not line 
the pore as clearly as in the case of the cyclic peptide. In most of the simulations, 
the average percentage of b-structure dropped to a value around 20%, compared 
to > 30% for the cyclic peptide (cf. Table 2, C1-C10). In the simulations in which a 
pore was formed, the peptide in closest vicinity of the pore preserved a somewhat 
higher percentage of b-structure (~28%). Two additional unbiased transition state 
simulations of the linear peptide in its native random-coil conformation were 




5 0.09 ± 0 20.7 45.7 10.3 23.4 94.8
7 0.09 ± 0 19.6 47.9 8.4 24.1 98.4
9 0.09 ± 0 25.2 26.2 45.4 3.4 97.7
Average 0.09 ± 0 22 ± 1 40 ± 6 31 ± 11 17 ± 6 97 ± 1
2
2 0.30 ± 0.05 29.9 43.8 2.8 23.6 92
3 0.78 ± 0.15 24.8 42.8 12.0 20.4 92.6
6 1.10 ± 0.15 36.0 32.2 14.2 16.5 91.7
8 1.50 ± 0.23 30.0 39.1 10.9 20.0 78.1
Average 0.9 ± 0.2 30 ± 2 39 ± 2 10 ± 2 20 ± 1 89 ± 3
3
4 1.59 ± 0.30 38.5 28.1 15.3 18.2 62.5
1 2.07 ± 0.25 45.4 8.6 30.9 15.1 33.6
Average 1.8 ± 0.2 42 ± 2 18 ± 7 23 ± 6 17 ± 1 48 ± 10
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performed. We found that, in the extended conformation, the peptide could not 
stabilize even those head-groups that were already inserted into the membrane, 
and the bilayer recovered immediately from the large perturbations induced by the 
cyclic peptide. An overview of the poration features of the cyclic and linear peptide 
is presented in Table 4.
Figure 5. The linear peptides cause large perturbations from the in-silico modified transition state. Time course of a 
transient pore formed by a linear peptide (simulation L7). The time point 0 ns corresponds to the transition 
state taken from the simulation with the cyclic peptide. After 10-30 ns, large perturbations were seen and a 
few water molecules crossed the bilayer. Please note that in most simulations the bilayer relaxes and such 
large perturbations are not seen.
Table 4. Summary of pore features created by the cyclic peptide and the linear peptide.
Pore features Cyclic peptide Linear peptide 
Pore propensity High Low
Pore diameter 1-2 nm < 1 nm
Number of peptides inside 3 1
% β-structure 34 % 21 %
Outer leaflet deviation ± 0.55 ± 0.48
Number of porated states 6/10 3/10
Number of lipid head-groups 8-11 6-10
Number of water molecules 100-123 76-84
Formation time 1-4 ns 3-30 ns
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DCFBA reveals the mechanism of action on liposomes
Figure 6 shows the result of DCFBA experiments carried out with BPC194 and BPC193 
in the presence of DiD-labeled DOPG vesicles filled with the internal marker, GSH-
AF488. In such an experiment, poration of liposomes reduces the internal marker 
concentration and the DCFBA population histogram shifts to lower concentration 
values. In contrast, membrane fusion or aggregation results in a decrease in the 
number of detected liposomes, which is observed as a decrease in the area of the 
population histogram. For the cyclic analogue, at low P:L ratios (≤ 1), the number of 
liposomes decreased, which is indicative of fusion or aggregation (Figure 6A). The 
membrane fusion/aggregation activity was confirmed by confocal imaging of the 
liposomes and was accompanied by leakage of the internal marker (Figure 6A, panel 
b, P:L ratio of 0.3). Intriguingly, adding an excess of peptide (P:L ratios of 1-5) such 
that the vesicles are completely shielded by peptide preventing aggregation/fusion, 
the number of detected liposomes was restored and the concentration of molecules 
inside the liposomes dropped (Figure 6A, panel g), which is indicative of pore 
formation. The linear peptide, BPC193 also caused membrane fusion or aggregation 
but at higher P:L ratios than its cyclic counterpart (Figure 6B). This was confirmed 
by confocal imaging at the highest concentration of the linear peptide (P:L ratio of 5) 
where large membrane aggregates were formed without loss of the internal marker, 
indicative of the lack of pore formation (Fig. 6A, panel d).
To present the overall data comprehensively, the average membrane fluorescence per 
liposome and the relative concentration of the internal marker are plotted in Figures 
5C and 5D (see Materials and Methods for more details). For BPC194, the average 
membrane fluorescence peaked at a P:L ratio of 0.5-1, while the relative concentration 
of the internal marker already dropped to zero at a P:L of 0.3. This behavior confirms 
the leaky fusion/aggregation action of the cyclic peptide. On the other hand, for 
BPC193, an increase in the membrane population and constant relative internal 
marker population was seen, thereby corroborating its non-leaky fusion/aggregation 
propensity.
Using the DCFBA technique and encapsulating bigger internal markers we could 
estimate the size of the pore. The smallest molecule that did not leak out was the 
10 kDa Dextran-Fluorescein (Figure 7A) with a dimension of 2.1 nm (shortest axis 
measured assuming is a prolate ellipsoid), while GSH-AF488 leaked out with a 
diameter of ~1.7 nm (Figure 7B, measured by FCS). We conclude that the size of the 
pore is between 1.7 and 2.1 nm.
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Figure 6. Mechanism of action of peptides studied by DCFBA. (A-B) DCFBA population histograms of BPC194 
and BPC193, respectively. The numbers in the bottom right of the graphs refer to P:L ratios. The y-axis 
corresponds to the number of liposomes, the x-axis to the arbitrary marker concentration inside the 
liposomes. Top right panels: Confocal images of vesicles probed in the experiments shown in (A) and (B), 
indicated by Greek symbols (α-δ); left panels: membrane probe, DiD; right panels: internal marker probe, 
GSH-AF488. The scale bar is 20 μm. (C-D) Average DiD population (circles, solid line) and relative GSH 
population (squares, dotted line) for the cyclic and the linear peptide, respectively.
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Figure 7. Cyclic and linear peptides fuse or aggregate liposomes. (A) DCFBA experiment of the peptide BPC194 
with DiD-labeled vesicles and 10 kDa Dextran-Fluorescein as internal marker. Left: BPC194 induces 
liposome fusion/aggregation without leakage. Right: Confocal images of vesicles probed in the DCFBA 
experiments. Panel α represents the intact vesicles, panel β shows a P:L ratio where the peptide caused fusion/
aggregation without leakage, and panel γ shows a P:L ratio where little fusion/aggregation was observed 
and the vesicles did not leak. The scale bar is 20 μm. (B) Data dimensions of internal size marker molecules. 
1Calculated on the basis of molecular weight, using the following equation:
where rs is the Stokes radius of the molecule, Mw is the molecular weight, NA the Avogadro constant and ρ 
the density of the particle (calculated from composition, using the program Sednterp from http://jphilo.
mailway.com/download.htm). 
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2The diffusion coefficient was determined in water at 20oC by fluorescence correlation spectroscopy (FCS), 
as described previously (199). The Stokes radius was calculated from the D values, using the Einstein-
Stokes relationship:
where, kB is the Boltzman constant, T the temperature and γ the viscosity of the medium.3 The dextran is 
assumed to be a prolate elipsoid with an axial ratio of 4 (for a 9.5 kDa Dextran, (200)). The semi-minor axis 
(α) and semi-major axis (β) are calculated using the rs, measured in this work by FCS, from the dependence:
The dimensions of the dextran molecules should be taken with caution since they are not spherical and 
may lose their water shell while passing through the pore.
Discussion
Nature of the transition state. The simulations presented here elucidate the nature 
of the transition state of the poration process. One may assume that starting from a 
true transition state, the chance of arriving at either side of the transition state barrier 
is approximately equal (here the porated membrane versus the intact membrane). 
Although our statistics are necessarily limited, we observe 6 out of 11 simulations 
with the cyclic peptide to reach a porated state, starting from the state in which a 
large perturbation was observed in the original simulation (cf. Table 2, C1-10). In the 
remaining 5 out of 11 simulations, counting also the original trajectory, the system 
relaxed back to the intact membrane state. This intermediate or transition state is 
characterized by a single peptide bridging the two leaflets (cf. Figure 1B, 0 ns). The 
results are in line with kinetic models that suggest that such a state is important in 
pore formation (201).
Disordered toroidal pore. Using the transition state as seed for many independent 
trajectories, we were able to show that the deepest-embedded peptides may stabilize 
a toroidal-shaped pore of 1-2 nm diameter, which is in line with the electrophysiology 
and pore-sizing DCFBA experiments. Only two/three peptides actually lie in the 
pore while some of the remaining peptides line the mouth of the pore and stabilize 
the membrane curvature. The structure of the pore is reminiscent of pores seen in 
previous MD studies (34, 35, 181, 202) and has been termed the disordered toroidal 
pore.
Structure-function relationship. The simulations also highlight the importance of 
secondary structure in stabilizing the porated state. In the simulations, a constrained 
secondary structure rather than a high percentage of secondary structure was 
required to stabilize the pore. The importance of the secondary structure, induced on 
membrane binding and stabilized in the porated state, appears to be the alignment 
of the charged residues such that they fit the toroidal shape of the pore (cf. Figure 
4D). This explains why the linear peptide is less active – for entropic reasons a folded 
structure is less favorable. This entropic penalty is ‘prepaid’ by the cyclic peptide. 
Thus, the linear peptide cannot open a pore but may stabilize it, if the starting 
structure is the transition state structure obtained with the cyclic peptide (cf. Figure 
5). 
Conductance, pore properties and fusion/aggregation. BPC194 forms stable and non-
selective ion pores in planar lipid bilayer experiments, with a unitary conductance of 
0.61 ± 0.12 nS, corresponding to a pore diameter of 1.5-1.9 nm. This is in contrast to 
other cyclic peptides such as gramicidin S that do not form stable pores (203). Stable 
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pores have however been seen for linear antimicrobial peptides such as alamethicin, 
magainins and defensins (204). Both the cyclic and linear peptides are fusogenic or 
cause aggregation, as indicated by DCFBA measurements, but only the cyclic peptide 
caused leakage as well. Similar to melittin (38), BPC194 causes leakage at the same 
concentration regime at which it fuses or aggregates DOPG membranes. However, 
further studies in this intriguing fusion/aggregation action are in progress.
Conclusions
There is now compelling evidence that cyclization of certain sequences of membrane-
active peptides enhances their antimicrobial performance. In this paper, we analyze 
the molecular basis for the differences in activity of analogous cyclic and linear 
antimicrobial peptides. We show that the molecular basis for the enhanced activity 
resides most likely in the restriction of the number of conformations in the cyclic 
peptide. We show that it can adopt a favorable orientation towards the membrane 
and acquire an ordered structure that allows a high charge density and amphipathic 
arrangement. The latter allows the cyclic peptide to perturb the membrane 
substantially and to form discrete pores. Cyclization of the linear sequence locks the 
peptide in a poration-ready state, allowing it to perturb the bilayer and stabilize the 
curvature of a toroidal transmembrane pore. Without cyclization, entropy destabilizes 
the formation of a folded structure and consequently its amphipathic-like character 
and hence the linear peptide has a much lower propensity to induce pores. The work 
presented here provides detailed insight into the mode of action of cyclic peptides 
and will aid rational design of new antimicrobial molecules.
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Membrane active peptides can perturb the lipid bilayer in several ways, such as poration and fusion of 
the target cell membrane, and thereby efficiently kill bacterial cells. We probe here the mechanistic basis 
of membrane poration and fusion caused by membrane-active, antimicrobial peptides. We show that the 
cyclic antimicrobial peptide, BPC194, inhibits growth of Gram-negative bacteria and ruptures the outer 
and inner membrane at the onset of killing, suggesting that not just poration is taking place at the cell 
envelope. To simplify the system and to better understand the mechanism of action, we performed Förster 
resonance energy transfer and cryogenic transmission electron microscopy studies in model membranes 
and show that the BPC194 causes fusion of vesicles. The fusogenic action is accompanied by leakage as 
probed by dual-color fluorescence burst analysis at a single liposome level. Atomistic molecular dynamics 
simulations reveal how the peptides are able to simultaneously perturb the membrane towards porated 
and fused states. We show that the cyclic antimicrobial peptides trigger both fusion and pore formation 
and that such large membrane perturbations have a similar mechanistic basis.
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Introduction
Membrane active peptides (MAPs) represent a class of molecules that are able to 
interact with membranes, leading to fusion, poration and/or translocation. Depending 
on their mode of action, these peptides have been traditionally classified in three 
different categories: fusogenic peptides, antimicrobial peptides and cell-penetrating 
peptides (24, 205-207). More and more data suggest that this classification is too rigid 
as some peptides have multiple functionalities (43, 45, 208-215). For example, both 
fusogenic and antimicrobial peptides have been shown to induce leaky fusion in 
vesicles (43, 44, 216), and a cell-penetrating peptide has been shown to induce leaky 
fusion of liposomes (45). For antimicrobial peptides it has been speculated that this 
“multihit mechanism” increases their potency (27, 167). Despite much progress in 
the characterization of peptide-membrane interactions, the molecular details of the 
events leading to membrane fusion, poration, and peptide translocation are still 
poorly understood. A powerful tool to study peptide-membrane interactions at the 
molecular level is the molecular dynamics (MD) technique (158, 217-219).
Here, we combine MD simulations with a number of experimental techniques, 
including Dual-Color Fluorescence Burst Analysis (DCFBA), Förster Resonance 
Energy Transfer (FRET) and cryogenic Transmission Electron Microscopy (cryo-
TEM), to explore the process by which peptides are able to act on a membrane in a 
dual way. Moreover, we relate our findings to cryo-TEM studies in Escherichia coli 
cells. The peptide investigated, BPC194: c(KKLKKFKKLQ), is a cyclic antimicrobial 
peptide that adopts a β-sheet structure upon interaction with the membrane (220). 
The peptide was selected from a library of de novo synthesized head-to-tail cyclic 
peptides (139, 140), which showed a high antimicrobial activity towards Gram-
negative plant pathogenic bacteria like Erwinia amylovora, Pseudomonas syringae and 
Xanthomonas vesicatoria. We have previously probed the pore forming propensity of 
this peptide and showed that the β-conformation of the peptide is optimal for the 
stabilization of the curvature of the transmembrane pore (163).
We show here how BPC194 also induces membrane fusion, probing the process at an 
atomistic, molecular and ensemble level. Two seemingly unrelated processes: pore 
formation and membrane fusion are shown to occur simultaneously and influence 
the paths of both modes of action. Our in silico and in vitro observations correlate 
with in vivo data and provide a mechanistic framework for growth inhibition of 
bacterial cells by BPC194.
Materials and methods
Reagents and apparatus
The 2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethanesulfonic (HEPES) was from Roche 
Diagnostics GmbH; 1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol (DOPG) was 
from Avanti Polar Lipids; 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarbo-cyanine 
perchlorate (DiD), 3kDa dextran-fluorescein, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (NBD-PE) and LissamineTM 
Rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (Rh-DHPE) 
were from Invitrogen. For in vivo experiments, the medium used was Luria Broth 
(10 g/L Bacto Tryptone (Becton Dickinson), 5 g/L Yeast extract (Becton Dickinson) 
plus 10 g/L NaCl; Merck). The buffer used for cell imaging with the light microscope 
was 10 mM sodium phosphate, pH 7.5, containing 150 mM NaCl. For cryo-TEM 
assay with E. coli cells we used the buffer 120 mM potassium phosphate, pH 7.0, 
which has an osmolality equal to that of LB (measured by determination of the 
freezing point in an Osmomat 030, Gonotec) or sodium phosphate buffer (same for 
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light microscopy). In vitro solutions were prepared in 10 mM HEPES-NaOH, pH 
7.2, containing 150 mM NaCl (the so-called physiologic ionic strength). The peptides 
BPC194, c(KKLKKFKKLQ), and its linear counterpart BPC193, H-KKLKKFKKLQ-
OH, were synthesized as described previously (220) and purified by reverse-phase 
preparative HPLC (purities > 95%). 
Strains, growth and cell imaging
Escherichia coli (E. coli) K-12 strain MC1061 (221) was grown from single colonies in 
LB at 37ºC under vigorous aeration until the culture reached an OD600 of 0.15 for light microscopy, 0.1 for peptide stability study and 0.6 for electron microscopy. Prior to the 
light microscopy, 1 mL of cells was washed twice with fresh LB medium and the pellet 
was finally resuspended in a 400 µL of LB to get an optimal cell density. Afterwards, 
1.5% agarose solution in LB was pipetted onto a multispot microscope slide of 12 wells 
(Hendley-Essex). The coated slide was left to solidify at 4ºC for 15 min. A 1 µL drop of 
cell suspension mixed 1:1 (v/v) with buffer or peptide solution (final concentration 
range from 0.75 µM to 100 µM) was placed on each well and immediately covered 
with a coverslip. Cells were imaged for approximately 4 hours using Differential 
Interference Contrast (DIC) transmitted-light in an inverted microscope Observer 
Z1 (Carl Zeiss), equipped with a Zeiss LCI Plan-NeoFluar 63x objective (numerical 
aperture of 1.3) and a Cool-Snap HQ2 CCD camera (Photometrics). Cell growth rates 
were calculated from the increase in cell number over time; growth rates in liquid LB 
medium and LB-agarose were comparable. For electron microscopy, the cells were 
centrifuged (4 min; 10,000 x g; room temperature) and concentrated to a final OD600 of 100. 
Peptide stability followed by High-Performance Liquid Chromatography 
(HPLC)
A 1 mL volume of E. coli cells, OD600 of 0.1, was pellet by centrifugation (4 min; 10,000 x g; room temperature) and resuspended in 1 mL 10 mM potassium phosphate, 150 
mM NaCl, pH 7 (equiosmolar with LB medium) supplemented with 100 µM cyclic 
peptide, BPC194, or linear homologue, BPC193. Aliquots were taken after 5, 10, 
30 and 60 min of incubation at r.t., and samples were centrifuged. Cell pellets and 
supernatants were kept at 4ºC until they were analyzed by HPLC. Reversed-phase 
HPLC with UV detection was performed on a Shimadzu system consisting of two 
LC-20AD pumps, SPD-M20A detector, a SIL-20AC HT auto-sampler and a CBM-
20A system controller (Shimadzu, Kyoto, Japan). The peptides in the supernatant 
solutions were separated on a XTerra MS C18 column (3 × 150 mm) (Waters). The 
column temperature was set to 35ºC. Analyses were performed using a linear 
gradient of 5–95% eluent B (acetonitrile with 0.1% TFA; eluent A was water with 0.1% 
TFA) at a flow rate of 0.5 mL/min over 40 minutes. UV detection was carried out at 
220 nm (PDA spectra 190–700 nm). The reversed-phase HPLC retention time of each 
peptide was determined when the peak was at its maximum height, and the area of 
the peak was used to determine the (relative) concentration of the peptides (using 
the appropriate standards and time zero samples). Since a fraction of the peptides is 
bound to cells, we treated cell pellets with 6M urea (final concentration) plus 1.5% 
(v/v) Triton X-100. After 30 min of extraction, the sample was centrifuged and the 
supernatant was analyzed by HPLC. In control experiments, standard samples of 
peptide were incubated with urea plus Triton X-100 in the same manner.
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Preparation of lipid vesicles
Large unilamellar vesicles (LUVs) were prepared as described elsewhere(163). 
Briefly, rehydration of a dried DOPG lipid film was done in 10 mM HEPES-NaOH, 
150 mM NaCl, pH 7.2. Vesicles were then subjected to five cycles of flash freezing in 
liquid nitrogen and rapid thawing at 37ºC. Subsequently, liposomes were extruded 
11 times through a 200 nm polycarbonate filter (Avestin). 
For the DCFBA experiments the lipid film was made by mixing the membrane dye 
DiD with DOPG lipids at a molar ratio of 1:12,000 (corresponding to ~15 molecules 
of DiD per liposome for vesicles with a diameter of 200 nm) and the rehydration 
was done in the presence of the lumen cargo molecule: 3 kDa dextran labeled 
with fluorescein (5 µM). Liposomes were separated from the non-encapsulated 
fluorophores by centrifugation (20 min; 270,000 x g; 20ºC) and resuspended in the 
buffer to a final lipid concentration of 80 µM. 
For the FRET assays, the lipid film contained 1 mol% NBD-PE and/or 1 mol% Rh-
DHPE, and the final lipid concentration was 125 and 250 µM DOPG.
For cryo-TEM, the liposomes were briefly sonicated before extrusion to increase the 
unilamellarity of the vesicles (5 pulses of 1 sec. at 75% amplitude with a Sonics Vibra 
Cell VCX 130 sonicator) and the final lipid concentration was 5 mM DOPG.
DCFBA
In the DCFBA experiment, liposomes were labeled with two, spectrally non-
overlapping fluorescent probes (198). The DiD probe was incorporated in the 
phospholipid bilayer, while the fluorescein-labeled dextran filled the aqueous interior 
of the liposomes. By using a dual-color laser-scanning microscope, we monitored 
membrane-disrupting effects at the single liposome level. Different amounts of 
peptide (0 to 27 µM) were added to 80 µM DOPG liposomal solutions, yielding 
total peptide-to-lipid (P/L) ratio from 0 to 0.3. The samples were equilibrated for 10 
minutes at room temperature after each addition of peptide. The fluorescence bursts, 
resulting from the diffusion of the liposomes through the detection volume, were 
measured for 10 min. The internal cargo concentration (C) of the ith liposome (burst) 
is given by:
where IL is the fluorescence intensity of the lipid marker, DiD, above a certain threshold between t1 and t2 . IIC is the fluorescence of the internal cargo. The average concentration of internal cargo, Cav, over all the liposomes can be obtained from Ci: 
where N corresponds to the number of liposomes (198). Samples were imaged on a 
commercial laser-scanning confocal microscope, LSM 710 (Carl Zeiss MicroImaging, 
Jena, Germany), using an objective C-Apochromat 40×/1.2NA, a blue argon ion laser 
(488 nm) and a red He-Ne laser (633 nm). 
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FRET
Fusion was monitored using the Förster resonance energy transfer (FRET)-
based methodology described before by others, using a Cary Eclipse fluorescence 
spectrophotometer (Varian). Two different FRET assays were performed, i.e., positive- 
and negative-FRET. In positive-FRET, DOPG vesicles labeled with 1 mol% NBD-PE 
(donor) were mixed with DOPG vesicles labeled with 1 mol% Rh-DHPE (acceptor) at 
a molar ratio of 1:1. If fusion occurs, the lipids of the donor and acceptor vesicles will 
mix and the FRET efficiency, as monitored by an increase in the acceptor emission 
(intensity at λem = 590 nm, Rhodamine emission), will increase. On the other hand, in the negative-FRET assay, DOPG vesicles labeled with both 1 mol% NBD-PE and 
1 mol% Rh-DHPE were mixed with unlabeled vesicles at a molar ratio of 1:3. In this 
case, as the vesicles fuse, the average distance between donor and acceptor increases. 
Thus, the FRET efficiency decreases proportionally and is monitored by an increase 
in the donor emission (intensity at λem = 530 nm, NBD emission). In both assays 
the peptide BPC194 was added to a final concentration in the range of 0 to 200 µM. 
The absorbance peaks of samples were kept <0.1, and various controls were done to 
minimize the inner filter effects (Fig. 1A-B). Quantification of fusion was calculated 
from the increase in NBD emission in the negative-FRET assay at two different 
lipid concentrations (125 and 250 µM). The 0% fusion was taken from the intensity 
of free-peptide vesicles. The other end of the fusion scale (100%) was calculated by 
adding CaCl2 (194 mM) as a fusogenic agent to the vesicle suspension (222). Control experiments to correct the intensities for quenching of NBD and Rhodamine upon 
peptide and calcium addition were also performed (Fig. 1C-F).
Cryo-TEM
Samples for cryo-TEM were prepared by deposition of a few µL of vesicle solution 
(with buffer or peptide at a final P/L ratio of 0.01) or cell solutions (mixed 1:1 (v/v) 
with either buffer for the control or BPC194 to a final P/L ratio of 0.02 or 0.4) on 
holey carbon-coated grids (Quantifoil 3.5/1, Quantifoil Micro Tools). After blotting 
the excess liquid, the grids were vitrified in liquid ethane in a Vitrobot (FEI) and 
transferred to a Philips CM 120 cryo-electron microscope equipped with a Gatan 
model 626 cryo-stage, operating at 120 kV. Images were recorded under low-dose 
conditions with a slow-scan CCD camera. For the in vivo system, images were taken 
at two time points, one or 30 minutes after mixing with peptide. For the in vitro 
system, images were taken 10 minutes after mixing with peptide and a total of 98 
cells were analyzed in the presence of peptide and 58 cells without peptide. 
Simulations system set-up
The starting system consisted of two solvated DPPG (dipalmitoyl-phosphatidylglycerol; 
anionic lipid) bilayers in the fluid phase, comprising of 512 lipids each and placed at a 
distance of about 3 nm from each other. The DPPG lipids and their palmitoyl tails are 
well characterized in our group and have been used in our previous study on pore 
formation by BPC194 (163, 220). We emphasize that this lipid is in the fluid phase 
at conditions in the molecular dynamics simulations. BPC194 peptides were placed 
between the bilayers in the water phase at a P/L ratio of 1:15. The cyclic peptides 
were modeled based on a previous study (163, 220). The system consisted of about 
32000 water molecules. K+ ions were added as counter-ions for anionic lipids and Cl- 
ions were added to neutralize the overall system. Five simulations were set up with 
different starting random velocities to obtain statistically significant results. A pure 
DPPG bilayer was also simulated for reference. Furthermore, a simulation where the 
inactive linear analog (BPC193) was tested at the same conditions as the active cyclic 
peptide was performed as a control. The linear peptide was modeled based on our 
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previous study with charged termini to best represent the experimental conditions 
(163, 220). For an overview of the simulations see Table 1. 
Simulations parameters
The GROMACS software package (147) was used to perform all MD simulations. The 
GROMOS force-field 43a2 (148) was used to describe the peptide and peptide-solvent 
interactions. The force-field for DPPG lipids was taken from a previous study (163, 
220). All force-fields were parameterized for use with a group-based twin range cut-
off scheme (using cutoffs of 1.0/1.4 nm and a pair-list update frequency of once per 10 
steps), including a reaction field (RF, (154)) correction with a dielectric constant of 78 
to account for the truncation of long-range electrostatic interactions. The water was 
modeled using the SPC model (155). A time step of 2 fs was used. Bond lengths were 
constrained using the LINCS algorithm (156). The simulations were performed in the 
NP|PZT ensemble using periodic boundary conditions. The temperature was weakly coupled (coupling time 0.1 ps) to T = 320 K using the Berendsen thermostat (157). 
The pressure was also weakly coupled (coupling time of 1.0 ps and compressibility 
of 4.5 x 10-5), using a semi isotropic coupling scheme in which the lateral (P|) and perpendicular (PZ) pressures were coupled independently at 1 bar, corresponding to a tension-free state of the membrane. The simulation setup is similar to that used in 
previous studies of peptide-membrane interactions (34, 35, 42, 163, 220).
Characterization of lipid tilting and splaying
The tilt of the lipids was calculated by the angle between the vector of three atoms (P, 
C2A and C2P) and the z-axis as a reference. The values close to 0º mean no tilt whereas 
values close to 90º mean complete tilt. The splay of the lipids was calculated by the 
angle between the vectors of two atoms of one lipid tail (C2A, C2P) and the other 
lipid tail (C1A, C1P). The values close to 180º indicate the splay of the hydrocarbon 
tails.
Results
Cell growth inhibition and cell envelope defects by BPC194 
To analyze the mechanism of action of BPC194, we monitored the aggregation, growth 
and morphology of E. coli cells by light microscopy and used the linear analog of 
BPC194, which lacks activity, as a control. Figure 2A summarizes the results of the 
cell growth over 4 hours of imaging (see also Movies S1-3 from doi:10.1371/journal.
pone.0061541, (223)) The linear analog, BPC193, did not effect the cell growth up to 
a concentration of at least 100 µM. BPC194 already inhibited the growth at an order 
of magnitude lower concentration. The growth rate of E. coli as a function of peptide 
concentration is shown in Fig. 2C. Unlike the linear peptide, the cyclic peptide 
caused severe inhibition of growth and aggregation of the cells. This is a remarkable 
difference because both peptides have identical sequence and overall charge (+6 at 
physiological pH). To determine whether or not the different effects of BPC194 and 
BPC193 are caused by (partial) degradation of the peptides by E. coli cells, we tested 
their stability. The fate and concentration of the peptides was followed by reverse-
HPLC. The results show that there is no observable degradation of the peptides after 
1h of incubation with cells (or even cell lysates), that is, under conditions that BPC194 
is completely inhibiting growth and BPC193 is having no effect (Fig. 3). To investigate 
further the effect of the cyclic peptide on the ultrastructure of the cells, we performed 
cryo-TEM (Fig. 2B). BPC194 caused disruption of the cell envelope (shown in black 
arrows) in all the cells analyzed, most notably the integrity of the inner and outer 
membrane (IM and OM) was disrupted. The cell envelope is no longer smooth (panel 
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B2) with the presence of contact sites between the IM and OM (panel B3) in about 
30% of the cells, and in some regions the membrane was pinched off or budding off of 
vesicle-like structures was observed (panel B4). The results show that only the cyclic 
peptide is able to abolish cell division, which is preceded by cell aggregation. The 
positive charge of the peptide is not sufficient for cell aggregation and subsequent 
disruption of the cell envelope, as the linear analog does not show similar effects. The 
locked cyclic conformation of BPC194 might be the key factor in the initial interaction 
with the cell envelope, causing large physical stress and damage, what leads to 
inhibition of cell division and ultimately to cell death.
Table 1. Overview and statistics of the MD simulations.
The percentage of lipids in the contacting monolayers which, during the simulation, tilt by more than > 85º 
or splay by more than > 170º is indicated. The standard error of the average is obtained from the standard 
deviation between all five simulations. The simulation length and formation of pores is also indicated.
Figure. 1. Controls for inner 
filter effect and quenching of 
fluorophores by peptide and 
calcium. (A-B) NBD and 
Rhodamine fluorescence 
as a function of lipid 
concentration. The dotted 
lines show the linear 
regime where inner filter 
effects are not present. (C-
D) NBD and Rhodamine 
fluorescence as a function 
of peptide concentration. 
The dependence of I0/I 
on peptide concentration 
(see equation) was used to 
correct for the quenching. 
(E-F) NBD and Rhodamine 
fluorescence as function 
of calcium concentration. 
Calcium does not quench 
NBD emission intensity but 
does quench the Rhodamine 
fluorescence.
Simulation Time (ns) Nr. Pores Time scale Pore (ns) Tilt > 85º Splay > 170º
Pure DPPG 100 - - 0 2
F1 360 2 40 / 58 24 9
F2 210 - - 18 8
F3 590 1 150 28 12
F4 160 2 10 / 70 10 6
F5 230 - - 16 10
Average - - - 19.2 ± 3.1 8.9 ± 1.1
60
Figure 2. Growth inhibition and cell envelope defects by BPC194. (A) Cell growth imaging of E. coli without 
peptide (control) and with 12.5 µM of BPC193 or BPC194 during four hours. Note that the first image was 
taken after 1h. and one or two cell divisions had already taken place in the control and BPC193 samples. 
(B) Cryo-TEM micrographs of E. coli cells without (B1) and with BPC194 (B2-B4). Black arrows point out 
severe disruption of the cell envelope: membrane irregularities (B2); putative contact sites between IM and 
OM (B3); rupture of the cell envelope and budding off of vesicle-like structures (B4). Scale bars represent 
100 nm. (C) Cell growth rates of E. coli in the presence of different concentrations of BPC194 (full circles) 
and its linear analog, BPC193 (empty circles). The values are normalized to the growth rate in the absence 
of peptide, which corresponded to 1.15 h-1.
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Figure 3. Stability of peptides. Normalized peak area 
of BPC194 (full circles) and BPC193 (empty squares) 
after incubation with E. coli cells for different periods 
of time. The data points at 90 min. (depicted with 
a crossed-circle or –square for BPC194 or BPC193, 
respectively) represent the aliquots incubated for 60 
min with cells and subsequently another 30 more 
min in the presence of 6M urea plus 1.5% (v/v) 
Triton X-100. Peptides not exposed to cells but 
incubated with urea plus Triton X-100 did not show 
any decrease in the peak area (data not shown). The 
retention times were 20.0 min for BPC193 and 23.4 
min for BPC194. As is evident from the data, we did 
not observe significant breakdown of either BPC193 
or BPC194 upon incubation with E. coli cells up to a 
period of at least 1h.
Simultaneous pore formation and fusion action of BPC194
The use of model systems is required to get fundamental chemical understanding 
of the mode of action of membrane-active compounds as whole cells are simply 
too complicated for such an analysis. We used DOPG vesicles albeit that, similar 
observations have been made in membranes composed of mixtures of zwitterionic 
and anionic lipids (220). However, the higher the fraction of anionic lipids, the 
stronger the binding and poration of BPC194. We used solely negatively charged 
lipids as in this system the pores are stable for long periods of time (on the time scale 
of minutes) as inferred from electrophysiology studies (163). DCFBA, FRET and cryo-
TEM techniques were used to probe the peptide-membrane interactions of BPC194, 
using BPC193 as negative control. First, DCFBA experiments were performed upon 
addition of different amounts of peptide to the DiD-labeled vesicles, filled with the 
internal cargo 3 kDa dextran-fluorescein (198). The average concentration of internal 
cargo and the normalized intensity of membrane-associated DiD per liposome as a 
function of peptide-to-lipid ratio are summarized in Fig. 4A. As the P/L ratio increases 
the amount of dextran inside the vesicles, Cav, decreases, which is indicative of the poration activity of the peptide (full circles). In parallel with the cargo leakage, we 
observed that the amount of DiD per vesicle increased, which points towards vesicle 
fusion or aggregation (empty squares). The DCFBA data (Fig. 4A) in conjunction 
with the confocal images (Fig. 4B) confirm the two concurrent events, poration and 
fusion/aggregation. In panel γ, mesoscopic aggregates can be observed in the DiD 
channel, whereas the corresponding signal of internal cargo has disappeared due to 
leakage. 
To distinguish between fusogenic action (lipid mixing of vesicles) and aggregation, 
we performed both positive-FRET (Fig. 4C) and negative-FRET (Fig. 4D) (222). The 
fusogenic action of the cyclic peptide BPC194 was confirmed by both assays, thus 
classifying the observations of Fig. 4B γ as fusion of vesicles. Using the emission 
intensity of the FRET donor, NBD-PE, after correcting for peptide quenching, 
we quantified the percentage of fusion at each P/L ratio with two different lipid 
concentrations (Fig. 4E). The percentage of fusion increased with the peptide 
addition until a P/L of roughly 0.3, at which the fusion of vesicles as probed by 
FRET was maximal. At this particular P/L ratio, the cargo of the vesicles had already 
completely leaked out (Fig. 4A and 4B). As a control, we analyzed the inactive linear 
analog of BPC194, that is BPC193, at the same peptide concentrations and there was 
no change in the FRET efficiency (Fig. 4C; inset). 
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Cryo-TEM also revealed the fusogenic behavior of BPC194 and the most representative 
images of vesicles without peptide, with BPC194 and BPC193 are shown in Fig. 4F. 
Vesicles without peptide were on average about 200 nm. BPC194 yielded larger 
vesicles, consistent with membrane fusion, whereas the linear BPC193 brought 
the vesicles close together but vesicle fusion was not observed (Fig. 4F). The linear 
BPC193 peptide was previously shown to be inactive and vesicles aggregates were 
already seen by confocal microscopy (163, 220).
Figure 4. Simultaneous pore formation and fusion activity of BPC194. (A) The normalized concentration of 
dextran inside the liposomes, Cav, (filled circles) and the normalized intensity of membrane-associated 
DiD per liposome (empty squares) at different P/L ratios. (B) Confocal images of the lipid vesicles in 
the DiD and dextran detection channel at three different P/L ratios; α, P/L=0; β, P/L=0.1; and γ, P/
L=0.3. (C) Positive-FRET upon peptide addition. The emission of Rhodamine increases due to vesicle 
fusion. Inset: Controls done with the ‚inactive’ linear analog of BPC194, that is, BPC193 at the same 
peptide concentrations. (D) Negative-FRET upon peptide addition. The emission of NBD increases due 
to a decrease in FRET efficiency as a result of vesicle fusion. (E) Quantification of fusion at different P/L 
ratios and at two different lipid compositions, 125 μM (full circles) and 250 μM (empty squares). (F) 
Representative cryo-TEM micrographs of DOPG vesicles without peptide (control) and with BPC194 or 
the linear analog BPC193.
We note that complete fusion occurs at a bound peptide-to-lipid ratio of around 0.15. 
It has been shown by Melo and coworkers that the bound peptide concentrations at 
the MIC value are comparable to those of the thresholds effects (pore formation) in 
model membranes (40, 175, 224). The apparent difference between the in vivo and 
in vitro numbers arises from the fact that in a standard MIC assay, the number of 
cells is very low and the lipid concentrations are in the nanomolar range. When all 
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these factors are taken into account, the corresponding P/L ratio in the bacterial cell 
is around 0.1 and thus very similar to what we find in the membrane model system. 
In accordance, substantial fusion and leakage were observed at similar P/L ratios 
in the in vivo and in vitro assays. The overall data indicate that the fusogenic and 
poration activity of the cyclic peptide occur simultaneously and points to a “multi-
hit” mechanism of action.
Molecular basis for concurrent fusion and leakage by MD simulations
To study the fusion and leakage events at an atomistic level, MD simulations of two 
DPPG bilayers were set up with multiple copies of the peptide placed between them 
(Fig. 5A).  We note that in the simulations DPPG is in the fluid, liquid-disordered 
state. The P/L ratio was set to 1/15, i.e. at intermediate values for fusion and 
poration as observed experimentally. A control simulation was performed with the 
linear analog, BPC193, at the same P/L ratio. The linear counterpart of BPC194 is not 
able to form pores, as shown previously (163) or fuse the two apposed bilayers (Fig. 
6). Five independent simulations were performed with the cyclic peptide, exploring 
a total time scale of more than 1 microsecond (Table 1). Representative snapshots 
showing the sequence of events in a particular simulation (F1, cf. Table 1) is depicted 
in Fig. 5B-D and the whole trajectory is shown in Movie S4 (from doi:10.1371/
journal.pone.0061541, (223)). The other four simulations showed qualitatively 
similar behavior. The following steps were observed: i) peptide binding leading to 
membrane contact, ii) lipid perturbations leading to membrane bridge formation, 
and iii) peptide penetration resulting in pore formation. 
Initial Membrane Contact: An initial fast binding of the peptides was observed with 
most peptides binding to one of the proximal monolayers, typically within 10 ns, (Fig. 
5B). The binding is facilitated by multiple electrostatic interactions of the positively 
charged lysine residues with the negatively charged head-group moieties of the PG 
lipids. Importantly, a few of the peptides were able to interact simultaneously with 
both membranes. As a result, these peptides formed a bridge between the apposing 
membranes. A close-up of a few of these bridging peptides is presented in Fig. 5E.
Membrane Bridge formation: Due to the effect of the bridging peptides, some of the 
lipids were perturbed locally and protruded out of the membrane and interacted with 
the apposing membrane, creating a membrane bridge (Fig. 5C). We refer to this state 
as a membrane bridge since full contact between the hydrophobic tails of lipids from 
the contacting leaflets did not occur, which is characteristic of membrane stalks. The 
membrane bridge remained stable during the length of the simulation. Formation of 
the membrane bridge takes place on a time scale of 10-20 ns, i.e., the time required 
for the bridging peptides to extract the lipid tails from the contacting monolayers. 
The membrane bridge showed high saddle spray curvature and can be considered an 
intermediate towards complete stalk formation during the process of fusion.
Pore formation: Subsequent to the formation of the membrane bridge, spontaneous 
pore formation was observed (Fig. 5D). In MD simulations, pores are distinguished 
by a disruption of the lamellar phase and water molecules are seen to traverse the 
bilayer freely via the pore. Pore formation was triggered by a few of the peptides, not 
involved in stabilizing the membrane bridge, that insert deeper into the bilayer. We 
would like to point out that the pores formed in the simulations are not fusion pores, 
rather they are formed adjacent to the membrane bridge and mimic the stalk/pore 
complex described elsewhere (225, 226). Whether or not pores are actually formed 
appeared to be a stochastic process, with three out of five simulations showing pore 
formation (Table 1). In two of the simulations even two pores were formed. In each 
case, the pores formed adjacent to the membrane bridge, on a time scale ranging 
between 10 to 150 ns. A close-up of the membrane bridge and pore complex is shown 
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in Fig. 5F. The pores formed are reminiscent of the disordered toroidal type as shown 
in previous simulation studies for this peptide (163) and other antimicrobial peptides 
(34, 35).
Figure 5. Molecular view of the sequence of events of the leaky fusogenic action of cyclic peptides. (A) 
Initial simulation setup with peptides placed between two bilayers. (B) Bridging of proximal leaflets of the 
two bilayers by BPC194. (C) Lipid bulging caused by the action of peptides associated with the bilayers. 
(D) Pre-stalk intermediate accompanied by disordered toroidal pore. (E) Close-up of the bridging peptides. 
(F) Close-up of the stalk-pore complex. (G-J) Splaying of a lipid during the course of a simulation. The 
peptides are depicted in pink, the phosphorous atoms in yellow and green respectively and the lipid 
chains in grey. The water is not shown for clarity. In panel F, the water molecules within the pore in one 
of the bilayers are shown in blue. The other pore cannot be seen in the zoom-in but is visible in panel D.
Figure 6. MD simulation of the inactive linear peptide in contact with a membrane. (A) Initial simulation setup of 
the linear analogue (BPC193), which is the same as for the cyclic peptide BP194 (0 ns). (B-D) From 8 to 70 
ns of the simulation, the linear peptides are not able to perturb the membranes and induce fusion. Poration 
or pre-stalk events are not observed. 
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To further characterize the perturbing effect of the peptides on the lipids, we 
quantified the splaying and tilting of the lipid tails (see methodology for details). 
The results are given in Table 1. In each of the five simulations, the tilting is quite 
substantial compared to a pure bilayer. For example, in simulation-F3, 28% of the 
lipids of the proximal leaflet tilted more than 85º from their initial position at least 
once during the simulation. In a reference simulation of a pure DPPG bilayer, no 
such extensive tilting is observed. In addition, several lipids were also significantly 
splayed to values larger than 170º, implying a full opening of the lipid tails. Not 
surprisingly, the lipids that are most perturbed are the lipids in direct contact with 
the peptides, and especially the lipids involved in the formation of the membrane 
bridge, and later the pore. An example is presented in Fig. 5G-J, showing how a single 
lipid is splayed by interacting with a few neighboring peptides (see Movie S5 from 
doi:10.1371/journal.pone.0061541, (223)). In this particular example, the splayed 
lipid tail remains stable over 50 ns. The stabilizing contacts between the peptides and 
the lipids are formed between the lysine residues and the charged head-groups, and 
the apolar phenylalanine and leucine residues shielding the hydrophobic tails of the 
lipids from the water.
Discussion
On the basis of the in vivo and in vitro experimental data as well as the molecular 
dynamics simulations, we show how a synthetic cyclic antimicrobial peptide, BPC194, 
operates by dual action. Two seemingly different mechanisms are shown to occur 
concurrently, namely membrane poration and fusion. The mechanism is similar to 
the leaky fusion mechanism but follows a different pathway since complete leakage 
of vesicular content is seen and pore formation is independent of fusion. Despite 
the differences and higher complexity of the whole cell system as compared to the 
membrane model system, aggregation phenomena were observed concomitant with 
the inhibition of growth while membrane rupture was demonstrated by cryo-TEM. 
Although we did not observe genuine fusion intermediates between the IM and OM 
in our cryo-TEM studies of E. coli cells, we note that in Gram-negative bacteria those 
membranes are in close contact (5-20 nm apart) (227) and both were obstructed or 
brought close to each other at the point where BPC194 inhibited growth. BPC194 will 
not fuse bacteria together but the ability to fuse membranes may increase the potency 
of the peptide in cell membrane permeation of Gram-negative bacteria, i.e. when the 
IM and OM are in close contact. 
Based on our atomistic molecular dynamics simulations and biophysical 
characterization, we propose a mechanism by which the peptides perform their dual 
action. Firstly, the peptides bind to the membrane/water interface. Both electrostatic 
interactions between the lysine residues and the lipid head groups and the partitioning 
of the hydrophobic side chains into the lipid bilayer stabilize this binding mode. 
In our previous work, we showed that the cyclic peptide, binds stronger compared 
to its linear analog, due to its pre-folded amphipathic conformation (220). When 
two membranes are present in close proximity as in our current simulation setup, 
the peptides are actually able to bridge the two membranes. Being able to keep 
two liposomes at close distance is likely a necessary condition for fusion, but not 
sufficient, as the linear analog can induce aggregation but not fusion (Fig. 4C, Fig. 
4F and Fig. 6A-D). By adsorbing at the interface the peptides exert considerable 
stress on the outer, contacting monolayers, which can be rationalized in terms of 
their wedge-like shape (228). The stress induced causes a strong disordering of the 
lipids in the vicinity of the peptides, leading to lipid splaying, tilting, and protrusions 
as evidenced by our MD simulations. Eventually, a membrane bridge is formed, in 
which multiple (bridging) peptides and lipids form a large protrusion connecting 
the two apposing monolayers. The membrane bridge (also referred to as the pre-
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stalk in literature (229, 230)) has been suggested to be an important intermediate 
in the stalk-mediated pathway to fusion. In particular, recent MD studies show 
that at least under conditions of low hydration, early membrane fusion kinetics is 
not determined by the stalk energy but by the energy of pre-stalk transition states 
involving solvent-exposed lipid tails (229, 230). Likewise, in MD studies of vesicle 
fusion mediated by either lung surfactant protein SP-B (231) or by SNARE complexes 
(232), the proteins are observed to trigger spontaneous fusion events by anchoring 
two vesicles and facilitating the formation of a lipid bridge between the proximal 
leaflets. Also of interest is a coarse-grained simulation study of another small 
antimicrobial cyclic peptide, RRKWLWLW (190). At high enough concentrations, 
coating of the membrane caused extrusion of lipids from the exposed bilayer leaflet, 
leading ultimately to a release of phospholipid micellar aggregates (in this study 
no apposing membrane was present). Thus, destabilization of lipids by membrane 
active peptides appears to be a generic feature.
Interestingly, concurrent with the formation of the membrane bridge, our MD 
simulations show that a pore is induced in the lipid membrane, pointing to a dual 
role of the BPC194. Pore formation is generally viewed as the main mode of action of 
antimicrobial peptides leading to cell content leakage or even complete lysis of the 
cell membrane. However, we speculate that under conditions where membranes are 
in close proximity, both stalks and pores can be formed as another way to relieve the 
lipid stress caused due to asymmetric peptide binding. A system with both fusion 
stalks and adjacent pores (distinct from the fusion pores) has been termed a stalk/
pore complex and has recently been shown to represent a key intermediate in a 
possible fusion pathway (225). Although apposing membranes are pre-established 
in our simulation studies, they also occur in our in vitro studies in which liposomes 
are found to aggregate, possibly as a result of the bridging peptides. The stalk/pore 
pathway is distinct from the traditional pathway of fusion, which proceeds via the 
formation of a stalk that expands in a radial way forming a hemifusion diaphragm 
(225, 233-236). Fusion is completed when the hemifusion diaphragm ruptures (via a 
fusion pore). In the stalk/pore pathway, one or more pores appear in the vicinity of 
the stalk, allowing propagation of the stalk along the edge of the pore. Upon closure, 
the HD state is reached, or, in the case when two pores have formed, full fusion 
is accomplished. Such a pathway has been predicted to be energetically favorable 
based on mean field calculations (237). In fact, in MD simulations, the stalk/pore 
complex is stabilized by fusion peptides, and the peptides and lipids form an 
inverted cubic phase consisting of a network of stalk/pore complexes (238, 239). The 
pores seen in our simulations in the proximity of the membrane bridge is reminiscent 
of such a pathway and may be considered an intermediate prior to a stalk/pore 
complex. Thus, we believe that BPC194 can lower the energy barrier towards fusion 
by stabilizing the stalk/pore complex. The experimental work also suggests that 
AMPs can stabilize non-lamellar phases, and particularly inverted cubic phases 
(240). The ability of AMPs to induce saddle-splay curvature has furthermore been 
linked to the lipid composition of the membrane, and has been implicated to be a 
generic mechanism for formation of pores, blebs, buds, and tubes(241). These results 
point to a stabilization of saddle-splay (Gaussian) curvature by membrane adsorbed 
peptides. In this respect, BPC194, a synthetic cyclic antimicrobial peptide may act 
similar to fusion peptides.
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Conclusions
In conclusion, by using in vivo, in vitro and in silico methods, we have established that 
fusion and poration are correlated in the case of BPC194, a synthetic antimicrobial 
peptide. This dual action is most likely functionally relevant and may contribute to 
the high potency towards bacterial killing. As probed by DCFBA and optical imaging, 
poration and fusion occur simultaneously at the same concentration regimes. In fact, 
in the DCFBA profiles, an increase of leakage coincides qualitatively with an increase 
in membrane fusion. Cryo-TEM corroborates the fusogenic action of the peptide. The 
MD simulations furthermore show that pores and stalk-like membrane bridges are 
formed simultaneously. We believe that the interaction of the cyclic antimicrobial 
peptide BPC194 with bilayers promotes saddle-splay curvature that is required 
for both stalks and pores. In case of isolated membranes, pores are formed, but in 
case membranes are in close proximity the peptides are able to bridge them. This, 
in turn, leads to the formation of a stalk/pore complex, which is an on-pathway 
intermediate for membrane fusion. Together, these results explain the dual action 
of cyclic peptides causing both fusion and leakage. The results are consistent with 
the whole cell studies, which correlate membrane reorganization with bacteriostasis. 
Based on our current work and recent studies in other groups (226, 231, 232, 238, 
239), we believe that the stalk/pore pathway could be a common mode of action of 
membrane active peptides.
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We show how DNA is a suitable and simple scaffold to assemble and control the aggregation behavior of 
an analog of the pore-forming peptide, Alamethicin, to modulate the poration state. Two strategies were 
used: DNA-templated peptide oligomerization via base pairing, resulting in a dimer, and via G-quadru-
plex motif, resulting in a tetrameric arrangement.
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Introduction
Membrane permeability is regulated through complex transmembrane proteins 
that serve as transporters or channels. Generally, transporters pump ions or solutes 
against their concentration gradient, using either ATP or electrochemical gradients. 
Channels facilitate the movement of molecules down their concentration gradient 
and operate orders of magnitude faster than transporters. The high flux of ions (or 
neutral solutes) through channels allows for various applications. They have been 
used for their high charge or size selectivity in sensing devices, or switches have 
been incorporated to control their assembly or activity (242). Ion channels based 
on protein or peptides have been engineered to sense external stimuli such as pH, 
light, small molecules, temperature or ions (67, 142). One of the most investigated 
and engineered membrane protein is the staphylococcal α-haemolysin (αHL). The 
pore formed by the wild-type protein contains seven subunits assembled around a 
central axis, resembling a mushroom, with a well-defined β-barrel hydrophilic pore 
lumen (243). Bayley and co-workers developed several mutants of αHL that undergo 
stochastic sensing at the single molecule level. They have been engineered to sense 
compounds such as metal ions (244, 245), organic molecules, incl. amino acids (246, 
247) and proteins (248). αHL has also been used for single molecule DNA sequencing 
with direct identification of individual nucleotides molecules by the pore (249, 250). 
Besides αHL-based pores, there have been several attempts to successfully sequence 
DNA using synthetic nanopores (251). Recently, a synthetic membrane channel 
constructed entirely from DNA and anchored to the lipid membrane via cholesterol 
has been reported. This synthetic DNA nanopore serves as a single molecule biosensor 
and discriminates analyte molecules on the basis of geometry and size (87). 
Small peptides have also been engineered to control their aggregation and pore 
formation. Alamethicin is an antimicrobial peptide from the family of peptaibols, 
produced by Trichoderma viride and active against Gram-positive bacteria and 
fungi. It consists of 20 amino acids and is acetylated at the N-terminus and has a 
phenylalaniol moiety at the C-terminus. Owing to the high content of aminoisobutyric 
acid (Aib), the peptide has a typical α-helical conformation(30, 252). The amphiphilic 
monomers self-assemble into a bundle of helices forming a so-called ‘barrel-stave’ 
pore, as shown by molecular modeling (70), electrophysiology studies (71, 72) and 
recently by X-ray diffraction (73), solid-state NMR (74) and electrochemical scanning 
tunneling microscopy (EC-STM) (75). The bundle of helices traverses the membrane 
and gives rise to a voltage-dependent ion channel, with the hydrophilic face of the 
helices forming the pore of the channel (253). The oligomerization of the alamethicin 
peptides does not occur with a fixed stoichiometry. Once inserted into the membrane, 
the monomers associate and dissociate leading to different sub-conductance states, 
which relate to different pore sizes (254). It is thought that pores are formed from 3-4 
to 10-12 peptides but direct evidence is limited (71, 255-258).
Various alamethicin analogues have been synthesized to obtain more insight in the 
process of ion-selectivity, pH gating, temperature dependence of the oligomerization 
and structure of the different conducting states. Covalent anchoring of the peptides 
has been shown to stabilize specific conductance state as shown by their increased 
life time. Linking the monomers together reduces their freedom of movement, and 
the defined helical bundles give information on the conductance and oligomeric 
state. In 1 M KCl the trimer, tetramer, pentamer or hexamer showed conductances 
ranging from 0.1 nS to 1.5 nS. However, single mutations in the alamethicin channels 
or the strategy used to covalently tether the monomers had a great influence in the 
conductance state (76). 
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Different scaffolds such as flexible linkers, fullerenes, cyclic templates or simple 
disulfide bonds have been used to link the alamethicin peptides together. Alamethicin 
conjugated C-terminally to fullerene or lipid moieties led to increased life times and 
stabilization of 4 different defined oligomer assemblies (259). The synthesis of two 
different covalent dimers attached by flexible linkers resulted in three particular 
conductance states stabilized with life times, depending on the linker, 50- to 170-fold 
longer than observed with alamethicin monomers. The lowest state was attributed to 
the tetramer (two dimers), the second state to the odd number of five monomers and 
the third state to the hexamer; the latter having a conductance of approximately 1 nS 
in 1M KCl (260). Similar conductance levels were observed upon dimerization of two 
alamethicin monomers via a disulfide bond between N-terminal linkers. Channels 
had 100 times longer life times, and two main conductance levels were stabilized (261). 
Okazaki and co-workers assigned the lowest conductance state to be the tetramer 
(and the next one the hexamer), in agreement with You and Jaikaran but opposite 
to what Hanke and Boheim presumed earlier (260, 262). Tetrameric alamethicin was 
also obtained by chemically linking the monomers via the side chains of four lysines 
present in a octameric peptide with the C-terminus of the alamethicin monomers, 
which resulted in channels with a conductance of 60 pS in 1M KCl (263). In another 
strategy, a porphyrin moiety was used as scaffold for tetramerization. Single-channel 
recordings of the porphyrin-templated peptide showed much smaller but more 
uniform conductance channels than produced by the monomeric peptide. Long-lived 
channels were observed in 1M HCl but not in KCl (264). The cyclodextrin-scaffolded 
alamethicin produced long-lived channels with only one conductance state (77). 
There is also great potential for non-covalent linking of alamethicin analogues, as 
this allows reversible switching of ion conductance. To control the peptide assembly, 
an extramembrane leucine zipper segment was attached to the alamethicin, and the 
resulting channel was stabilized in a single open state. The conductance of the channel 
was 0.12 nS in 1M KCl (78). The stabilization of alamethicin channel has also been 
achieved via metal ions such as Zn2+, Ni2+ and Co2+, bearing and extra histidine at the 
N-terminus (82). By adding a chelator, the channel can in principle be destabilized. 
Also, it has been possible to fully reduce the ion conductivity of alamethicin channels 
by binding of carbonic anhydrase II (CA II) to a benzenesulfonamide group present 
at the C-terminus of the peptide. The ion transport is restored upon addition of 
excess competitor group to the solution, which released CA II (80). Another example 
to dramatically reduce the channel current is via C-terminal tagging of alamethicin 
with biotin and introducing streptavidin to the system. Further addition of biotin 
hydrazide recovered the channel activity (81). 
DNA has been used as a template to control several processes such as chemical 
reactions by modulating the effective molarity of highly dilute reactants (83), to 
perform DNA-based asymmetric catalysis (84, 85) or to control protein activity (86). 
Here, we report the use of DNA to modulate the alamethicin assembly and thus 
the size of the channel. Scheme 1 shows the dimerization strategy, using two DNA-
peptide hybrids, Alm dUL-C-3’DNA and Alm dUL-C-5’DNA. The complementary 
DNA strands are covalently attached to the peptides through a linker. The 
gathering of two peptides is based on the base-pairing concept by anchoring each 
monomer to a complementary DNA sequence, resulting in the hybrid duplex. 
We use electrophysiology measurements and dual-color burst analysis (DCFBA) 
to characterize the channels formed. We also use a G-quadruplex motif to tether 
four peptides together (see Appendix). This report demonstrates the potential of 
extramembranous DNA coupling to design new and controllable channels that could 
find a future application in the field of nano-switches and biosensors. 
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Scheme 1. Schematic representation of the dimerization of DNA-
peptide hybrids. (A) Alm dUL-C-3’DNA. (B) Alm dUL-C-5’DNA. 
(C) Hybrid duplex. Cilinders, Alm dUL-C peptide helices; the 
complementary DNA strands are presented in red and blue.
Materials and methods
Reagents and apparatus
Alm dUL-C: Ac-LPLALAQLVLGLLPVLLEQFC-NH2 was purchased from Cambridge 
Peptides Ltd (Birmingham, UK). 3-Maleimidopropionic and 6-maleimidohexanoic 
acid N-hydroxysuccinimide esters were acquired from TCI Europe. Synthetic 11-mer 
oligonucleotides Oligo 1 (5’ACCATGCTTAA3’-(CH2)6-NH2) and Oligo 2 (H2N-(CH2)6-5’TTAAGCATGGT3’) were purchased from BioTez (Berlin Buch). Oligonucleotide 
concentrations were determined using the Nanodrop ND-100 (Thermo Fisher 
Scientific). Column chromatography was performed on silica gel. Reversed phase-
HPLC (RP-HPLC) analysis were performed on a Shimadzu LC-10AD VP, Waters 
Xterra MS C18 column (3.0 x 150 mm, particle size 3.5 μm) using generally the 
gradient A (for DNA samples) of CH3CN/Triethylammonium acetate (TEAA) buffer 
50 mM pH = 7.0. Gradient A: 05/95 from 0 to 10 min, to 35/65 at 60 min, to 70/30 at 65 
min, to 05/95 at 70 min for 20 min; flow of 0.5 mL/min. For purification purposes of 
the DNA-peptide hybrid compounds, a Waters Xterra Prep MS C18 column (7.8 x 150 
mm, particle size 10 μm) was used in combination with solvent gradient B. Gradient 
B: 20/80 from 0 to 10 min, to 100/0 at 55 min for 15 min, to 20/80 at 80 min for 10 
min; flow of 1.0 mL/min. MALDI-TOF measurements were done on a Voyager-DE 
Pro apparatus (Matrix: 20 μL of a solution of 2, 4, 6-Trihydroxyacetophenone 0.5 M in 
EtOH + 10 μL of a solution of ammonium citrate dibasic 0.1 M in double distillated 
(dd) H2O + 2 μL sample solution in dd H2O). Phospholipids 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylcholine (POPC) and 1,2-dioleoyl-sn- glycero-3-phosphatidyl-
ethanolamine (DOPE) were from Avanti Polar Lipids (Alabaster, AL). The n-decane 
was from Sigma-Aldrich (St. Louis, MO).
Synthesis of the maleimide-functionalized DNA
300 µL of amino-modified oligonucleotide, Oligo 1 (3’DNA) or Oligo 2 (5’DNA), 
solubilized in dd H2O at 200 µM was mixed with 200 µL of 200 mM sodium phosphate 
pH 7.2 and 100 µL of the maleimido N-hydroxysuccinimide ester solution (compound 
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1 or 2, 20 mg/mL in DMF), yielding maleimide(1 or 2)-3’DNA and maleimide(1 or 
2)-5’DNA. The reaction was vortexed at room temperature for 4h. The functionalized 
DNA was purified by size exclusion chromatography (Sephadex G-15, eluting with 
50 mM TEAA buffer, pH 7.0) and characterized by RP-HPLC and MALDI-TOF.
Maleimide(1)-3’DNA 
RP-HPLC rt = 40 min  
MALDI-TOF (m/z) = 3648 [M+Na]+ 
(calculated 3652)
Maleimide(1)-5’DNA 
RP-HPLC rt = 35 min  
MALDI-TOF (m/z) = 3722 [M+Na]+ 
(calculated 3722)
Maleimide(2)-3’DNA 
RP-HPLC rt = 40 min.  
MALDI-TOF (m/z) = 3672 (calculated 
3671)
Maleimide(2)-5’DNA 
RP-HPLC rt = 36 min  
MALDI-TOF (m/z) = 3741 (calculated 
3742)
Synthesis of the DNA-peptide hybrids
100 µL of maleimide(2)-3’DNA or maleimide(2)-5’DNA at 100 µM, solubilized in 
50 mM TEAA buffer pH 7.0, was added to 300 µL Alm dUL-C of a freshly made 
solution of peptide in DMF (2.0 mg/mL). The solutions of DNA and peptide were 
flushed under nitrogen atmosphere before and during the overnight stirred reaction. 
The crude mixture was centrifuged and the supernatant was purified by RP-HPLC, 
using gradient B. The products, Alm dUL-C-3’DNA hybrid and Alm dUL-C-5’DNA 
hybrid, were analyzed by RP-HPLC and MALDI-TOF.
Alm dUL-C-3’DNA hybrid  
RP-HPLC rt = 42 min  
MALDI-TOF (m/z) = 5974 
(calculated 5976)
Alm dUL-C-5’DNA hybrid  
RP-HPLC rt = 42 min 




A planar lipid bilayer setup (or black lipid membrane – BLM) was used as described 
below. The bilayer was formed by painting with 1 μl of a 20 mg/ml solution of 
POPC/DOPE (3/7) lipid in n-decane across the 250 μm opening of a Delrin cup 
that separates two solution-filled compartments, designated cis and trans (191-193). 
Both compartments were filled with a buffer solution consisting of 1 M KCl. The 
transmembrane current (Im) at different clamping potentials (V) was monitored, 
using an integrating Bilayer Clamp Amplifier BC-535 (Warner Instruments). Currents 
were filtered through an 8-pole low-pass Bessel Filter LPF-8 (Warner Instruments) 
and digitized using Clampex 10.2 software (Axon Molecular Devices). Membrane 
conductance (g) events were identified as g = Im/V and analyzed with the Clampfit 
software (Axon Molecular Devices) (163). Before adding the peptide, the membranes 
were checked for stability by applying the same range of voltage as in the presence 
of compound. The compounds were added to the cis side of the planar lipid bilayer 
and stirred for 1 minute without applying voltage. Three traces per compound were 
recorded with freshly prepared membrane. The pore diameter was estimated by an 
extended version of the model proposed by Hille (66, 265), given by Cruickshank et 
al. (196): 
Eq. 1 
where d is the diameter of the pore, r is the resistivity of the buffer, g is the measured 
conductance, and l is the length of the pore. The unitary pore conductance, g, was 
estimated from all recordings. The resistivity of the buffer, 1M KCl, was assumed 
to be 0.1 Ωm (266). The length of the pore equals the membrane thickness and was 
assumed to be 3.5 nm.
DCFBA
Liposomes were prepared as described by van den Bogaart (37). Briefly, 
1,1’-dioctadecyl-3,3,3’,3’-tetramethylindodicarbo-cyanine perchlorate (DiD; 
Invitrogen, Carlsbad, CA) labeled-liposomes were prepared by rehydration of a 
DOPC/DOPE (3:7) dried lipid film in the presence of glutathione (GSH)-labeled 
Alexa Fluor 488 (AF488), 3 kDa dextran labeled with fluorescein (Invitrogen) or 10 
kDa dextran labeled with fluorescein (all from Invitrogen) as aqueous phase markers 
in 10 mM 2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethanesulfonic acid (HEPES; Roche 
Diagnostics, Mannheim, Germany), pH 7.0, containing 150 mM NaCl (Merck, 
Whitehouse Station, NJ). The DiD/lipid molar ratio was 1:40,000. Subsequently, the 
liposomes were extruded 11 times through a 200 nm polycarbonate filter (AVESTIN, 
Ottawa, Ontario, Canada). The liposomes were separated from the non-encapsulated 
fluorophores by centrifugation (20 min, 270,000 g, 20˚C) and resuspended in the same 
buffer to a final lipid concentration of 625 µM. Fluorescence burst analysis was carried 
out on a laser-scanning confocal microscope, LSM 710 (Carl Zeiss MicroImaging, 
Jena, Germany), using an objective C-Apochromat 406/1.2 NA, a blue argon ion laser 
(488 nm) and a red He-Ne laser (633 nm). Different compounds were added to the 
liposomes to a final concentration of 5, 10 or 20 µM. The samples were equilibrated 
for 10 min at room temperature after each addition. The fluorescence bursts of single 
liposomes were measured for 5 min. The results are presented in the DCFBA profiles 
as the population-distribution histogram of liposomes with a given internal marker 
concentration, Ci, given by:
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Eq. 2 
where IL is the fluorescence of the lipid marker and ISM is the fluorescence of the 
internal size marker in each fluorescence burst (38). The amount of vesicles was taken 
as the total number of lipid bursts.
Results
Synthesis of the DNA-peptide hybrids and the dimer hybrid duplex 
The non-natural amino acid Aib of alamethicin complicates the synthesis of the 
peptide. Therefore, we use the analogue Alm dUL, firstly synthesized by Molle et 
al. (267), in which the Aib residues and the C-terminal phenylalaniol (Pheol) are 
replaced by leucine (Leu) and an amidated phenylalanine (Phe), respectively. The 
acetylated N-terminus was maintained. This analogue showed a behavior consistent 
with the ‘barrel-stave’ model with conductance ratios of the sub-levels very similar 
to those of wild-type alamethicin. However, the life times of the channels were about 
one order of magnitude shorter (267, 268). An extra cysteine (Cys) on the C-terminus 
was added to couple the peptide to the maleimide functionality introduced into the 
DNA. 
Synthesis of maleimide(2)-3’DNA and maleimide(2)-5’DNA
The DNA-peptide hybrids, Alm dUL-C-3’DNA and Alm dUL-C-5’DNA, were 
synthesized from two different starting oligonucleotides, Oligo 1 and Oligo 2. 
Oligo 1 (modified at the 3’-terminus) and Oligo 2 (modified at the 5’-terminus) 
bearing a hexyl amino linker were reacted with the 3-maleimidopropionic acid 
N-hydroxysuccinimide ester 1 (Scheme 2A, shows the reaction for Oligo1). The 
maleimide moiety of the modified DNA proved to be instable during the reaction 
conditions of the conjugation to the peptide (Scheme 2). 
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Scheme 2. Synthesis of the DNA-peptide hybrid from Oligo 1 with ester 1.
We thus decided to couple the DNA to a longer maleimide linker, ester 2. (Scheme 
3). An excess of maleimide ester 2 was added to the solution of the amino-modified 
DNA, Oligo 1 and Oligo 2, in 200 mM sodium phosphate, pH 7.2 (Scheme 3A). The 
reactions were followed by HPLC and purified by size-exclusion chromatography 
resulting in yields between 78-88 %. Analytical HPLC traces of the two resulting 
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Scheme 2. Synthesis of the DNA-peptide hybrid from Oligo 1 with ester 1.
We thus decided to couple the DNA to a longer maleimide linker, ester 2. (Scheme 
3). An excess of maleimide ester 2 was added to the solution of the amino-modified 
DNA, Oligo 1 and Oligo 2, in 200 mM sodium phosphate, pH 7.2 (Scheme 3A). The 
reactions were followed by HPLC and purified by size-exclusion chromatography 
resulting in yields between 78-88 %. Analytical HPLC traces of the two resulting 



















































































Figure 1. RP-HPLC traces of maleimide-functionalized DNA and DNA-peptide hybrids. (A) Maleimide(2)-
3’DNA. (B) Maleimide(2)-5’DNA. (C) Alm dUL-C-3’DNA. (D) Alm dUL-C-5’DNA.
Synthesis of the Alm dUL-C-3’DNA and Alm dUL-C-5’DNA
The synthetic peptide was highly insoluble in water, making the coupling procedure 
more challenging than expected. Different solvents in mixture with water were 
tested to solubilize the peptide, but always some precipitation of the peptide was 
observed. The optimum reaction conditions were found with the peptide solubilized 
in a polar solvent like DMF and the functionalized DNA in TEAA buffer (50 mM, pH 
=7.0), using DMF:TEAA ratio of 3:1 for the conjugation (Scheme 3B). An undesired 
product was obtained during the reaction, which was identified with MALDI-TOF. 
The peptide reacted with 6-maleimidohexanoic acid of which there were still trace 
amounts present in the functionalized DNA obtained after purification by size-
exclusion chromatography. Excess of the Alm dUL-C was used (10-30 equivalent) 
to bring the reaction to completion. The reaction was conducted under nitrogen 
atmosphere to minimize disulfide bond formation between cysteine residues of two 
monomers. The hybrids, Alm dUL-C-3’DNA and Alm dUL-C-5’DNA, were purified 
by RP-HPLC (Figure 1C and 1D) with a final yield of 10-13% over two steps and 
characterized by MALDI-TOF (Figure 2). 
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Figure 2. MALDI-TOF spectra of the DNA peptide hybrids. (A) Alm dUL-C-3’DNA, m/z = 5974. (B) Alm 
dUL-C-5’DNA, m/z = 6051.
Hybridization
The hybridization was carried out by mixing equal volumes of 300 µM DNA-peptide 
hybrid solution. The mixture was then heated to 90˚C and subsequently cooled down 
to room temperature. The dimeric hybrid duplex solution had a concentration of 
150 µM, assuming hybridization. Unfortunately, neither RP-HPLC nor MALDI-TOF 
characterization could be performed since dissociation of the duplex occurred under 
the conditions of analysis. 
DNA hybridization stabilizes Alm-formed pores
To evaluate the electrical behavior of the DNA-peptide hybrids and the dimeric 
hybrid duplex, the planar lipid bilayer setup was used. Figure 3 shows the 
recorded single-channel traces. Alm dUL-C peptide without DNA showed short-
lived events and conductance states of 0.2 nS, 0.6 nS and 1 nS; the first one being 
the most populated (Fig 3A). These results are in agreement with those obtained 
with Alm dUL (conductance of 0.12, 0.56 and 1 nS), showing that the monomers 
have the freedom to assemble together with different oligomeric states. These three 
difference conductance levels are thought to represent tetrameric, pentameric and 
hexameric channels (267). The two DNA-peptide hybrids, Alm dUL-C-3’DNA and 
Alm dUL-C-5’DNA also gave very short-lived channel openings but with smaller 
conductance than observed with Alm dUL-C, which might be at attributed to the 
presence of the 11-mer oligonucleotide. The process of self-assembly of the hybrid 
duplex resulted in a major conductance ~0.75 nS or multiples thereof (Fig. 3D). The 
other conductance states are all of uniform size, implying that channels of similar 
conductance are opening simultaneously. Using Eq. 1 we estimate the pore size of 
the hybrid duplex to be about 0.6 nm in diameter. We tentatively assign the 0.75 nS 
level to a hexameric channel (three dimers). The hybrid duplex also shows two lowly 
populated conductance states of around 1 and 1.9 nS. These could represent higher 
oligomeric states but we did not characterize them further. Molle et al. assigned a 1.9 
nS channel to the octameric state. However, the membrane lipid composition was 
different from ours and the datasets cannot be compared directly (267). The channel 
life times of the hybrid duplex also appeared longer, around 4 ms on average, 
compared to the ones of Alm dUL-C and the two hybrids Alm dUL-C-3’DNA and 
Alm dUL-C-5’DNA, around 0.3 ms on average. All modified Alm channels tested 
allowed the flux of both positive and negative ions (data not shown). 
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Figure 3. Single-channel recordings. Left and middle panels show two different magnifications of the traces, 
and the right panels show the population of the conductance levels. (A) Alm dUL-C, 7.5 nM. (B) Alm dUL-
C-3’DNA, 7.5 nM. (C) Alm dUL-C-5’DNA, 7.5 nM. (D) Hybrid duplex, 0.75 nM. Numbers in the middle 
panel represent the current values of the multiple levels in pA.
The DNA stabilized state is not concentration dependent
Next, we determined whether or not the occurrence of the conductance state of 0.75 
nS is peptide concentration dependent by analyzing the concentration range of 0.075-
3.5 nM (Figure 4). Our data show in all cases multiples of the 0.75 nS conductance 
and there was no correlation between the number of channels and the concentration 
peptide added to the buffer reservoir of the black-lipid membrane set up. This might 
mean that the local concentration at the membrane surface is similar in all the cases. 
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Figure 4. Single-channel recordings of hybrid duplex at different concentrations. Left and middle panels show 
two different magnifications of the traces, and the right panels show the population of conductance levels. 
(A) 3.5 nM. (B) 0.75 nM. (C) 0.15 nM. (D) 0.075 nM. 
As a control, we analyzed the mixture of the two hybrids, Alm dUL-C-3’DNA and 
Alm dUL-C-5’DNA, prior to DNA hybridization (Fig. 5A). The results are similar 
to those of Alm dUL-C and the two hybrid peptides analyzed separately (Fig. 
3A-C), indicating that the monomers assemble dynamically resulting in several 
oligomeric states. Importantly, these data demonstrate that in case of hybrid duplex 
(Fig. 3D), the two DNA-modified peptides indeed hybridized and this resulted in 
a preferred channel assembly. In another control the Alm dUL-C-3’DNA monomer 
was hybridized with Oligo 2 (Alm dUL-C-3’DNA/Oligo2) without bearing peptide 
(Fig. 5B), and so only monomers with double stranded DNA could be formed. As 
expected, the conductance states are very similar to those obtained by the Alm dUL-
C-3’DNA monomer (Fig. 3B). The probability of various conductance states differed 
somewhat and some additional conductance levels were obtained with Alm dUL-C-
3’DNA/Oligo2. This could be due to the hindrance caused by the two DNA strands 
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per monomer instead of one. 
Figure 5. Single-channel recordings of control samples. Left and middle panels show two different 
magnifications of the traces, and the right panels show the population of conductance levels. (A) Mixture 
of Alm dUL-C-3’DNA + AlmdUL-C-5’DNA without hybridization, 3.75 nM. (B) Alm dUL-C-3’DNA/
Oligo2, 3.75 nM. 
DCFBA to probe the dimensions of the Alm-DNA channels
To estimate the minimal pore diameter of the channels, we performed DCFBA with 
different size markers encapsulated inside the vesicles. We used GSH-AF488 (Fig. 
6A), 3KDa dextran-fluorescein (Fig. 6B) and 10 KDa dextran-fluorescein (Fig. 6C). 
We observed leakage of GSH-AF488 with Alm dUL-C-5’DNA and Alm dUL-C, as 
seen in fig. 6A (blue and black dashed line, respectively) by a left-shift towards lower 
vesicle concentrations. This indicates that the minimal pore diameter is at least 1.35 
nm (hydrodynamic radius of GSH-AF488).(163) The peptide without DNA showed 
greater leakage (Fig. 6A, black dashed and blue lines), indicating that the DNA has 
some influence on the conformation or dynamics of the pore. In the case of Alm dUL-
C-5’DNA we also observed substantial release of 3 KDa dextran and some of 10 KDa 
dextran (Fig 6B and 6C blue line). That would correspond to a pore size around 2 
nm by the dimensions of the 10 KDa dextran (shortest axis measured assuming the 
shape of a prolate ellipsoid).(163) Surprisingly, Alm dUL-C-3’DNA and the hybrid 
duplex did not leak any of the size markers even though these channels facilitated 
the flux of ions with conductances from 0.2-1.5 for Alm dUL-C-5’DNA and a main 
stabilized conductance of 0.75 nS for the hybrid duplex. These data clearly show 
that the structure of the DNA (hybrid duplex versus single-stranded, and 5’ versus 
3’linked) has major impact on the channel functioning. 
Figure 6D shows that the parental peptide, Alm dUL-C and the two DNA-peptide 
hybrids, Alm dUL-C-3’DNA and Alm dUL-C-5’DNA, resulted in a decreased number 
of vesicles detected, which either means that vesicles are fusing or aggregating in the 
presence of the DNA-peptide hybrids. When vesicle fusion or aggregation occurs, 
the diffusion of those slows down and less vesicles diffuse through the detected 
focal volume. Another reason for the decreased amount of vesicles could be vesicle 
disruption, although this can not be the case here as the background fluorescence in 
the DCFBA traces was similar in all cases. 
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Figure 6. Contents leakage via DNA-peptide hybrids and hybrid duplex by DCFBA analysis and using markers of 
different size. (A) GSH-AF488. (B) 3 KDa dextran-fluorescein (C) 10 KDa dextran-fluorescein. Black lines: 
intact vesicles, without peptide; red line: Alm dUL-C-3’DNA at 10 µM; blue line: Alm dUL-C-5’DNA at 
10 µM; dashed black line: Alm dUL-C at 10 µM; dashed red line: hybrid duplex at 20 µM. (D) The relative 
number of vesicles is given as percentage; error bars represent standard deviation of the mean (n = 3).
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Conclusions
We synthesized two complementary DNA-peptide hybrids, Alm dUL-C-3’DNA and 
Alm dUL-C-5’DNA, and by hybridization we formed the dimeric, hybrid duplex. 
All the compounds inserted into the POPC/DOPE (7:3) membranes as shown by 
the electrical recordings and observation of single-channel conductances. The non-
duplexed hybrids showed similar channel behavior as the parental Alm dUL-C 
peptide with conductance states in 1 M KCl of about 0.2, 0.6 and 1 nS, which by 
comparison with literature (267), could correspond to tetrameric, pentameric and 
hexameric channels. In contrast, the hybrid duplex gave a main conductance state 
of about 0.75 nS, which would be equivalent to a pore diameter of about 0.6 nm. 
Considering the hindering effects of the DNA strands, we assign this conductance 
state to the hexameric assembly. Tetrameric assemblies of alamethicin gave lower 
conductance levels (0.1-0.2 nS) (78). A pore size estimated from electrophysiology 
of about 0.6 nm is in agreement with the DCFBA experiments as none of the marker 
molecules leaked out of the vesicles when the hybrid duplex was used. The smallest 
marker, GSH-AF488, has an approximate diameter of 1.35 nm measured by its 
hydrodynamic radius) (163). Because GSH-AF488, the 3KDa-dextran and the 10 
KDa-dextran are released from one of the DNA hybrids, Alm dUL-C-5’DNA, the 
pore diameter must be at least 2 nm. The size is in agreement the highest conductance 
analyzed by this compound, 5.25 nS, corresponding to a pore diameter of 1.8 nm. 
The parental peptide Alm dUL-C only allowed the leakage of GSH-AF488, what 
corresponds to a pore size of at least 1.35 nm, also in agreement with the maximum 
conductance observed of 4 nS equivalent to a pore diameter of 1.55 nm.
In summary, the DNA-driven dimerization of Alm dUL-C stabilizes the channel and 
may be a means to control the gating by further functionalization of the DNA moiety. 
Disassembly of the dimers with competing DNA or other strategies could lead to 
release of molecules with a diameter up to about 1.35 nm. 
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APPENDIX: The use of G-quadruplex DNA as a scaffold for 
Alm dUL-C channels
We used the G-quadruplex DNA motif as a scaffold to build a tetrameric peptide-based 
channel (Scheme 4). G-rich synthetic nucleotides can have a unique structure that have 
found applications in biotechnology and nanotechnology (269). G-quadruplexes have 
also been investigated as building blocks for creating and mimicking ion channels. 
Different G-quadruplex structures have been reported depending on the orientation 
of the strands. Here, we use the Oligo G (GGGTT) that forms a parallel G-quadruple 
in the presence of potassium ions as depicted in scheme 4.
Scheme 4. Schematic representation of 
G-quadruplex DNA based peptide formation. 




Reagents. Oligo G (H2N-(CH2)6-5’GGGTT3’) and Oligo N (H2N-(CH2)6-5’GTATT3’) were 
purchased from BioTez (Berlin Buch). 
Synthesis of the maleimide-funcionalized DNA. Same procedure as for the 
maleimide(2)-3’DNA and maleimide(2)-5’DNA (see previous materials and methods)
Maleimide(2)-G 
RP-HPLC retention time = 30 min  
MALDI-TOF (m/z) = 1905 (calculated 1904) 
Maleimide(2)-Gnegative 
RP-HPLC retention time = 39 min  
MALDI-TOF (m/z) = 1865 (calculated 1863) 
Synthesis of the DNA-peptide hybrids. Same procedure as for Alm dUL-C-3’DNA 
and Alm dUL-C-5’DNA (see previous materials and methods)
Alm dUL-C-G hybrid 
RP-HPLC rt = 70 min  
MALDI-TOF (m/z) = 
[M+2K–H-]+ 4289 (calculated 
4288)
Alm dUL-C-Gnegative hybrid 
RP-HPLC rt = 43 min  
MALDI-TOF (m/z) = 4172 
(calculated 4170)
Results
Synthesis of the DNA-peptide hybrids and the G-quadruplex 
The Alm dUL-C-G hybrid was obtained via the complementary DNA strands (see 
previous section). Scheme 5 shows the two reactions carried out. The amino modified 
Oligo G reacted with ester 2, resulting in the maleimide conjugate of the oligo, 
Maleimide(2)-G (Scheme 5A). The compound was then purified by size-exclusion 
chromatography. The final hybrid was obtained by mixing the maleimide (2)-G in 
TEAA with the Alm-dUL-C in DMF under nitrogen atmosphere overnight (Scheme 
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Scheme 5. Synthesis of the DNA-peptide hybrids from Oligo G with ester 2. (A) Yield of 85 %. (B) Yield of 20 %. 
Total yield of 17 %.
Figure 7. RP-HPLC traces of maleimide-functionalized DNA and DNA-peptide hybrids. (A) Maleimide(2)-G. (B) 
Alm dUL-C-G hybrid.
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As a control we synthesized another DNA-peptide conjugate with the Oligo N 
(GTATT), that is not able to form G-quadruplexes. This hybrid, Alm dUL-C-Gnegative, 
remains monomeric and serves as a control for the tetrameric assembly of the GQ. 
Alm dUL-C-Gnegative was obtained by reacting the amino modified Oligo with the 
maleimide ester 2 (same reactions than in scheme 5) with a yield of 87 %. Then, by 
reaction with the Alm dUL-C, the hybrid was obtained with a yield of 23 % and final 
yield of 20 % over the two steps. Figure 8 shows the MALDI-TOF spectra of the two 
hybrids synthesized, Alm dUL-C-G hybrid and Alm dUL-C-Gnegative hybrid.
Figure 8. MALDI-TOF spectra of the DNA-peptide hybrids. (A) Alm dUL-C-G, m/z = 4289. The different 
peaks are the result of positive ions trapped in the quadruplex structure (e.g. Na+ and K+). (B) Alm dUL-
C-Gnegative, m/z = 4172.
The oligo G-peptide should fold and form a G-quadruplex motif in the presence of 
potassium ions. One of the techniques commonly used to identify and characterize 
the G-quadruplex formation is circular dichroism (CD) spectroscopy (270). Figure 
9 shows the CD spectra of the two DNA-peptide hybrids. The Alm dUL-C forms 
a α-helix peptide and yields a different CD spectrum than parallel G-quadruplex 
or β-DNA structures. The single strands of DNA are expected to be orientated 5’-3’ 
folding into a parallel G-quadruplex structure, with a positive band at ~260 nm and 
a negative band at ~240 nm. As anticipated, in the case of Alm dUL-C-Gnegative 
hybrid no G-quadruplex structure was obtained.
Figure 9. CD spectra of the DNA-peptide 
hybrids. Dashed black line represents the Alm 
dUL-C-G forming the GQ. Full black line 
represents the Alm dUL-C-Gnegative hybrid.
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GQ forms a channel with a main conductance state of 1 nS
The channel behavior of the G-quadruplex forming hybrid, Alm dUL-C-G, and 
the negative control, Alm dUL-C-Gnegative, was studied by electrophysiology 
measurements (see previous materials and methods). In this case, a voltage of 180 mV 
was applied for a few minutes to decrease the time needed to observe activity. All the 
recordings were subsequently conducted at 60 mV. Figure 10 shows the single-channel 
recordings. As expected, the Alm dUL-C-Gnegative yielded different conductance 
states, corresponding to a different number of monomers assembling together; the 
first observed level was populated the most and corresponded to a conductance of 
around 0.2 nS (Figure 10A), which is similar to the behavior of Alm dUL-C, Alm dUL-
C-3’DNA and Alm dUL-C-5’DNA (see above). The negative control was not able to 
form a stable preferred assembly but instead aggregates in a dynamic fashion. In 
contrast, the GQ mainly stabilizes one preferred conductance state of about 1 nS with 
relatively long-lived events (Fig. 10B), corresponding to a pore diameter of 0.7 nm by 
using Eq. 1. The other conductance levels represent multiples of 1 nS, corresponding 
to more than one channel opened simultaneously. Thus, the G-quartet motif dictates 
the aggregation of the peptides resulting in a tetrameric synthetic channel. 
Figure 10. Single-channel recordings of the DNA-peptide hybrids. Left and middle panels show two different 
magnifications of the traces, and the right panels show the population of conductance levels. (A) Negative 
control, Alm dUL-C-Gnegative hybrid, 3.5 nM (B) GQ, 3.5 nM.
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DCFBA shows no leakage of any size marker analyzed
The DCFBA analysis with the three different size markers of tetrameric G-quadruplex, 
GQ and the negative monomeric Alm dUL-C-Gnegative hybrid are shown in figure 
11. The results show no leakage of any size marker analyzed, not even the smallest 
i.e. GSH-AF488 which is 1.35 nm in diameter (Fig. 11A-C; dashed black lines). 
Surprisingly, the negative control, Alm dUL-C-Gnegative gave similar results, even 
though the monomers have the freedom to associated and dissociate. DNA repulsions 
of the single strands may influence the number of monomers associating and thus the 
pore size.
Figure 11. Pore leakage by DCFBA analysis using different size markers. (A) GSH-AF488. (B) 3 KDa dextran-
fluorescein (C) 10 KDa dextran-fluorescein. Black lines: intact vesicles, without peptide; dashed black line: 
GQ at 10 µM; grey line: Alm dUL-C-Gnegative at 10 µM. (D) Relative amount of vesicles indicated as %; 
error bars represent the standard deviation of the mean (n = 3).
Conclusions
The synthesis of a tetrameric alamethicin-based synthetic channel was achieved by 
the hybridization of Alm dUL-C peptide with a 5-mer oligonucleotide that forms a 
G-quadruplex in the presence of potassium ions. The channel had a conductance of 
about 1 nS, which could correspond to a pore diameter of 0.7 nm. This pore size is 
consistent with the absence of contents release from vesicles shown by DCFBA. 
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Disaccharides are well known for their membrane protective ability by coating the lipid headgroups. Inte-
raction between sugars and multi-component membranes, however, remains largely unexplored. Here we 
combine molecular dynamics simulations and fluorescence microscopy to study the effect of mono- and 
disaccharides on model membranes that phase separate into Lo and Ld domains. Remarkably, we find that 
non-reducing disaccharides strongly destabilize the Lo phase leading to uniformly mixed membranes. 
Monosaccharides, on the other hand, do not have a noticeable effect on the phase behavior, even when the 
concentration is increased to a matching level of sugar rings. To unveil the driving force for this process, 
additional simulations were performed in which the sugar linkage was artificially modified. These data 
point to an incommensurate nature of the disaccharide geometry and the lipid cholesterol packing in the 
Lo phase. Together, our results show that non-reducing disaccharides can have a strong impact on lateral 
membrane organization. The mechanism by which disaccharides disturb the Lo domain might prove to be 
a more generic way by which surface bound agents could affect membranes.
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Introduction
One of the most intriguing phenomena in biology is the occurrence of anhydrobiosis 
in the life cycle of several organisms from all kingdoms of life such as yeasts, 
tardigrades, nematodes, bacteria and plants. In the anhydrobiotic state, the amount 
of liquid water in the organism is reduced to a level where the metabolism is 
completely (but reversibly) stopped (47, 48, 271). A common physiological response 
to anhydrobiosis is the synthesis of cryo-protective sugars, such as the disaccharides 
sucrose and trehalose, which are accumulated intracellularly also during temperature 
drifting, osmotic shifting and oxidative stress (272-274). 
The direct interaction between lipid and sugar molecules have been demonstrated by 
a diversity of experimental techniques, including infrared spectroscopy, differential 
scanning calorimetry, nuclear magnetic resonance (NMR), and X-ray diffraction (61, 
275-279). Sugars have proven to be effective in protecting membrane by lowering the 
gel-fluid phase transition upon dehydration. This phenomenon has been observed 
for the monosaccharide glucose and disaccharides sucrose and trehalose (49, 50, 
52-55). The effect can be explained by a direct replacement of the water molecules 
by the sugars, preventing the increase in the packing of the lipid acyl chains in the 
dry state. This effect is called the “water replacement” hypothesis (52, 55, 56, 60). 
Other explanations for the protection ability of sugars during dehydration are the 
“vitrification”, the “water-entrapment” and the “hydration repulsion” hypotheses, 
which indicate that sugars protect biomolecules by the formation of amorphous 
glasses, by concentrating water molecules close to the membrane or by being 
excluded from the surface (57-60). The latter would reduce the compressive stress of 
the membrane upon dehydration. Even though different hypotheses have been put 
forward, several studies have indicated that different mechanisms of protection may 
act simultaneously (60). 
In fully hydrated membranes the sugar-lipid interactions have been classified in the 
“interaction” and “exclusion” hypotheses. In the first one the sugars interact directly 
with the lipid membranes as seen by an expansion of the phospholipid monolayers 
when sucrose or trehalose are added (49, 62, 280, 281). The increased membrane area 
is caused by the sugars intercalating between the lipid headgroups. On the contrary, 
the “exclusion” hypothesis, describes a partial depletion of sugar in the hydration 
zone of the lipid bilayer (55, 59, 61, 62). Andersen and coworkers demonstrated that 
the two opposing views on lipid-sugar interactions might both be true and take 
place simultaneously. At low sugar concentration the attractive contribution between 
sugar and lipid by hydrogen bonding dominates, resulting in a lateral expansion of 
the membrane due to the intercalation of the sugars in between the lipid headgroups. 
At higher concentrations the kosmotropic contribution dominates, which causes a 
general depletion of sugars from aqueous interfaces (62). 
So far, studies have been mostly directed at simplified model membranes. Real 
membranes, however, consist of a complex mixture of hundreds of different lipid 
types and proteins. The current view describes biomembranes as a heterogeneous 
material in which preferential association of certain lipids, sterols, and proteins can 
lead to the formation of nanodomains, so-called “lipid rafts”. Such rafts, enriched in 
cholesterol and saturated lipids, display physicochemical properties different from 
those of their disordered fluid surroundings, and are believed to play an important 
role in the self-assembly of membrane proteins into functional platforms (1, 18, 282). 
Thus, a complete overview of the mechanism of action of different sugars should be 
undoubtedly analyzed and compared in terms of membranous lateral heterogeneity. 
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In this work we have used molecular dynamics (MD) simulations together with 
fluorescence confocal microscopy to study the effects of sugars on membranes with 
coexisting Lo and Ld domains.  We found that the lateral organization of the membrane 
is drastically affected by the interaction with small sugars. Single monosaccharides 
(glucose and fructose) and reducing disaccharides (including palatinose, maltose and 
gentiobiose) do not modify the Lo/Ld equilibrium, while non-reducing disaccharides (e.g. trehalose and sucrose) disrupt the domains and promote lipid re-mixing. The 




All simulations were carried out with the Gromacs MD package, version 4.0.5. 
The MARTINI coarse grained (CG) force field (283, 284) was used to describe the 
interactions. Molecules considered in this study are the saturated lipids dipalmitoyl-
phosphatidylcholine (diC(16:0)PC, DPPC), the unsaturated lipid dilinoleoyl-PC 
(diC(18:2)PC, DLiPC), cholesterol, and the sugars glucose (GLC), trehalose (TRH), 
and sucrose (SUC) at 60 mM, 200 mM, and 600 mM concentrations. An equilibrated 
Lo/Ld lipid bilayer (285) was used as initial conformation for our simulations. The system is composed of 769 DPPC, 507 DLiPC, and 538 cholesterol molecules (4:3:3 
molar ratio). Additional simulations of Lo and Ld mimetic membranes were used to 
probe the structural effects of sugar binding. The Lo membrane consists of 328 DPPC and 164 cholesterols (2:1 ratio), the Ld membrane of 448 DLiPC and 44 cholesterols (10:1 ratio). Temperature in each case was maintained by coupling to a heat bath at 
288 K.
GUVs preparation 
GUVs were prepared by electroformation (286, 287). Briefly, a lipid mixture of 
N-stearoyl-D-erythro-sphingosylphosphorylcholine (SM), 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC) and cholesterol was prepared from the lipid stock solution 
in chloroform/methanol (9:1) with a molar ratio of 4:3:3 (lipids were purchased 
from Avanti Polar Lipids). The fluorescent lipid marker DiI-C18 (1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate, Molecular Probes, Invitrogen) 
dissolved in chloroform, and the ovine brain ganglioside GM1 (GM1, Avanti Polar 
Lipids) dissolved in methanol were added to the lipid mixture at the amount of 0.1 
mol%. The lipid mixture was applied to indium-tin oxide-coated glasses, solvents 
were evaporated and glasses were pre-warmed at 50ºC before placing them in the 
electroformation chamber of Nanion Vesicle Prep Pro (Nanion Technologies GmbH, 
Munich, Germany). The chamber was filled with buffer (10 mM KPi, pH 7,2) or 
buffer containing different concentrations of saccharides, pre-warmed at 50ºC. An 
alternating current was applied across the cell unit with 1.1 V, 10 kHz of frequency 
and 50ºC for 1 hour. Sugar solutions osmolarities were checked on OSMOMAT 030 
(Genotec). GUVs had a diameter of 5–15 µm. As a control we repeated some of the 
experiments with DPPC instead of SM similar as in the MD simulations (data shown 
in Fig. 8 and Table 3).
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GM1 labeling with AF-488
Labeling was done according to an established protocol with minor modification 
(288). Briefly, GM1 was kept on ice for 30 min with oxidizing reagent (sodium meta-
periodate). After the oxidation of GM1, sodium sulfite was used to quench excess 
of sodium meta-periodate instead of using ultrafiltration (289). Subsequently, Alexa 
Fluor 488 hydrazide was added. The reaction was conducted at room temperature 
for 2 hours, after which GM1 was separated from free AF488 by size-exclusion 
chromatography (GE Healthcare NAP5 Sephadex G-25 column).
Confocal fluorescence microscopy and data analysis
GUVs were incubated for 10 minutes with the Alexa Fluor 488 conjugate of cholera 
toxin B subunit (AF-CTB, Molecular Probes, Invitrogen), for which GM1 is the natural 
receptor; the complex GM1-CTB was detected only in areas from which DiI-C18 was strongly excluded (290). Thus, AF-CTB reports SM-enriched (Lo) domains and DiI-C18 reports DOPC-enriched domains. After incubation, GUVs were immobilized with the hydrogel Articyt (Nano-FM), previously adjusted to the desired saccharide 
concentration to avoid osmotic stress. Samples were imaged on a commercial laser-
scanning confocal microscope, LSM 710 (Carl Zeiss MicroImaging, Jena, Germany), 
using an objective C-Apochromat 40×/1.2NA, a blue argon ion laser (488 nm) 
and a red He-Ne laser (633 nm) at 20ºC or 40ºC. The pixel dwell time for the laser-
scanning was 2,55 µs with a pixel step of 0.2 µm. Images were collected from two 
independent lipid preparations (biological replicates) for each sugar concentration 
and each preparation was analyzed three times (technical replicates), from which 
technical errors were subtracted. A total of 500 GUVs were analyzed from randomly 
chosen images of each sugar concentration. GUVs were classified in four categories: 
Mixed (where the probes of the liquid-ordered and disordered phases co-localize), 
Separated (where the two probes are localized in different domains), Red (vesicles 
stained with DiI-C18 and reporting the liquid-disordered phase) or Green (vesicles stained with AF-CTB and reporting the liquid-ordered phase). The purely red and 
green vesicles are likely due to the heterogeneity in the GUV formation, i.e. not all the 
vesicles constitute a ternary mixture of SM, DOPC and Cholesterol. We cannot rule 
out that in the red and green vesicles the complementary domains are present with 
dimensions below the optical resolution but consider heterogeneity in the vesicle 
by electroformation more likely. For each concentration, weighted averages and 
standard deviations were calculated (considering the number of GUVs per image) 
for the technical replicates and for the biological replicates. 
Solid state NMR
All ssNMR experiments were conducted using 3.2 mm triple-resonance (1H,13C,15N) 
probe heads at static magnetic fields of 18.8 T corresponding to 800 MHz, 1H 
resonance frequency. The maltose solution and lipid based samples were spun at 
magic angle spinning (MAS) rates of 3 kHz and 12 kHz, respectively, at 25˚C. The 
natural abundance 13C detected 1D experiments included cross polarization (CP) 
and direct excitation-based measurements (291). CP duration of 1 ms was employed 
according to the n=-2 Hartmann-Hahn matching condition with rf field strengths 
of 83 kHz (1H) and 50 kHz (13C) with SPINAL64 1H decoupling at 83 kHz during 
detection periods (292). All data were processed using a Brüker Topspin 2.1, Patch 
Level 6, and the 2D spectra were analyzed using SPARKY (293). Chemical shifts of 
the molecules were annotated on the basis of reported assignments for lipids (294, 
295) and maltose (296, 297).
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Results
Liquid-ordered domains dissolve when coated with disaccharides in 
computer simulations
To probe the effect of sugars on phase-separated membranes, we modeled a ternary 
membrane system composed of DPPC, DLiPC and cholesterol (4:3:3 molar ratio), 
which is laterally partitioned into two coexisting fluid domains: a Lo domain rich in saturated lipids (DPPC) and cholesterol, and a Ld domain containing a high amount of the polyunsaturated lipid (DLiPC) and a reduced level of cholesterol. We performed 
MD simulations of this system at a coarse-grained (CG) level of resolution, using the 
Martini force field (298). 
Figure 1A shows the CG topology for the different lipid and sugar molecules 
simulated, together with the starting structure of the system. In the absence of 
sugars, the domain separation is stable, in line with the experimental phase diagram 
for similar ternary mixtures (299). However, after the addition of 200 mM of sucrose, 
we observe a clear destabilization of the Lo and Ld domains as illustrated in the graphical snapshots from the simulation (Figure 1B). To quantify the mixing of the 
lipid constituents, the fraction of contacts between the saturated and unsaturated 
lipids was calculated (Figure 1C). The number of contacts steadily increases during 
the simulation, pointing to a destabilizing effect of sucrose on the domains. Towards 
the end of the simulation, after 2 µs, an almost homogeneously mixed membrane 
is observed. The mixing process seems to occur very fast, with nearly 75% of the 
final fraction of contacts established within 0.5 µs. We obtain similar results when we 
replace sucrose by another disaccharide, trehalose (Figure 1C). While the disturbing 
effect is observed with both disaccharides, the lateral distribution is more strongly 
affected by the addition of sucrose. At high sugar concentrations, 600 mM, the effect 
of trehalose is smaller than that of sucrose and even smaller than that of 200 mM 
trehalose. 
Remarkably, performing the simulations with the monosaccharide glucose, the 
domains appear perfectly stable (Figure 1C). To make sure this difference does not 
arise solely from the amount of sugar rings, we compared different concentrations 
monosaccharide and disaccharides containing the same moles of rings, e.g. 400 mM 
glucose compared to 200 mM trehalose. The results indicate that even when the same 
number of rings is present only trehalose and sucrose are affecting the membrane 
organization.
AF-CTB is the most suitable Lo marker 
Three different ways of labeling the liquid-ordered phase were studied as shown 
in Figure 2. Head-labeled GM1 with AF488 is localized in both, Lo and Ld, phases (Fig. 2A) albeit with a preference for Lo. Tail-labeled GM1 with BODIPY mislocalizes 
in the Ld phase, as seen by the co-localization with the Ld marker DiI-C18 (Fig. 2B). 
This is most likely due to the presence of the fluorophore in the lipid tail, which 
adds a degree of disorder. Free GM1 in the presence of AF-CTB is predominantly 
localized in the Lo phase and excluded from the Ld marker DiI-C18 (Fig. 2C). The 
toxin clusters the ganglioside by binding to different subunits. Those clusters have 
a stronger preference for the Lo phase than monomeric GM1. This method proved most suitable for discriminating Lo and Ld phases and mixing of lipid phases upon addition of saccharides. 
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Figure 1. Domain mixing induced by disaccharides. (A) Starting configuration, membrane phase separated 
into Lo and Ld domains enriched in saturated (green) and unsaturated (red) lipids, respectively. Cholesterol 
(grey) and sugars (white) are also depicted. Water is not shown. (B) Time series of lipid mixing after 
the addition of 200 mM sucrose. (C) Normalized number of contacts between saturated and unsaturated 
lipids after the addition of 100 mM sucrose (crosses), 200 mM sucrose (open circles), 600 mM sucrose 
(filled squares), 200 mM trehalose (open squares), 600 mM trehalose (filled triangles), 200 mM glucose 
(open triangles), and 400 mM glucose (stars). (D) Normalized number of contacts between saturated and 
unsaturated lipids after the addition of 200 mM sucrose using either longer bonds (crosses) or flexible 
rotation points (open circles) between the two independent sugar rings. The profile for normal sucrose at 
200 mM is shown as reference (open squares).
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Figure 2. Images of GUVs with different Lo labeling strategies. (A) Head-labeled AF488-GM1. (B) Tail-labeled 
BODIPY-GM1. (C) AF-CTB bound to GM1.
Confocal imaging confirms the potent effect of non-reducing disaccharides 
on membrane organization
To test the in silico predictions, we analyzed the lipid organization of GUVs by 
confocal fluorescence microscopy at 20ºC. GUVs composed of SM:DOPC:Cholesterol 
(4:3:3) were formed in the presence of different saccharides (Figure 3 for structures 
of all compounds used in this study). We quantified the disruption of the membrane 
organization by calculating the percentage of vesicles that showed lipid mixing, i.e. 
fluorescence co-localization of Lo and Ld domains in the presence of sugars. In all the experiments, we used the pair DiI-C18 and AF-CTB bound to the GM1 as Ld and Lo marker, respectively (Kahya JBC 2003), proven to be the best Lo/Ld labeling pair compared to DiI-C18 with either head- or tail-labeled GM1 (Fig. 2). 
Figures 4A and 4B show and example of a vesicle with Lo and Ld domain mixing 
and no mixing, respectively. The quantification of the lipid mixing in the presence of 
different concentrations of glucose, sucrose and trehalose is shown in Figure 4C. The 
two disaccharides, sucrose and trehalose, increased the mixing of the lipid domains 
more than the monosaccharide glucose did. However, at the highest concentration of 
trehalose, 800 mM, the mixing effect seems to decrease. In line with the simulations, 
at high concentrations trehalose has a less disruptive effect on the membrane 
organization than sucrose (Fig.1C), and in fact the trehalose gets expelled more from 
the bilayer. Overall, the MD simulations and experimental data are in agreement 
with each other. 
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Membrane domain disruption by disaccharides
The percentage of GUVs showing lipid mixing with the highest concentrations of 
disaccharides is not particularly high. This is most likely due to heterogeneity in 
the GUVs, i.e. not all the vesicles constitute a ternary mixture of SM, DOPC and 
Cholesterol. In all the samples we also observed a substantial amount of vesicles 
with only Lo or Ld staining, and seemingly formed by only one or two types of 
lipid (Table 1). However, there is a clear difference between the effects of the two 
disaccharides, sucrose and trehalose, and the monosaccharide glucose on the 
membrane organization. 


















50 0.052 0 ± 0 73.9 ± 6.8 18.8 ± 3.8 7.3 ± 2.9
100 0.113 0 ± 0 62.2 ± 5.5 22.4 ± 2.7 15.4 ± 2.8
300 0.325 0.2 ± 0.3 57.8 ± 1.7 36.5 ± 1.0 5.5 ± 1.0
400 0.439 0.5 ± 0.2 68.2 ± 6.7 27.2 ± 4.5 4.1 ± 2.1
600 0.616 0.8 ± 0.3 70.5 ± 4.2 23.5 ± 4.7 5.2 ± 0.1




50 0.040 0.4 ± 0.01 67.5 ± 0.2 22.6 ± 1.9 9.5 ± 1.7
200 0.214 1.3 ± 0.005 59.8 ± 0.5 35.7 ± 0.9 3.2 ± 0.4
300 0.299 4.3 ± 0.9 64.5 ± 0.1 26.0 ± 0.8 5.2 ± 0.3
400 0.405 8.5 ± 1.0 63.8 ± 12.5 23.5 ± 9.0 4.2 ± 2.9
600 0.604 14.6 ± 0.9 56.5 ± 8.1 22.8 ± 6.6 6.1 ± 2.5
800 - 16.3 ± 0.04 54.9 ± 0.8 22.6 ± 0.3 6.2 ± 0.5
Trehalose
100 0.118 2.0 ± 0.5 69.9 ± 1.6 22.2 ± 1.2 5.9 ± 0.1
400 - 4.9 ± 1.9 42.2 ± 7.7 23.1 ± 5.6 29.8 ± 12.8
600 0.584 11.8 ± 1.5 51.9 ± 12.7 19.1 ± 3.9 17.2 ± 6.8
800 - 8.0 ± 2.6 41.5 ± 3.7 32.1 ± 13.8 18.3 ± 11.1
Fructose + 
Glucose 300 - 0.8 ± 0.02 60.0 ± 6.9 26.8 ± 6.5 12.6 ± 13.4
Palatinose 400 0.399 1.3 ± 0.5 68.2 ± 5.0 25.1 ± 5.1 5.4 ± 0.3
Gentiobiose 400 0.395 1.6 ± 0.1 70.6 ± 1.5 21.6 ± 0.8 6.2 ± 0.6
Maltose 300 0.284 0.7 ± 0.08 73.4 ± 1.8 20.6 ± 1.4 5.3 ± 0.5400 0.420 0.7 ± 0.4 73.3 ± 0.3 17.4 ± 7 8.6 ± 7.1
Maltitol 400 0.402 1.4 ± 0.3 75.4 ± 3.4 21.6 ± 4.3 1.6 ± 1.1
Methyl-
Maltoside 400 - 7.3 ± 0.3 67.7 ± 3.0 19.0 ± 2.6 5.9 ± 0.7
Glycerol 600 0.570 0 ± 0 72.5 ± 9.9 25.6 ± 5.1 1.9 ± 0.7
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Figure 4. Domain mixing induced by saccharides in GUVs. (A) 3D projection of a GUV showing lipid mixing 
with the Lo and Ld domains co-localized. (B) 3D projection of a GUV with no lipid mixing, the Lo and 
Ld domains are segregated. Scale bars represent 2 µm. (C) Percentage of lipid mixing upon addition of 
glucose (empty squares), sucrose (full circles) and trehalose (empty circles) to SM:DOPC:Cholesterol 
(4:3:3) GUVs. (D) Percentage of lipid mixing upon addition of 300 mM sucrose, 300 mM mixture of glucose 
and fructose and 600 mM glucose. (E) Lipid mixing with the non-reducing sugars sucrose and trehalose, 
several reducing sugars e.g. palatinose, gentobiose and maltose; and two analogues of maltose, maltitol 
and methyl-maltoside; each at a concentration of 400 mM. Errors represent standard deviations of the 
biological replicates.
The number of sugar rings cannot explain the remarkable effect of the disaccharides; 
doubling the concentration of monosaccharides would yield the same effect 
and it clearly does not as shown in Figure 4D. The lipid mixing by 600 mM 
glucose is almost negligible (0.8 ± 0.3%) and lower than the 4.3 ± 0.9% mixing of 
300 mM sucrose. Furthermore, if we compare 300 mM sucrose with a mixture of 
the two monosaccharides that constitute sucrose i.e. glucose and fructose, at the 
same concentration the lipid mixing is again much lower by the mixture of two 
monosaccharides (0.8 ± 0.02%). These results, together with the MD data of Fig. 1D, 
indicate that the linkage between the two rings of the sucrose is crucial for the effect 
on the membrane organization of this non-reducing disaccharide.
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Saccharides directly interact with lipid headgroups in a concentration 
dependent manner
We have shown that disaccharides are able to modify the lateral organization of 
lipids in model bilayers, whereas monosaccharides do not. Moreover, the strength of 
the effect depends on the amount of carbohydrates in solution. A direct interaction 
between the sugars and lipids seems required to explain these effects. We therefore 
investigated the binding affinity of the sugars by analyzing the electron density 
profiles across the membrane, obtained from additional simulations of Lo and Ld 
membrane mimetics. The resulting profiles are shown in Figure 5A. In general, 
we see that sugars are able to bind to the membrane up to the level of the glycerol 
linkage, both for Lo and Ld mimicking membranes. At low sugar concentrations (60 mM), the sugars are enriched at the interface. This preferential binding mode of the 
sugars to the membrane/water interface is more pronounced for the disaccharides. 
On the contrary, at higher osmotic conditions (600 mM), a partial depletion of sugars 
away from the bilayer interface is observed with a concomitant increased tendency 
towards clustering of the carbohydrates in the aqueous subphase. Our results are 
consistent with the experimental data reported by Andersen and coworkers (62). 
Based on neutron scattering data combined with thermodynamic measurements, 
they show strong binding of sugars to membranes at low concentration and gradual 
repelling at concentrations exceeding ~200 mM. Interestingly, sucrose and trehalose 
show a peak in electron density right at the membrane/water interface. Such a peak 
is not observed in case of glucose, suggesting a stronger interfacial-binding mode for 
the disaccharides. Comparing the effects of the sugars on Lo and Ld membranes, we observe very similar behavior. Anderson et al. also noted little difference between 
binding of sugars to either fluid or gel phase membranes. A close up of the binding 
mode of glucose and sucrose to both Lo and Ld membranes, at 200 mM, is shown in Figure 5C. The presence of both a membrane-bound and membrane-depleted 
population at this concentration is clearly visible. Noticeable is also the stronger 
embedding of the disaccharide at the membrane/water interface, with individual 
sugar molecules intercalating between the phospholipid and cholesterol headgroups. 
The embedding of the interfacially bound sugars is very similar to that observed in 
all-atom MD simulations (300, 301). 
Taken together, our results indicate that sugars are able to destabilize the lateral 
heterogeneity of bilayers through direct contact with the phospholipid headgroups, 
and that this interaction is strongly affected by the amount of carbohydrates in 
solution. However, although the binding of disaccharides is somewhat stronger than 
monosaccharides, the difference is rather small and cannot account for the dramatic 
effect of disaccharides on the domain stability.
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Figure 5. Interaction of Lo and Ld domains with sugars. Electron density profiles for glucose, sucrose, and 
trehalose interacting with Lo (A) or Ld (B) membranes. In addition, right most insets show a close up of the 
interaction between the sugars and the membrane (full line glucose, broken line sucrose and dotted line 
trehalose) at different concentrations (black 60 mM, red 200 mM and blue 600 mM). (C) Snapshots of the 
sugar distribution across the lipid-water interface for glucose (left) and sucrose (right) interacting with Lo 
(top) and Ld (bottom) membranes at 200 mM sugar.
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Constrained geometry of disaccharides perturbs tight packing of Lo phase
The only remaining candidate for explaining the different behavior of mono- versus 
disaccharides, is the sugar linkage. To test the effect of the glycosidic linkage, we 
performed additional MD simulations in which the linker was either made longer 
(an increase in size from 0.429 nm to 1.0 nm), or made completely flexible (i.e. all the 
dihedral terms corresponding to the plane-plane orientation were excluded). The 
results in case of sucrose are shown in Figure 1D, in terms of a plot of the contact 
fraction between saturated and unsaturated contact lipids over time. Remarkably, 
sucrose in which the two monomers are linked at a larger distance is unable to 
disperse the domains. Keeping the linkage at the natural distance but increasing its 
flexibility, on the other hand, results in fast mixing of the lipids. The speed of the 
domain disruption is even larger compared to normal sucrose. We conclude that the 
close proximity of two sugar rings, a distinguishing feature of disaccharides, causes 
the destabilization of Lo/Ld coexistence. 
Membrane organization is exclusively altered by non-reducing sugars
We showed that sucrose and trehalose affect the lipid organization of the membranes, 
whereas glucose does not. Our in silico data suggest that the presence of two sugar 
rings linked closely together is a prerequisite for this effect. To further prove that 
we need disaccharides to disrupt the membrane organization, we checked other 
disaccharides with our experimental setup. Surprisingly, none of the disaccharides 
tested (palatinose, gentiobiose and maltose) have an actual effect on mixing the 
lipid domains at 400 mM (Figure 4E). As opposed to sucrose and trehalose, these 
disaccharides are reducing sugars. In solution, reducing sugars can have the second 
monosaccharide ring open containing an aldehyde group, which is in equilibrium 
with the hemiacetal (when the pyranose ring is formed). In order to verify whether 
the lack of lipid mixing of the reducing sugars is due to the opening of the hemihacetal 
to aldehyde, we analyzed two analogues of maltose, maltitol and methyl-maltoside 
(see structures in Fig. 3). Maltitol is a hydrogenated maltose and does not possess an 
aldehyde in its open form, so the reaction back to the hemiacetal (closed pyranose) 
is not possible, giving rise to a fully open ring. In contrast to maltitol, methyl-
maltoside has an extra methyl group in the hydroxyl of the hemiacetal, eliminating 
the equilibrium towards the aldehyde and locking the saccharide in its closed form. 
As shown in Figure 4E, maltitol acts similarly to the regular maltose, having a low 
effect on lipid mixing. On the contrary, methyl-maltoside, has a vast increase in the 
percentage of lipid mixing. These results show that only disaccharides containing 
two closed rings, either the two non-reducing (sucrose and trehalose) or the synthetic 
maltose analogue methyl-maltoside, are able to disrupt the lipid organization. This 
difference on lipid mixing by non-reducing sugars against reducing sugars or 
monosaccharides is even more pronounced when performing the experiments at 40ºC 
instead of 20ºC (Figure 6 and Table 2). The results show an increased lipid mixing of 
nearly 25% with 400 mM sucrose compared to 8% at lower temperature. In the case 
of 400 mM glucose or maltose, there is no lipid mixing at higher temperatures.
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Figure 6. Domain mixing induced by sugars at low and high 
temperature. The percentage of vesicles with lipid mixing 
upon addition of the non-reducing sugar sucrose, the reducing 
sugar maltose, the monosaccharide glucose and buffer to 
SM:DOPC:Cholesterol (4:3:3) GUVs at 20˚C (empty bars) 
and 40˚C (full bars). The concentration of all sugars was 400 
mM.
Table 2. Percentage of GUVs at 40°C.
To test whether the opening of the second ring of the reducing saccharides is favored 
upon binding to the lipid bilayer, we performed solid state NMR (ssNMR) of maltose 
in solution and in the presence of the SM:DOPC:Cholesterol (4:3:3) bilayer. The 13C 
results are shown in Figure 7. When compering the maltose in solution, depicted in 
green, and the maltose in the presence of membranes, in blue, there are two main 
chemical shift changes. Those changes are illustrated in the top panel of Figure 
7, highlighted with circles. There is an extra peak appearing around 82 ppm that 
could correspond to a chemical shift of maltitol, hydrogenated maltose with the 
second ring open. The discrimination between maltose and maltitol with ssNMR 
is not straightforward since they have almost all the 13C chemical shifts identical. 
The only exceptions are the carbon-4 of the second glucose unit that is ~82 ppm 
and for maltitol it is ~77 ppm, and the anomeric carbon that is ~92 and ~96 ppm for 
α and β of maltose, respectively, and ~63 ppm for the same carbon in maltitol (see 
chemical shifts of both molecules in http://sdbs.riodb.aist.go.jp; National Institute 
of Advanced Industrial Science and Technology). These extra peaks appearing for 
maltose in the presence of membranes could represent the open form of the second 
ring. The other noticeable difference is that the chemical shifts of the anomeric carbon 
of maltose are slightly shifted towards higher values (three peaks in the range of 95-
105 ppm) and the peaks are broader. This might be an effect of the hydrogen bonding 
with the membrane. When comparing the rigid fraction of maltose (Fig. 7 red line) 
with the rigid + mobile fraction (Fig. 7 blue line) of maltose, we conclude that maltose 













KPi 0 0 0.3 ± 0.2 57.1 ± 0.6 33.5 ± 3.9 9.1 ± 3.0
Glucose 400 0.439 0.9 ± 0.3 70.2 ± 3.4 23.9 ± 3.7 5.0 ± 0.03
Sucrose 400 0.405 24.4 ± 1.8 54.4 ± 3.5 14.8 ± 5.9 6.4 ± 0.5
Maltose 400 0.420 1.1 ± 0.6 69.5 ± 3.5 19.6 ± 1.9 9.8 ± 2.1
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Overall, the NMR measurements provide qualitative evidence that there is a change 
in the maltose structure in the presence of membranes. We speculate that a significant 
fraction of maltose has the second ring in an open form, which might be the reason 
that maltose is not able to disrupt the membrane organization. Our work thus 
indicates that not all disaccharides are able to disturb the membrane organization. 
The closed conformation of the second monosaccharide ring is a key factor in the 
lipid mixing. Amongst all saccharides found in nature, non-reducing sugars sucrose 
and trehalose are the only two capable of reorganizing the lipids of the membranes.
Figure 7. 13C chemical shifts of maltose and membranes. Bottom panel highlights the entire spectra and the 
boxed region and top panel illustrates the specific signals for maltose and the chemical shift changes in 
presence of lipids. Maltose in solution (green), maltose in the presence of SM:DOPC:Cholesterol (4:3:3) 
membranes (rigid components in red and rigid + mobile components in blue).
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Figure 8. Domain mixing in GUVs with different lipid 
composition. The percentage of vesicles with lipid mixing 
upon addition of the non-reducing sugar sucrose, the 
reducing sugar maltose, the monosaccharide glucose 
and buffer to SM:DOPC:Cholesterol (4:3:3) GUVs 
(empty bars) and DPPC:DOPC:Cholesterol (4:3:3) 
GUVs (full bars). The concentration of all sugars was 
400 mM.
Table 3. Percentage of GUVs with a membrane composition of DPPC:DOPC:Cholesterol at 4:3:3, molar 
ratio.
Discussion
The picture emerging from our combined computational and experimental approach 
is the following. Mono- and disaccharides interact with lipid membrane by direct 
interactions of the carbohydrates with the phospholipid headgroups as shown by the 
MD simulations. These interactions affect the organization of lipid domains present 
in membranes formed by saturated lipids, unsaturated lipids and cholesterol. The 
extent of lipid mixing is directly related to the amount of sugar present in solution. 
However, the disruption properties are exclusive to non-reducing disaccharides such 
as sucrose and trehalose, which insert quite deeply at the membrane/water interface 
when compared to glucose. A possible explanation could be that monosaccharides 
are small enough to fit in between the lipid polar groups without destabilizing them. 
On the contrary, non-reducing disaccharides, sucrose and trehalose, are composed 
of two pyranoses without a free hemiacetal. Those disaccharides are much bulkier, 
so once they are bound to the lipids in specific positions they might spread them 
to some extent. Thus, preventing tight interactions between the lipid headgroups 
and the lipid tails. In other words, non-reducing disaccharides stabilize a disordered 
phase. As a consequence lipids comprising the Lo phase become loosely packed, causing mixing of the domains and resulting in a homogeneous lateral organization 
of the bilayer. Reducing sugars, once they are bound to the lipids, might be stabilized 
in the open form where only the first pyranose ring is present. This conformation 
might not be bulky enough to spread the lipids sufficiently to cause mixing. Reducing 
sugars change their structure in water almost without any energy loss, so opening the 
second ring does not require a lot of energy. There is no quantitative data available 
about the opening and closing of reducing sugars in the presence of membranes, 
but the observations of maltose and maltitol opposed to those of methyl-maltoside 
in the lipid mixing together with the structural observations by ssNMR support this 













KPi 0 0 0 ± 0 86.1 ± 9.6 11.2 ± 4.9 2.7 ± 1.8
Glucose 400 0.439 0.2 ± 0.2 78.1 ± 4.7 19.3 ± 3.6 2.4 ± 0.8
Sucrose 400 0.405 6.2 ± 0.6 79.6 ± 0.5 10.6 ± 1.1 3.6 ± 0.9
Maltose 400 0.420 1.2 ± 0.1 87.4 ± 1.05 8.1 ± 1.0 3.3 ± 2.0
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agreement, even though in the initial experiments the Lo phase was composed of a 
different type of saturated lipid. The MD simulations were performed with DPPC, 
whereas in the experiments SM was used. A control experiment showed the same 
behavior on lipid mixing by sucrose, maltose and glucose with membranes composed 
of DPPC instead of SM (Figure 8 and Table 3). 
Importantly, the non-reducing sugars sucrose and trehalose are the only two 
saccharides accumulated in large amounts by numerous organisms under conditions 
of complete dehydration; these sugars are also synthesized or taken up under 
conditions of osmotic stress (partial dehydration). It is well accepted that these 
sugars may replace the water molecules around the polar residues of membranes 
and proteins. This stabilizes the membranes by avoiding the shrinkage, lateral stress 
and the increase in the phase transition temperature when water is removed in 
the process of drying (272). Besides substituting the water molecules, sucrose and 
trehalose expand the membrane. Upon binding to lipid monolayers, the area per 
molecule increases. The expansion occurs at low and high temperatures, which is 
different from the effect of glycerol that only expands the membrane at temperatures 
above the phase transition temperature of DPPC monolayers. In our experimental set 
up with GUVs, glycerol had no effect on the lipid organization (Table 1). The efficiency 
of expanding the monolayer films is directly related to the ability to stabilize the 
membrane structure and function at low water contents (49). If sugars have similar 
effects on the structure of native membranes, then the synthesis or accumulation 
of non-reducing disaccharides might dissolve the nanoscale assemblies present in 
the plasma membrane of eukaryotic, which may impact the functioning of several 
membrane proteins. 
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The Plasma Membrane (PM) of S. cerevisiae is described as a polarized environment in which proteins 
are segregated between: eisosomes, rafts and endocytic sites. The ensemble behaviour of proteins in the 
PM has been studied using conventional fluorescence microscopy such as Fluorescence Recovery After 
Photobleaching (FRAP), showing that the slow diffusion of polytopic membrane proteins allows for its 
polarization. In this study, we will analyse whether the origin of the slow diffusion and polarized localiza-
tion is due to membrane confinement and/or oligomerization of the proteins. As a model system we use 
Lyp1p and Can1p basic amino-acid transporters from the yeast PM, of which Can1p is reported to reside 
within, and outside of, eisosomes. We have probed the ensemble diffusion behaviour of these proteins 
using FRAP, as well as Single Particle Tracking (SPT) to study the behaviour at a single molecule level. 
FRAP and SPT analyses confirm the slow diffusion of the proteins, 5-10*10-4 µm2/s, which is in the same 
order as found for Pma1p. Super-resolution imaging by PALM confirms that Can1p and Lyp1p have a 
polarized distribution at the PM, however none of the proteins appeared to be confined by SPT analysis. 
Clustering or oligomeric state effects were probed by counting the number of fluorophores from single 
diffraction-limited fluorescent spots showing that the majority of can1p and lyp1p is monomeric and that 
the polarized distribution arises because of the low copy number of these proteins in the PM. 
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Introduction
The lateral organization and compartmentation of cellular functions is a key step in 
the evolution of eukaryotic cells. Within lipid membranes, specific domains can exist 
due to phase separation of lipids and embedded proteins. Saccharomyces cerevisiae is 
an excellent model system to study membrane domain formation and is often used 
comparatively with mammalian cell systems. A clear example is the presence of ‘lipid 
rafts’ as segregated lipid-protein entities rich, which are rich in sphingolipids and 
sterols. In the yeast plasma membrane there are the so-called MCC/eisosome and 
MCP domains, occupied by and named after the H+/Arginine symporter Can1p and 
the plasma membrane H+-ATPase Pma1p, respectively (98, 101-104). The former is 
thought to be enriched in ergosterol, whereas MCPs are rich in sphingolipids (302, 
303). Thus, even though both domains are thought to contain sterol (i.e. ergosterol) 
and sphingholipid (the dominant lipid in yeast PM), the relative abundance differs. 
Owing to the patch-like organization of MCC/eisosomes and the accommodation of 
several proteins they are frequently denominated lipid rafts (98, 101, 106, 107, 302), 
but their properties seem different from those in mammalian cells (100) or membrane 
model systems such as GUVs (Chapter 6). The yeast PM division into two defined 
and stable compartments seems to be too strict. Can1p has been shown to localize 
in the patch-like MCC/eisosome domain, excluded from the MCPs (101, 106, 107). 
However, other measurements indicate that 70% of the Can1p is localized outside 
of MCCs (113). By counting the number of MCC/eisosomes per cell and assuming 
dimensions of 300 x 50 nm, the domains make up about 5 % of the PM surface and 
thus Can1p would be accumulated in the MCC/eisosomes several fold. A recent 
study has revealed uneven distributions of all PM proteins suggesting that numerous 
domains coexist, partially overlapping, in the yeast plasma membrane (114). Thus, 
questioning whether MCC is the solely patch-like domain in the yeast PM.
The segregation of proteins in the PM of yeast has also been associated with the 
extremely slow diffusion of proteins and lipids in the membranes and may lead to 
polarization in the cell. The way cells can maintain this membrane polarization is by 
keeping a balance between the lateral diffusion, the directed transport to the PM and 
endocytosis (115, 124, 304). By studying the dynamics at the single molecule level we 
analyze whether Can1p is strictly confined in the MCC domains and compare the 
observations to that of another basic amino acid permease, Lyp1p. The localization 
and dynamics of this H+/Lysine symporter have not been studied before. 
Many membrane proteins function as multimers and oligomerization of these 
proteins has been associated with slowed diffusion rates in mammalian cells 
(305). For instance, the lateral diffusion of E-cadherin is reduced by 10 to 40 upon 
oligomerization in the plasma membrane of mammalian cells. However, this result 
is inconsistent with the general understanding of the physicochemical basis of 
translational diffusion in lipid bilayers, where the mobility of proteins within the 
two-dimensional space of the membrane is rather insensitive to changes in the size 
of the diffusing unit (64, 306). In fact, for proteins with radii (R) up to 5 nm it has 
been shown that the lateral diffusion coefficient scales with ln(1/R). The slowed 
diffusion rates in mammalian cells upon oligomerization have been explained by the 
trapping of the molecules in the membrane skeleton. In case of AAP transporters, 
the family to which Lyp1p and Can1p belong, there is virtually no information on 
their oligomeric state in the PM or internal membranes. From genetic screens there is 
some evidence that the general amino acid permease Gap1p might form oligomers 
(307) and for other transporters there is evidence that they need to oligomerize for 
proper trafficking through the early secretory pathway (308). The crystal structure of 
a bacterial homologue of the yeast amino acid transporters, the arginine/agmatine 
exchanger AdiC (309, 310), points to a homodimeric structure, which is supported by 
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glutaraldehyde crosslinking studies. Another two examples are the dimeric H+/Na+ 
antiporter, Nha1p, and the tetrameric glycerol channel, Fps1p (311, 312). We use those 
two proteins to compare the differences on the diffusion rates with Can1p and Lyp1p.
In this study, we analyze the diffusion, polarized localization and oligomerization 
of plasma membrane proteins by ensemble and single molecule measurements. 
We correlate the phenomena to understand the basis for the slow diffusion and 
localization pattern in the yeast PM. 
Materials and methods
Plasmids and strains
All strains are based on S. cerevisiae strain BY4742 bearing the ura3 selection marker 
(Table 1). All plasmids were generated using uracil excision-based cloning (313). 
Genomic DNA isolation of S. cerevisiae BY4742 was carried out according to Sherman 
et al. (314) For the amplification of DNA with uracil containing primers polymerase 
chain reactions (PCR) were performed with PfuX7 (315). Amplified fragments were 
assembled into full plasmids (Table 2) by treatment with DNA glycosidase and 
DNA glycosylase-lyase endo VIII, commercially available as USER, following the 
manufacturer’s instruction (New England Biolabs, Ipswich, Ma, USA). Ligation 
products were transformed into chemically competent E. coli MC1061 cells (316). 
All constructs assembled from PCR fragments were verified by DNA sequencing. 
Genomic tagging and deletion of genes were done with standard PCR-based 
homologous recombination, using the primers listed in Table 3. Transformation of 
plasmids and linear constructs into S. cerevisiae was performed as described by Drew 
et al. (317) 
Plasmid generation
The sequences of oligonucleotide primers used in this study are listed in Table 3. The 
plasmid pRS426GAL1-lyp1-Ypet-his was constructed by a four PCR fragment ligation, 
in which the backbone of the pRS426GAL1-GFP vector was amplified with primer 
pairs Pr1/Pr2 and Pr3/Pr4 in two fragments that excluded the GFP coding region. 
The fragment coding for the ypet gene was amplified from a synthetically generated 
coding sequence ordered from (GeneArt, Regensburg, Germany), using primer pair 
Pr5/Pr6. The lyp1 gene was amplified from S. cerevisiae BY4742 chromosomal DNA 
with primer pair: Pr9/Pr10. Ligation of the four PCR amplified fragments using USER 
enzyme resulted in a fusion of lyp1 and ypet, separated by a sequence for tobacco etch 
virus (TEV) protease cleavage site and followed by sequence for a His8 tag (i.e. lyp1-TEV-YPet-his8). 
To construct pRS426GAL1-lyp1-Ypet-Ypet-his the ypet gene was amplified twice, 
using primer pairs Pr5-Pr8 and Pr6-Pr7. Annealing of the five fragments and USER 
ligation resulted in a plasmid carrying a lyp1-TEV-Ypet-Ypet-his8 fusion gene. Similar plasmids were constructed for can1, nha1 or fps1 in place of lyp1, using primer pairs 
Pr11/Pr12, Pr13/Pr14 and Pr15/Pr16, respectively. For all constructs, plasmids were 
isolated from the E. coli host and the sequences of the fusion genes were verified. 
Each plasmid was then transformed into a S. cerevisiae By4742 knockout strains that 
lack the chromosomal copy of the corresponding gene. 
The plasmid Pug72-mEos3.1 was constructed from 3 PCR fragments, using the 
uracil excision based cloning method. The backbone and the ura3 marker were both 
separately amplified from the Pug72 plasmid using primer pairs Pr17/Pr20 and 
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Pr18/Pr19, respectively. mEos3.1 was amplified using primer pair Pr21/Pr22 from 
a synthetically generated coding sequence, ordered from (GeneArt, Regensburg, 
Germany). The fragments were treated with USER and transformed into E. coli 
MC1061 as described previously. 
For the construction of the S. cerevisiae BY4742 Δart1/Δart2 strain we made use of 
the ura3 selection marker and the ability for its counter selection on 5 fluoro-orotic 
acid (5FOA) as described by Alani et al. (318). The ura3 cassette was amplified from 
the Pug72 plasmid with primer pairs Pr23/24 and Pr25/Pr26 for the disruption 
of art2 and art1, respectively. Primers were designed in a similar way as described 
by Akada et al. (319). A region of 50-90 bp downstream of the targeted gene was 
included in the upstream primer, creating two homologous flanking regions to the 
ura3 selection marker. The amplified art1 disruption cassette was transformed into S. 
cerevisiae BY4742 and the cells were recovered on a uracil-depleted medium to select 
for recombinants. In a second round of selection, double-crossover recombinants 
lacking the ura3 marker were isolated by growth on a medium containing 5FOA. The 
art2 gene was disrupted by repeating the procedure on the Δart1 strain.
For genomic replacement of lyp1 and can1 with lyp1-meos3.1 and can1-meos3.1, we 
amplified the meos3.1-ura3 cassette from the Pug72-mEos3.1 plasmid using PCR. For 
the tagging of lyp1 and can1 we used primer pairs Pr27/28 and Pr29/30 respectively. 
Integration and counter selection of the meos3.1-ura3 cassette was performed as 
during construction of the Δart1 strain. 
Table 1. Yeast strains used in this study.
Strains Characteristics Reference
S. cerevisiae BY4742 Matα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Invitrogen 
E. coli MC1061 – Casadaban et al.1980
S. cerevisiae BY4742 Δlyp1 Matα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δlyp1 kanMx Giaever et al. 2002
S. cerevisiae BY4742 Δcan1 Matα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δcan1 kanMx Giaever et al. 2002
S. cerevisiae BY4742 Δnha1 Matα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δnha1 kanMx Giaever et al. 2002
S. cerevisiae BY4742 Δfps1 Matα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Δfps1 kanMx Giaever et al. 2002
S. cerevisiae BY4742 ΔArt1 ΔArt2 
lyp1-mEos3.1
Matα his3Δ1 leu2Δ0 lys2Δ0 Art1Δ0 Art2Δ0 lyp1-
mEos3.1 ura3 This study
S. cerevisiae BY4742 can-mEos3.1 Matα his3Δ1 leu2Δ0 lys2Δ0 Art1Δ0 Art2Δ0 can1-mEos3.1 ura3 This study
S. cerevisiae BY4742 lyp1-mEos3.1 Matα his3Δ1 leu2Δ0 lys2Δ0 lyp1-mEos3.1 ura3 This study
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Table 2. Yeast plasmids used in this study
Growth conditions 
Yeast cells were grown at 30˚C in synthetic dropout media lacking uracil (320). Cells 
were initially grown in medium containing 2% [w/v] glucose to an optical density at 
600 nm (OD600) of 0.2–0.4. For single particle tracking and oligomeric state analysis, 
the cells were centrifuged (1600 x g, at room temperature for 2 min), resuspended 
to OD600 ~0.2-0.4 in medium containing 2% [w/v] raffinose in place of glucose and 
grown one more hour. At this stage, most cells contained < 10 fluorescent protein foci 
when imaged on a single-molecule fluorescence microscope (see below). For PALM 
experiments, cells grown in glucose medium were concentrated by centrifugation 
to OD600 ~10 prior to imaging. For time-lapse PALM measurements, the cells were 
grown at 30˚C to an OD600 of 0.2–0.4 in glucose media that contained either standard 
concentrations of lysine and arginine (76 mg/L each), or 10 times lower levels (7.6 
mg/L each). For FRAP experiments, cells grown in glucose medium were transferred 
to medium containing both raffinose (2% [w/v]) and glucose (0.1% [w/v]) and 
sustained at mid-exponential growth phase over 36 hours (OD600 of 0.2-0.5). Then, 
the cells were induced with 0.2 % [w/v] galactose for 2.5 hours prior to the FRAP 
measurement. For Can1p- and Lyp1p-labelled cells, lysine, arginine and methionine 
were omitted from the raffinose/glucose medium. 
Plasmids Characteristics Reference
pRS426GAL1-GFP pRS426 with gal promoter and GFP-His fusion cassette with ura3 selection marker Newstead et al. 2007
pRS426GAL1-lyp1-Ypet-his pRS426GAL1-GFP derivative with lyp1 fused to ypet This study
pRS426GAL1-lyp1-Ypet-Ypet-his pRS426GAL1-GFP derivative with lyp1 fused to ypet-ypet This study
pRS426GAL1-can1-Ypet-his pRS426GAL1-GFP derivative with can1 fused to ypet This study
pRS426GAL1-can1-Ypet-Ypet-his pRS426GAL1-GFP derivative with can1 fused to ypet-ypet This study
pRS426GAL1-nha1-Ypet-his pRS426GAL1-GFP derivative with nha1 fused to ypet This study
pRS426GAL1-fps1-Ypet-his pRS426GAL1-GFP derivative with fps1 fused to ypet This study
Pug72 AmpR, Ura3 chromosomal integration cassette Güldener et al. 2002
Pug72 mEos3.1 Pug 72 with ura3 flanking homologous regions and reverse mEos3.1 fusion gene This Study
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Table 3. Primers used in this study (italics represent identical regions introduced for metabolic excision 
marker after genomic integration of the Pug72 mEos3.1 cassette)
Primer name Sequence Purpose
Pr1 4158 ACCACCACCAUCATCATCATCATTAACTGCAGGAATTC Rev primer for amplification of pRS426GAL1-GFP vector annealing at histag for swaping c terminal fusion protein.
Pr2 3631 AGCACTACCCUTTAGCTGTTCTATATGCTGCC Fw primer for amplification of pRS426GAL1-GFP
Pr3 4158 ACCACCACCAUCATCATCATCATTAACTGCAGGAATTC Fw primer for amplification of pRS426GAL1-GFP vector starting at histag for swaping c terminal fusion protein 
Pr4 4171 ATTTTGGGAUCCACTAGTTCTAGAATCCGGGG Rev primer for pRS426GAL1-GFP backbone amplification anneals behind gal promoter.
Pr5 4159 AGGGGAAAAUTTATATTTTCAAGGTTCTAAAGGTGAAGAATTATTCACTGG Fw primer for amplification of ypet gene and insertion into pRS426GAL1-GFP.
Pr6 4160 ATGGTGGTGGUGGAGCTCTTTGTACAATTCATTCATACC Rev primer for amplification of ypet gene and insertion into pRS426GAL1-GFP.
Pr7 4566 ACAAAGAGCUCGGAGGAGGATCTAAAGGTGAAGAATTATTCACTGG Fw primer for amplification of ypet gene for construction of double ypet fusion.
Pr8 4565 AGCTCTTTGUACAATTCATTCATACCCTCGG Rev primer for amplification of ypet gene for construction of double ypet fusion including a linker.
Pr9 4165 ATCCCAAAAUGGGCAGGTTTAGTAACATAATAACGTCC Fw primer for amplification of S. cerevisiae lyp1 gene for insertion into pRS426GAL1-GFP.
Pr10 4166 ATTTTCCCCUCCTGCAACAGCAGCCCAGAATTTCTC Rev primer for amplification of S. cerevisiae lyp1 gene for insertion into pRS426GAL1-GFP.
Pr11 4164 ATTTTCCCCUCCTGCTACAACATTCCAAAATTTGTCCC Fw primer for amplification of S. cerevisiae can1 gene for insertion into pRS426GAL1-GFP.
Pr12 4163 ATCCCAAAAUGGGAACAAATTCAAAAGAAGACGCCGACATAG Rev primer for amplification of S. cerevisiae can1 gene for insertion into pRS426GAL1-GFP.
Pr13 4402 ATCCCAAAAUGGCTATCTGGGAGCAACTAGAAG Fw primer for amplification of S. cerevisiae nha1 gene for insertion into pRS426GAL1-GFP.
Pr14 4403 ATTTTCCCCUCCCTTATTGAGACCAAGCGTTTTTGATAGCG Rev primer for amplification of S. cerevisiae nha1 gene for insertion into pRS426GAL1-GFP.
Pr15 4508 ATTTTCCCCUCCTGTTACCTTCTTAGCATTACC Fw primer for amplification of S. cerevisiae fps1 gene for insertion into pRS426GAL1-GFP.
Pr16 4507 ATCCCAAAAUGGGCAGTAATCCTCAAAAAGCTCTAAAC Rev primer for amplification of S. cerevisiae fps1 gene for insertion into pRS426GAL1-GFP.
Pr17 4309 AGTCCGACCUGGGCGCGCGCGAATTAGCCGCGGCGTGGCCTTCCCAAATTT GGGTAGGGCGTCTAGAGATCCCAATACAACAGATCAC
Primer for construction of the Pug72 mEos3.1 fusion cassette, 
containing upstream homologous region flanking Ura3, for 
excision of the Ura3 marker after genomical integration. 
Pr18 4310 ACTAACCCGUGGGCGCGCGCGAATTAGCCGCGGCGTGGCCTTCCC AAATTTGGGTAGGGCCTCGAGAACCCTTAATATAACTTCGT
Primer for construction of the Pug72 mEos3.1 fusion cassette, 
containing downstream homologous region flanking Ura3, for 
excision of the Ura3 marker after genomical integration.
Pr19 3756 ACGGGAACGUCGTACGAAGCTTCAGCTGGC Rev primer for amplification of Pug72 backbone for insertion of 
fluorescent protein in Pug72 vector..
Pr20 4101 ACGGGTTAGUAGCTCGTTTTATTTAGGTTCTATCGAGG Rev primer for amplification of Ura marker for Pug72 mEos3.1 cassette.
Pr21 4105 ACGTTCCCGUATGAGTGCGATTAAGCCAGACA Fw primer for Amplification of mEos3.1 for Pug72 mEos3.1 fusion cassette 
Pr22 4106 AGGTCGGACUTTATCGTCTGGCATTGTCAGGC Rev primer for Amplification of mEos3.1 for Pug72 mEos3.1 fusion cassette
Pr23 4686 TCATTCTTCATCACTCATCAAAGGCACTATTTCGTCATAA CGCGGAGGCTGTCTAGAGATCCCAATACAACAGATCAC






Rev primer for amplification of art2 specific knockout cassette 
from Pug72 vector.
Pr25 4684 CTACTGGGTTATTCTATTGGAATCTAGAAAATCGGAAAAGTTT TGTATTCTGATATCGTCTAGAGATCCCAATACAACAGATCAC






Rev primer for amplification of art1 specific knockout cassette 
from Pug72 vector.
Pr27 3537 GCGAAATGGCGTGGAAATGTGATCAAAGGTAA TAAAACGTCATATCTGATATCACCTAATAACTTCG
Fw primer  for amplification of can1 specific meos3.1 fusion cassette 
from Pug72 mEos3.1.
Pr28 3543 CTATTTTTTTATTTTTTTCTATTTTGAAGGCATGCAA 
GAGGTTCTGTGACTGATATCACCTAATAACTTCG
Fw primer  for amplification of lyp1 specific meos3.1 fusion cassette 
from Pug72 mEos3.1.
Pr29 4191 GAAGACGACGAGCCTAAGAATTTATGGGAGAAATT CTGGGCTGCTGTTGCAATGAGTGCGATTAAGCCAGAC
Rev primer  for amplification of lyp1 specific meos3.1 fusion 
cassette from Pug72 mEos3.1.
Pr30 4194 GAAGATCATGAACCAAAGACTTTTTGGGACAAAT TTTGGAATGTTGTAGCAATGAGTGCGATTAAGCCAGAC
Rev primer  for amplification of can1 specific meos3.1 fusion 
cassette from Pug72 mEos3.1.
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Microscopy equipment 
For single particle tracking, oligomeric state analysis and PALM measurements, 
a fully automated home-built Olympus IX-81 inverted microscope with a high 
numerical aperture objective (100 X, NA = 1.49, oil immersion, Olympus, UApo) was 
used, as shown schematically in Scheme 1. Solid-state lasers were from Coherent 
(Santa Clara, USA): 405 nm (cube, 100 mW), 514 nm (Sapphire, 150 mW) and 568 
nm (Sapphire, 150 mW). Laser pulses were automatically generated using computer-
controlled shutters, and neutral-density filter wheels were used to attenuate the 
laser power. Laser beams were collimated with lenses and combined using dichroic 
mirrors. Imaging was performed in epi-fluorescence mode and emitted light was 
collected on a 512x512 pixels Electron Multiplying Charge Coupled Device (EM-
CCD) camera (C9100-13, Hamamatsu, Japan).
For FRAP measurements a commercial laser-scanning confocal microscope, LSM 710 
(Carl Zeiss MicroImaging, Jena, Germany) was used. The microscope was equipped 
with a C-Apochromat 40x/1.2 NA objective and a blue argon ion laser (488 nm).
FRAP measurements
Cells were immobilized in between two microscope slides and the focal plane 
positioned to the mid-section of the cells. Subsequently, an area at the each of the 
cell, corresponding to the PM, with a radius of 0.5-1.0 µm was photo-bleached with a 
short (26 µs) focused high power light pulse. Immediately afterwards several images 
of the fluorescence recovery were collected every 20 s over a total time period of 
2400 s, using 1 % of the laser output power. During the entire experiment, the stage 
was heated to 30°C using a Pecon climate chamber. Data analysis was carried out 
in imageJ (321). Images were corrected for x-y drift using cross correlation fitting. 
The fluorescence intensity over time of the PM was corrected for photo-bleaching 
effects by fitting the decay to a single exponential. The bleaching area was selected 
and the recovery was fitted to a single exponential to find the half time of recovery. 
The diffusion coefficient (D) was estimated according to equation 1, derived from 
Axelrod et al. (322): 
Eq. 1 
where D is the diffusion coefficient, w the radius of the bleaching spot, t0.5 the half 
time of recovery and γ a correction factor which is 0.88 for circular beams. The radius 
of the bleaching spot was 1.0 μm ± 0.1 μm as determined by Meinema et al. (121). 
Single-particle tracking 
Cells were embedded and immobilized in 0.5 % (w/v) agarose and placed in between 
two microscope slides. Fluorescent microspheres (TransFluoSpheres, d=0.04 µm, ex/
em=488/560 nm, Invitrogen) were premixed with the cells and, post data collection, 
their position used to correct for x-y drift. The experimental setup permitted cell 
growth (which was slow relative to the time span of the experiments) and provides a 
low fluorescence background necessary for single molecule imaging. The focal plane 
was placed at the mid-section cells. Time-lapse movies were recorded once every 34 
ms, 100 ms, 300 ms, 1 s, 10 s, 11 s or 30 s. Typically, 100 - 200 frames were collected 
per measurement. All movies were recorded using 34 ms exposure times per frame. 
Application of excitation light (λ=514 nm at 50 W/cm2) was synchronized with the 
camera exposures. Throughout the experiment, the microscope stage was heated to 
30°C. ImageJ was used to correct the drift at sub-pixel level, and to fit and track the 
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peaks. The diffusion coefficient (D) of the particles was calculated in two different 
ways: (i) from the linear time dependence of the mean square displacement (MSD) 
using Eq. 2 and assuming a 1D diffusion along the plasma membrane (PM) and (ii) 
by fitting step-size distributions with the 1D diffusion Eq. 3. 
Eq. 2 
where n is the dimensionality, D is the lateral diffusion coefficient, t is time, d is 
displaced distance and c is an offset arising from localization uncertainty.
Eq. 3 
where p(d) represents the probability of a particle displaced at a distance d, A is the 
proportionality constant, D is the diffusion coefficient and t is frame time (323). 
In both cases, only trajectories corresponding to the PM and having a minimum 
length of 8 steps were selected (for 30 s-sampling measurements, a minimum of 5 
steps was taken). Plots of MSD versus time were produced by averaging data from 
several trajectories. The distribution of step sizes of the experiments performed at 
different rates was plotted and fitted using a 1D diffusion model (Eq. 3).
Oligomeric state analysis 
Sample preparation and data acquisition was the same as described under single-
particle tracking. The first frame of each recording, before photo-bleaching takes 
place, was used to analyze the fluorescence intensity of each diffraction limited 
focus. Frames towards the end of each movie captured single YPet molecules as they 
spontaneously returned from a dark state to the fluorescent state. These observations 
were used to determine the fluorescence of a single YPet molecule. The intensities of 
unbleached foci were divided by the average intensity of a single molecule to reveal 
the number of molecules per focus. 
Photo-Activated Localization Microscopy (PALM)
A single layer of cells was placed in between two microscope slides, which would 
sufficiently immobilize them for the time period of the experiment (typically 3 min). 
For mEos3.1 and mEos3.2 imaging excitation light (λ=568 nm) was introduced at 180 
W/cm2 for all the samples except the chromosomal Lyp1p-mEos3.1 in the Δart1/
Δart2 deletion strain, in which case the laser power was set to 450 W/cm2 to increase 
the signal-to-noise ratio. A second laser (λ=405 nm) was used to induce individual 
mEos3.1 molecules to switch from the green fluorescent state to the red fluorescent 
state. The laser power was adjusted to activate only a small sub-set of molecules at 
a time and was kept the same for all the experiments. Typically, 5000 frames were 
collected per measurement, with the microscope at room temperature (~23˚C). PALM 
reconstructions were generated by processing the acquired data with home-written 
PALM software. Foci originating from individual molecules were identified and 
their point spread functions fit with a 2D Gaussian function allowing their position 
determined with a resolution of ~30 nm. 
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FRAP simulations
The program SmoldynTM was used to perform all the simulations (http://www.
smoldyn.org/index.html) and data were analyzed using Mathematica. A yeast cell 
was represented as a sphere with a diameter of 5 μm. 4000 particles were randomly 
positioned over the surface of the cell except for the bleaching spot. The bleaching 
spot was a square with sides of 2 µm long. The center of the bleaching spot was 
positioned at the center of the focal plane. The particles were allowed to move over 
the surface by Brownian diffusion with a diffusion coefficient of 0.03 μm2/s. The 
simulation time step was 1 ms and the total simulated time 100 s. The positions of all 
particles were extracted every 2 s. The number of molecules in an area of 1 μm high 
and as wide as the bleaching spot (2 μm at t=0) was monitored and fit with equation 
4. 
Eq. 4 
where A is the number of particles in the region at equilibrium, t is the time and τ 
the recovery time constant. The calculated τ from Eq. 4 was used to calculate the 
diffusion coefficient with equation 5.
Eq. 5 
where D is the diffusion coefficient, ω is the width of the bleached region and τ the 
recovery time constant.
SPT simulations
Again, Smoldyn was used to perform the simulations and the data were analyzed 
in Mathematica. Twelve simulations were performed with the following diffusion 
coefficients: 0.0001, 0.00015, 0.00025, 0.0005, 0.001, 0.0015, 0.0025, 0.005, 0.01, 
0.015, 0.025 and 0.05 μm2/s. The displacement of particles within the focal plane 
(represented with a band) in the middle of the cell was used for the analysis; the band 
thickness in the z-direction was 1 μm. The localization noise was included in each 
simulation by taking as noise the experimental displacement data from the fastest 
sampling time, 34 ms. We assumed that due to the extremely slow diffusion of the 
analyzed proteins the apparent displacement originates primarily from localization 
uncertainty. The diffusion coefficients obtained in the simulations were compared 
against the input values and their relationship was used to correct the experimental 
data. Each simulation was started with a 1000 particles randomly positioned on the 
membrane band at the middle of the cell. The particles were allowed to move over 
the surface by Brownian motion. The simulation time step was 0.1 ms and the total 
simulated time was 90 s. The positions of all particles were extracted every 10 s. 
All the step sizes (displacements) on this 10 s time step were put in a distribution. 
Only those particles that remained within the band during the entire simulation were 
used, and the distributions were fitted with Eq. 3.
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Scheme 1. Scheme of live cell imaging single molecule 
fluorescence microscopy set up. Optical scheme 
composed of various continuous wave lasers, 
computer-controlled shutters, neutral-density 
attenuation filters and dichroic mirrors. Inverted 
Olympus IX-81 microscope with a fully automated 
XYZ stage and coupled to an EM-CCD camera. 
Results
Lateral diffusion of polytopic membrane proteins in the PM of yeast is 
extremely slow 
We probed the lateral diffusion of polytopic membrane proteins localized at the plasma 
membrane using Fluorescence recovery after photo-bleaching (FRAP). We expressed 
Ypet fusions of the lysine-H+ symporter Lyp1p, the arginine-H+ symporter Can1p, the 
sodium/H+ antiporter Nha1p and the glycerol channel Fps1p. Despite differences in 
structure and PM domain partitioning of the proteins, the lateral diffusion of Lyp1p, 
Can1p and Nha1p is very similar, as shown in Figure 1. The recovery profiles could 
be fitted to a single exponential function, indicating that there is one mobile fraction. 
These curves yielded very similar diffusing coefficients of 0.00045 ±0.00009, 0.00065 
±0.00011 and 0.00050 ±0.00012 μm2/s, for Lyp1p, Can1p and Nha1p, respectively. 
For Fps1p the recovery curve is a function of two mobile fractions; one showing 
faster diffusion (D = 0.0035 μm2/s) than the other proteins and one showing slower 
diffusion (D = 0.00006 μm2/s). Despite the small variation in lateral diffusion rates 
between Lyp1p, Can1p and Nha1p they differ in normalized recovery; for Lyp1p and 
Nha1p, the values are 64 % and 53 %, respectively. In case of Can1p we observed a 
relatively large variation in fluorescence recovery between cells, with ranges from 60 
% to 100 %. The differences in Can1p recovery might be attributed to residence of a 
fraction of the molecules in MCCs/eisosomes. 
In order to validate our analysis technique, we analyzed simulated diffusion data 
(Figure 2) Molecules were allowed to diffuse freely with a diffusion coefficient of 
0.03 µm2/s. The region representing the focal plane analyzed with the confocal 
microscope (see previous section) was taken with a thickness of 1 µm. The recovery 
of the particles in the photo-bleached region was followed and fitted the same way 
as the experimental data. The diffusion coefficient obtained, 0.032 µm2/s, was very 
similar to the theoretical one, 0.03 µm2/s, validating the analysis strategy. Overall, the 
diffusion rates of proteins in the S. cerevisiae PM are 1–3 orders of magnitude slower 
than proteins of similar size in the vacuolar membrane (Valdez-Taubas et al. (115); our 
own measurements on Vba1p yield D = 0.07 µm2/s, data not shown).
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Figure 1. FRAP measurements of plasma membrane proteins of yeast. Normalized fluorescence recovery of 
Lyp1p (A), Can1p (B), Nha1p (C) and Fps1p (D). Confocal images of before and different time points after 
photo-bleaching are shown in the right panels. Scale bars represent 2 µm. (E) Diffusion coefficient values 
and normalized recoveries with the respective standard deviations of each protein. 1Fast fraction and 2slow 
fraction of Fps1p.
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Figure 2. FRAP simulation. Simulation of Brownian diffusion in a cell with 4000 particles. Photo-bleached 
region of 2 µm width and 1 µm thick. Recovery of the particles in the bleached region (blue dots) and 
exponential fitting of the data (red line). 
Single-particle tracking confirms slow diffusion of Lyp1p and Can1p
The ensemble-averaged behavior of Lyp1p, Can1p, Nha1p and Fps1p show that 
the lateral diffusion of these PM molecules is extremely slow, irrespective of their 
assumed location in the membrane (see Introduction on MCC, MCP and possible 
other domains). However, conventional methods such us FRAP probe only long-
range diffusion of molecules. If molecules are confined in specific membrane 
domains, diffusion within these compartments may go unnoticed when probed by 
FRAP. We thus performed single-particle tracking of the two homologous proteins 
present in the PM of yeast (see Scheme 2 for sequence alignment): Can1p, thought 
to accumulate in MCC domains, and Lyp1p, which is not known to partition in a 
specific membrane domain. We carried out the step size analysis to determine 
whether or not the microscopic diffusion (SPT) of the molecules is as slow as the 
macroscopic diffusion (FRAP). To probe possible physical confinement of the proteins 
or interaction with other components of the cell, we determined the relationship 
between the mean squared displacement (MSD) and time. Figures 3 and 4 show the 
step size distributions (A-G) and the estimated diffusion coefficients at different frame 
times (H). The apparent rates of diffusion decrease with longer sampling times until 
reaching a plateau. The distributions indicate slow diffusion. At fast sampling rates, 
the proteins produce very small displacements between frames and the measured 
step-size distributions are dominated by localization uncertainty. Only once the 
delay between images is sufficiently long, we can resolve protein displacements from 
the localization noise. The data obtained in those longer experiments (3, 10 and 30 s 
sampling) were used to calculate the averaged diffusion rates. By SPT we measure 
diffusion coefficients of 0.00041 ± 0.00018 µm2/s and 0.00038 ± 0.00027 µm2/s, for 






























Figure 3. Step size analysis of Lyp1p-YPet diffusion at different frame times. (A-G) Step size (displacement, 
d) distribution of experiments performed at frame times of 34 ms, 100 ms, 300 ms, 1 s, 3 s, 10 s and 30 s. 
The diffusion coefficients obtained by 1D diffusion fit are shown. (H) Diffusion coefficients plotted as a 
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Figure 4. Step size analysis of Can1p-YPet protein at different frame times. (A-G) Step size (displacement, d) 
distribution of experiments performed at frame times of 34 ms, 100 ms, 300 ms, 1 s, 3 s, 11 s and 30 s. 
The diffusion coefficients obtained by 1D diffusion fit are shown. (H) Diffusion coefficients plotted as a 
function of the frame time. Averaged diffusion and standard deviation of the last three frame times (E-G) 
are shown.
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SPT simulations show how the diffusion coefficients obtained 
experimentally are somewhat underestimated
In order to verify the step size analysis we performed simulations of the single 
particle tracking data. Figure 5A shows an example of a step size distribution 
obtained by simulating the data with an input diffusion coefficient of 0.025 μm2/s. 
The localization noise was taken from the displacement obtained with the fastest 
frame time, 34 ms. From the acquisition speed up to 3 s/frame the displacement 
is constant, which corresponds to the localization noise. The displacement of the 
proteins is greater than the localization noise from 3 s/frame, where an increase is 
seen with higher frame times (Figure 6). The distribution of displacements was fitted 
with a 1D diffusion model (Eq. 3) to calculate the observed diffusion coefficient. 
Figure 5B depicts the relation between the obtained coefficients (Dobs) and the ones introduced before running the simulation (Din). Across a range of input diffusion 
rates there is a discrepancy between the input and measured diffusion coefficients 
(Fig 5B). This discrepancy arises due to the difference in the geometry of yeast and 
the simulated cell, which was not taken into account in our analysis. The corrected 
diffusion coefficients for Lyp1p and Can1p were taken from the relationship between 
Din and Dobs data resulting in 0.0011 and 0.0009 µm2/s, respectively. 
Figure 5. SPT simulation. (A) Step size distribution of a spherical cell 5 µm in diameter. The band where the 
particles were analyzed was 1 µm thick and the input D was 0.025 μm2/s. Displacements, d, obtained from 
the simulation are depicted in black circles and the 1D fit as a line. (B) Relationship between the Dobs and 
Din considering the localization noise in the data. D obtained from displacements along the x-axis depicted 
in full circles and the y-axis in empty circles.
Figure 6. Mean displacements of Lyp1p and Can1p at different frame times. (A) Lyp1p displacements in the 
x-axis (grey) and y-axis (black). (B) Similar data for Can1p.
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No evidence for confinement
The step size analysis shows that the microscopic diffusion of both proteins, Lyp1p 
and Can1p, is very similar to the ensemble diffusion coefficients obtained with FRAP. 
This slow diffusion could be due to anomalous diffusion produced by confinement 
or interaction with other proteins. In order to probe for these effects, we analyzed the 
relationship between the MSD and the step time interval. If protein diffusion follows 
a random unhindered random walk, the MSD will be linear with time. However, 
if the diffusion is hindered or restricted the MSD-time plot will be irregular, and 
with protein confinement the MSD will plateau and not exceed the diameter of the 
confined area. Figures 7 and 8 (A-G) show MSD plots for Lyp1p and Can1p imaged 
with different sampling times. While the trajectories are relatively short due to photo-
bleaching and diffusion out of the focal plane, all plots are well fit by a linear function. 
Each line intercepts the Y-axis at a value greater than zero. This is a known effect 
of localization uncertainty in the measurements (324). The gradients of the fit lines 
are similar across all measurements and yield diffusion coefficients consistent with 
those calculated from step-size distributions and FRAP, 0.00049 ± 0.00005 µm2/s and 
0.00069 ± 0.00005 µm2/s, for Lyp1p and Can1 respectively. Since we did not account 
for the cell shape during the analysis, there are likely to be minor discrepancies with 
the real values. 
The data are not consistent with confined diffusion. By averaging all the MSD-time 
plots we assume that all proteins reside in the same environment and undergo the same 
type of diffusion. We also produced MSD-time plots for each individual trajectory. In 
each case there is no convincing evidence of a plateau that would indicate confinement. 
This stands in contrast with the observation that Can1p accumulates in the MCC 
domains with dimensions of 50-300nm and suggests that Can1p diffuses freely in 
the yeast PM. There remains the possibility that the compartments or confined areas 
in yeast are too small to be probed given the spatial resolution of our technique (~50 
nm) and that our observations are of slower movements between compartments, as 
shown for mammalian cells (325, 326). If this is true, the compartments must have 
an average area less than ~0.005 µm2 (the localization uncertainty) and molecules 
must reside in these compartments for only tens of milliseconds. Alternatively, it is 
possible that Can1p is not kinetically trapped in MCCs and diffuses in and out freely, 
and that the partitioning is due to a different membrane lipid composition (106). 
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Figure 7. MSD of Lyp1p protein at different frame times. (A-G) MSD-time plots of experiments performed at 
the frame times of 34 ms (n = 6), 100 ms (n = 8), 300 ms (n = 4), 1 s (n = 16), 3 s (n = 21), 10 s (n = 6) and 30 
s (n = 7). The diffusion coefficient was obtained from the slope of each graph. Errors represent averaged 
standard deviation. (H) Diffusion coefficients plotted as a function of the frame time. Averaged diffusion 
and standard deviation of the last three frame times (E-G) are shown.
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Figure 8. MSD of Can1p protein at different frame times. (A-G) MSD-time plots of experiments performed at 
frame times of 34 ms (n = 42), 100 ms (n = 17), 300 ms (n = 9), 1 s (n = 36), 3 s (n = 16), 11 s (n = 10) and 30 
s (n = 34). The diffusion coefficient was obtained from the slope of each graph. Errors represent averaged 
standard deviation. (H) Diffusion coefficients plotted as a function of the frame time. Averaged diffusion 
and standard deviation of the last three frame times (E-G) are shown.
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Lyp1p and Can1p are monomeric 
We set out to determine the oligomeric state of Lyp1p and Can1p within the yeast PM. 
There are many methods to determine the oligomeric state of membrane proteins in 
the detergent-solubilized state (327). However, to determine the quaternary structure 
without disrupting the membrane environment is difficult. Single molecule analysis 
is arguably the method of choice to discriminate between monomeric, dimeric, 
trimeric and tetrameric species (328); for higher oligomeric states the method becomes 
tedious, however large complexes have been described by fluorophore counting 
(329). To determine the oligomeric state of Lyp1p and Can1p, we quantified the YPet 
fluorescence of individual proteins recorded during our single-particle tracking 
experiments. For each protein we analyzed both single-tagged (e.g. Lyp1p-YPet) 
and double-tagged (e.g. Lyp1p-YPet-YPet) constructs (bleaching steps of single- and 
double-tagged Lyp1p are shown in Figures 9C and 9D). In these experiments, as in 
the single particle tracking analysis, the expression levels were very low, in order 
to minimize spatial overlap between foci. In the case of Lyp1p-YPet, a relatively 
broad distribution is observed and is centered at 1 molecule per focus (Fig 9A). The 
distribution is likely broad because of noise. However, we assume that some of the 
brighter foci contain spatially overlapping molecules. For Lyp1p-YPet-YPet, a similar 
distribution is observed, but this time it is centered at 2 molecules per focus (Fig. 9A). 
Can1p-YPet-YPet produces a similar distribution, centered at two molecules per focus 
(Fig. 9B). These observations indicate that both Lyp1p and Can1p are predominantly 
in monomeric form in the yeast PM.
Figure 9. Oligomeric state of Lyp1p and Can1p. Number of YPet photo-bleaching steps molecules per 
diffraction-limited spot for fusions with Lyp1p (A) and Can1p (B). The proteins are expressed at low level 
in the plasma membrane of yeast. Striped bars represent the proteins labelled with one YPet and the full 
bars with two (tandem) YPet molecules. (C) Single YPet bleaching step along 500 frames. (D) Double YPet 
bleaching steps along 500 frames. 
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Heterogenous distribution of membrane proteins due to low expression 
levels
We here apply a high resolution imaging technique with fluorophore-tagged proteins, 
PALM, to study the organization of the plasma membrane of yeast. We studied Lyp1p 
and Can1p, each fused to the photo-switchable protein mEos3.1. Both fusion proteins 
were expressed at endogenous levels from their native chromosomal positions. 
Figure 10 shows the reconstructed images of Lyp1p-mEos3.1 (A) and Can1p-mEos3.1 
(B), together with the bright-field image of the cells. The localization precision is 30.8 
nm and 29.7 nm for Lyp1p and Can1p, respectively (C and E). Both proteins have a 
mean mEos3.1 fluorescence intensity of around 2000 in arbitrary units. Our results 
show that Can1p has a patchy organization at the plasma membrane, as would be 
expected of proteins associated with MCC domains (98, 101). Surprisingly, however, 
Lyp1p, which is not known to be present in these domains, also shows a patchy 
distribution on the PM. The number of patches is on average lower for Can1p (9.5 
patches per cell, n = 20) than Lyp1p (16.4 patches per cell, n = 20). Inspection of 
intensity fluctuations within the original movies suggests that these patches each 
contain one or two molecules that are repeatedly localized (Fig. 11). This suggests 
that the endogenous levels of those proteins in the PM are very low, in fact they 
are similar to the levels we induced for our single-particle tracking measurements. 
Putting MCCs and MCPs to the side, the low endogenous levels of these proteins 
suggest a simpler explanation for their heterogeneous distribution in the PM: there 
are simply not enough molecules to form a smooth distribution!
Figure 10. Localization of Lyp1p and Can1p. PALM reconstructions of Lyp1p-mEos3.1 (A) and Can1p-
mEos3.1 (B); both transporter genes were chromosomally tagged with mEos3.1. Localization accuracy of 
mEos3.1 (C and E). Fluorescence intensity of mEos3.1 (D and F). Scale bars represent 2 µm.
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Figure 11. Fluorescence intensity of a single molecule along the movie. (A) Lyp1p (B) Can1p.
The amount of Lyp1p at the PM increases when the lysine/arginine 
concentration is reduced
We analyzed whether the protein levels increase when their substrate levels (lysine 
and arginine) are decreased, and if so, whether this causes a change in the localization 
pattern. Figure 12 shows the reconstructed images of a cell grown with normal levels 
of substrate, 76 mg/L (Fig. 12A) and 10 times lower, 7.6 mg/L (Fig. 12B). The number 
of patches increases on average from 16.4 (n = 20) to 21.2 (n = 14) as can be seen in Fig. 
12A and 12B, respectively. By looking at the fluorescence intensity profile along the 
PM when the substrate levels are lower, the gaps in between each patch are smaller 
in size but the localization is not fully homogeneous (Fig. 12C and 12D, start and end 
point of the profile are illustrated by the arrows in the PALM reconstructions). As 
shown in Figure 12E, by lowering the concentration of lysine and arginine 10 times, 
the total number of Lyp1p-mEos3.1 localizations per cell increased 2-fold (Fig. 12E). 
Levels of other PM transporters in yeast, such as Gap1, have been shown to increase 
in response to decreasing substrate concentrations, suggesting that the substrate 
concentration controls the level of protein at the plasma membrane (307). As before, 
each of the patches we observe appears to contain one or two molecules, thus even 
under low-substrate conditions the levels of Lyp1p in the PM remain relatively low.
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Figure 12. Localization of Lyp1p in cells incubated with different amounts of substrate, lysine and arginine. (A) 
Localization of Lyp1p in standard medium containing 76 mg/L of lysine and arginine and (B) medium 
containing 10 times less lysine and arginine, 7.6 mg/L. The bright-field images are depicted in the right 
panel. Arrows define the direction along the PM used to calculate the fluorescence intensity profile of 
Lyp1p in standard medium (C) and low substrate medium (D). Number of localizations per cell in different 
media with different concentrations of lysine and arginine (E). Errors represent standard deviation from 
the mean of 16 cells. Scale bars represent 2 µm.
Deletion of art1 and art2 decreases the internalization of Lyp1p 
To investigate the effect of Lyp1p turnover on the organization of the protein in the 
PM, we performed PALM imaging in Art1 and Art2 null strains. It is known for yeast 
that Art1 and Art2 play a direct role in the down regulation of Lyp1p at the PM. 
Art1 and Art2 are members of the ART family (arrestin-related trafficking adaptors) 
and target Lyp1p for ubiquitination by Rsp5 and subsequent internalization to the 
multi vesicular endosome (MVE). Lyp1p internalization is triggered by two distinct 
pathways, one involves a high concentration of lysine in the medium and the other 
involves stresses such as the addition of cycloheximide, conditions known to trigger 
endocytosis of polytopic PM proteins (e.g. Can1p) (330). Art1 is required for the 
lysine-induced Lyp1p endocytosis, whereas Art2 is required for the stressed-induced 
internalization of the transporter (331). Figure 13A shows that Lyp1p in the double-
knock out strain is spread more evenly over the PM as compared to the wild-type 
strain. The gaps between the localized proteins are less frequent and smaller as 
shown by the fluorescence intensity profile along the PM (Fig. 13B). We conclude 
that the residence time of Lyp1p at the PM is increased in the Art1/2 null strain, and 
that higher levels of protein accumulate. These experiments reinforce the conclusion 
that the dynamics of Lyp1p regulation at the PM is mostly at the level of (biogenesis 
and) endocytosis.
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Figure 13. Localization of Lyp1p in Art1/2 null strain. (A) Localization of Lyp1p (left panel) and the bright-
field image (right panel). The arrow defines the direction along the PM used to calculate the fluorescence 
intensity profile of Lyp1p (B). Scale bars represent 2 µm.
Discussion
In this study we analyzed the diffusion of membrane proteins by ensemble-averaged 
FRAP measurements and single-molecule SPT. The results indicate similar diffusion 
speeds for Nha1p, Lyp1p and Can1p within a range of 0.00045-0.00065 µm2/s. The 
values are very similar to the ones obtained for the plasma membrane ATPase Pma1p 
and Gap1p with diffusion coefficients of 0.0004 to 0.0007 μm2/s (116, 119). These 
proteins contain 10-13 transmembrane (TM) helices. On the contrary Fps1p, with 6 TM 
helices, showed two distinct mobile fractions, a fast one with a diffusion coefficient 
of 0.003 µm2/s and a slow one of 0.00006 µm2/s. The results of a previous study 
suggest Fps1p to be a tetramer in the PM of yeast. We consider it unlikely that the 
slower diffusing population corresponds to the tetramer, whereas the fast population 
relates to the monomeric state. The immobile fractions of all the membrane proteins 
tested by FRAP could be explained by clustering or ER/vesicle trapping prior to PM 
delivery due to high protein levels. 
The diffusion coefficients of Lyp1p and Can1p obtained by SPT are in perfect 
agreement with those of the FRAP measurements. As shown here and by others 
(115, 117), the diffusion of plasma membrane proteins in yeast is at least two orders 
of magnitude slower than in mammalian cells. This slow diffusion of integral 
membrane proteins and lipids seems to be a general feature of the plasma membrane 
proteins of S. cerevisiae. The specific lipid composition of yeast might be an important 
factor in the slow diffusion of PM proteins. It is already known that the number 
of sphingolipids and ergosterol increases along the secretory pathway, and the PM 
being the organelle with the higher amounts and thus tighter membrane packing 
(2). Moreover, the dominant sphingolipid in yeast is the inositol-P-ceramide (IPC), 
which has a hydroxylated C26 acyl chain (90). This very long chain fatty acid differs from the chains of sphingomyelin in mammalian cells and is predicted to increase 
the lipid packing of the membrane. Intriguingly, the diffusion coefficient of similar 
size membrane proteins in the endoplasmic reticulum (ER) and vacuolar membrane 
of yeast are 2-3 orders of magnitude faster than in the PM (115, 120, 121). There is 
only a 4-fold difference between the lateral diffusion of lipid anchored proteins in the 
vacuole and the PM (119). In our analysis the diffusion of palmitoylated fluorescent 
reporters, anchored to the inner leaflet of the PM solely via the acyl chain, is relatively 
slow (D = 0.02 µm2/s) albeit much faster than that of the integral membrane proteins. 
This suggests that the outer leaflet of the membrane or unknown interactions 
contributes enormously to the slow diffusion of polytopic membrane proteins.
The stoichiometry of a complex is usually well regulated and often linked to the 
function of the protein (327). For instance, Nha1p has been shown to function as 
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antiporter only when dimers are formed (311). Can1p and Lyp1p are shown to be 
monomeric, at least when expressed endogenous protein levels. This analysis rules 
out the formation of big protein aggregates as the cause for the slow diffusion.
PALM imaging shows how Can1p and Lyp1p distribute laterally in distinct areas, 
i.e. in a few patches along the PM. In general, cells have very few of those patches, 
around 10 seen when imaging the cross-section of the cell. By analyzing the intensity 
profile along the movies, we find that the patches accommodate only one or two 
proteins. This, together with the oligomeric state analysis, indicating that Lyp1p and 
Can1p are monomeric, shows that low amounts of the proteins are present in the PM. 
Our data agree with a recent study by Spira and co-workers, who showed that none 
of the proteins analyzed are co-localizing in the yeast PM (114). They interpret the 
data as the coexistence of various protein domains that only partially overlap. Their 
observations can be easily explained by the low number of proteins in the PM of 
yeast. The number of Lyp1p patches is increased when the substrate levels are low or 
when the proteins responsible of the Lyp1p recycling are deleted. This suggests that 
not only the low amounts but also protein endocytosis is influencing the polarization 
of the PM. This was already suggested on the basis of theoretical considerations and 
some experimental data for other proteins in the yeast PM (115, 124, 304). 
Our SPT analysis shows the absence of any protein confinement. Therefore, the 
polarized patch-like distribution of Lyp1p and Can1p at the PM is not due to 
physical barriers hindering the proteins to diffuse further. There is still the remote 
possibility that compartments are present with sizes below our spatial resolution, 
approximately 0.005 µm2 in area. The lack of confinement does not necessarily 
contradict the observations made by others where Can1p is shown to reside in a 
domain of 300 nm in diameter (98, 101, 102, 302). Can1p may partition in MCCs/
eisosomes but the diffusion in or out of the domains may be fast and the diffusion in- 
and outside the MCCs may be similar. Thus, Can1p may not be kinetically trapped 
but thermodynamically favor the MCC domain. This would also be in accordance 
with the observation made by Brach and co-workers that 70% of Can1p resides 
outside of MCC/eisosome compartments and that endocytosis of Can1p takes place 
outside the MCC (113). In fact, Strádalová et al. demonstrated that the endocytosis is 
excluded from the cortical ER and the MCC/eisosomes (126). This is supported by 
observations made by Grossmann and co-workers, who showed that protonophores 
or deletion of genes specifying MCC proteins increased protein endocytosis (106). 
We propose a simple model to explain the heterogeneous distribution of Lyp1p and 
Can1p in the yeast PM. The levels of these proteins in the PM are kept low through a 
combination of slow synthesis/PM delivery and Art1/2-dependent internalization. 
Once in the PM, membrane proteins diffuse slowly. Because of this, individual 
molecules appear as foci or small patches when imaged in the milliseconds to seconds 
time-regime, which is standard practice in the field. Moreover, if two proteins are 
delivered by the same vesicle to a given position at the PM, it will take long before 
they segregate. And this may explain why we observe either one or two proteins 
per focus. The slow diffusion we observe is not caused by the formation of large 
aggregates and is unlikely due to confinement within micro-compartments. If there 
are no physical barriers, the yeast lipid composition (highly rich in sphingolipids and 
ergosterol) and/or the crowding might be responsible for the extremely slow diffusion. 
To confirm this hypothesis, diffusion studies in vitro using model membranes (giant 
unilamellar vesicles) composed of yeast PM lipids with reconstituted proteins are 
required. It is also possible that the diffusion of integral membrane proteins is hindered 
through their interaction with cell wall components or ER anchors. Dual-color PALM 
measurements could be used to probe for co-localization and coordinated motion of 
membrane proteins, which would provide valuable insight into the environment in 
which the proteins function in the yeast PM.
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Interaction of small molecules with membranes: Amphipathic 
pore-forming peptides
Antimicrobial peptides appear potentially effective in inhibiting or killing microbial 
cells without much negative effect on host cells, which makes them important targets 
for therapeutic applications. In this thesis, we describe the molecular basis for the 
antimicrobial activity of a cyclic peptide compared to its linear inactive analogue. The 
secondary structure acquired upon peptide binding, caused the right arrangement 
of the hydrophilic/positively charged and hydrophobic residues allowing pores to 
be formed. An amphipathic arrangement is a very common feature of antimicrobial 
peptides and facilitates the insertion of the peptide into the hydrophobic core of 
the membranes. However, the overall structure of the amphipathic cyclic peptide 
is unique and different from f.i. amphipathic helices that also form pores. Some 
antimicrobial peptides can also translocate the cell membranes and interact directly 
with intracellular processes or targets. The combination of multiple modes of action 
is currently being investigated and related to the low resistance that microbial cells 
present to these compounds. The multi-modes of action described in vitro are not easy 
to correlate to mechanistic processes that occur in vivo. The cyclic peptide studied 
here also showed a dual-mode mode of action by causing membrane poration and 
fusion. This tandem mechanism has been also observed by the G13A mutant of the 
influenza hemagglutinin, which possesses a leaky fusion phenotype (43). The lack of 
microbial resistance together with the wide range of cell targets makes antimicrobial 
peptides attractive for the discovery and development of novel anti-infective agents. 
The rational design of new agents will require further understanding of the molecular 
basis of their selective activity with low cytotoxicity and more detailed structure-
activity relationships. The combination of molecular modeling with experimental 
approaches is the key to this understanding and will amplify the antimicrobial 
effectiveness of conventional antibiotics. 
Interaction of small molecules with membranes: reducing 
versus non-reducing sugars
The survival of many organism to extreme conditions such as high or low temperatures, 
desiccation, high salt concentration, and lack of oxygen, have intrigued scientists for 
centuries. Anhydrobiosis, the best known form of cryptobiosis, is derived from the 
Greek and means “life without water” (274). In this state the organisms may stay 
alive for years or even centuries with their metabolism dropped to a minimum; cells 
are activated upon rehydration (273). 
Non-reducing sugars like sucrose and trehalose have been shown to stabilize 
membranes and proteins upon dehydration, and many organisms are able to 
synthesize these compounds in high amounts, allowing them to survive desiccation. 
We have shown that these sugars are able to affect the membrane organization 
by disrupting the tight packing of the liquid-ordered lipid phases. Sugars spread 
the lipids by intercalating in between the head groups, increasing the lipid area 
and expanding the membrane. The increased degree of disorder in those lipid 
domains results eventually in a homogeneous distribution of lipid phases in model 
membranes. The relatively short linkage in between the two sugar rings and the non-
reducing nature of sucrose and trehalose are crucial for the lipid domain mixing. 
Eukaryotic cell membranes have been shown to compartmentalize lipids and proteins 
in nanoscale domains, lipid rafts (see introduction), where vital processes take place. 
Non-reducing saccharides could also perturb the confinement of those proteins 
affecting their function and at the same time stabilizing them during anhydrobiosis. 
The change in the membrane lipid environment could affect the function and stability 
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of proteins, which is likely to be critical during anhydrobiosis. 
Design of novel membrane pores: Applications in synthetic 
biology
Natural membrane channels have been widely used as inspiration for the development 
of new ion pores in synthetic biology. They have appealing applications as antibiotics, 
drug delivery vehicles, catalysts, detectors and sensors. In this thesis we have used the 
natural antimicrobial peptide, alamethicin, as the membrane channel in combination 
with the versatile DNA chemistry to modulate the channel behavior. The use of 
complementary DNA strands or G-quadruplex motifs has resulted in the stabilization 
of a preferred oligomeric state of the channel units, leading to pores with a stable 
unitary conductance. The approach of combining pore-forming properties of peptides 
with functionalization by DNA has potential application in the drug delivery field. 
However, further improvements in the design are needed, which could include the 
development of synthetic channels with controlled disassembly of the DNA scaffolds 
and thus freeing the peptide monomers eliminating the size restriction that they 
initially possessed. In such a design, the delivery of large macromolecules could take 
place in a controlled fashion. The in vivo application of these systems would require 
the injection of complementary DNA strands or alternatives to potassium ions to 
stabilize the G-quadruplex motif. They could also be tested and used as antimicrobial 
agents due to the self-insertion propensity of those peptide-DNA hybrids. The drug 
delivery field is still in need of future progress in mechanistic and structural studies 
to maximize the efforts towards the design and synthesis of effective compounds 
“beyond the simple hole”.
Protein dynamics in the plasma membrane of Saccharomyces 
cerevisiae 
Eukaryotic cell membranes have proven to be highly organized with the capability 
to sub-compartmentalize, which impacts the intracellular membrane trafficking and 
signaling. One of the well-established membrane organizations is the formation of 
membrane ‘rafts’, which are described as dynamic nanoscale sterol, sphingolipid-
enriched, ordered assemblies of specific proteins (1). Saccharomyces cerevisiae serves 
as a model system for mammalian cells to study several processes, including the 
membrane organization. The yeast plasma membrane has found to be organized in 
the MCC/eisosome, MCP and MCT domains. However, recent studies also suggested 
that the plasma membrane of yeast accommodates several protein domains that 
partially overlap with each other (114). In this thesis, we have shown that the 
amino acid transporter Can1p, thought to be component of the MCC domain, is not 
confined to a specific domain when expressed at endogenous levels (chromosomal 
expression). The lateral diffusion of the protein in the plasma membrane (PM) is 
extremely slow and similar to that of other polytopic membrane proteins tested such 
as Lyp1p, Nha1p and Fps1p. Our super-resolution imaging experiments have shown 
that the polarized distribution of these proteins along the PM might be the result 
of low expression levels under normal conditions. This localization pattern is also 
influenced by the slow mobility of the proteins as proteins inserted into the PM do not 
readily diffuse away from each other. The high contents of sterols and sphingolipids 
in the PM increase the ordering and stiffness of the membranes, which is likely the 
basis for the slow diffusion of the proteins. Our results favor the hypothesis that 
plasma membrane polarity is reached by the resultant of slow protein diffusion, 
high membrane viscosity and low protein levels. The next question that needs to 
be answered is whether the described microdomains in the PM of yeast are real or 
whether overexpression has contributed to apparent heterogeneities. 
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Dual-color PALM will allow us to analyze the co-localization of PM transporters with 
well-known protein components at high resolution and resolve issues on membrane 
domains in the PM of yeast. Such experiments together with studies of the dynamics 
of proteins in model membranes prepared from yeast PM lipids should allow us 
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This thesis is not only the result of four years of research but also the reflection of 
my evolution and growth as a scientist during my PhD. I have divided the thesis 
into four parts, reflecting different aspects of the study of the molecular basis of 
membrane stability and dynamics. 
I started working on the characterization of the mode of action of membrane-active 
amphipathic peptides since the first day I came to Groningen, a project in close 
collaboration with the group of Siewert-Jan Marrink. Later on, I took a synthetic 
biology approach, making use of amphipathic peptides for the design of new 
membrane pores (in collaboration with the group of Gerard Roelfes). In parallel, I 
worked on the interaction of small molecules with membranes, again, with the group 
of Siewert-Jan Marrink. Finally, I used my expertise in membrane biology to address 
outstanding questions on the organization and dynamics of amino acid transporters 
in Saccharomyces cerevisiae. Every topic has provided me with further knowledge and 
understanding of membrane biology, which, together with the beauty of working 
with different people, made my PhD program a very pleasant and fruitful journey.
Interaction of small molecules with membranes: Amphipathic pore-forming 
peptides
Chapters 2-4 describe studies on the mechanism of action of antimicrobial peptides. 
We focused on two small peptides, the cyclic BPC194 and its linear analogue BPC193. 
Although they have the same amino acid sequence, only the cyclic peptide is able 
to kill microbial cells. Using a combination of fluorescence-based techniques and 
molecular dynamic simulations, we have shown that the cyclic peptide adopts 
a specific conformation upon membrane binding, which allows the molecule to 
insert deeply into the bilayer and form pores. Remarkably, the cyclic peptide unlike 
the linear analogue is also able to fuse membranes when two bilayers are in close 
proximity. We thus present a novel dual-mode of action for an antimicrobial peptide 
that is active against a wide range of prokaryotic organisms.
Design of novel membrane pores: Applications in synthetic biology
In chapter 5, we describe the design, synthesis and characterization of DNA-
peptide hybrids that self-assemble into a membrane pore. In one strategy we used 
complementary DNA strands to form peptide dimers. In the other strategy we used a 
G-quadruplex motif to form tetrameric structures. In both cases, the resulting pore had 
a preference for a specific oligomeric state and a well-defined ion conductance. These 
first designs of DNA-peptide hybrids suggest great potential for the functionalization 
of membrane pores on the basis of nucleic acids.
Interaction of small molecules with membranes: reducing versus non-reducing 
sugars
In chapter 6, we describe the effects of carbohydrates on the organization of lipids 
in synthetic membranes. We combined fluorescence microscopy with molecular 
dynamic simulations and discovered that non-reducing disaccharides, sucrose and 
trehalose, have a specific effect on the organization of biological membranes, which 
results in mixing of lipids that are normally segregated into liquid-ordered and 
liquid-disordered phases. Our studies offer rationale as to why sucrose and trehalose 
are frequently used in biology to allow organisms to survive in extreme desiccation 
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conditions. 
Protein dynamics in the plasma membrane of Saccharomyces cerevisiae
In chapter 7, we determined the localization, oligomeric state and dynamics of plasma 
membrane amino acid transporters of S. cerevisiae. The distribution of the proteins 
in the plasma membrane is not homogeneous. We hypothesize that the apparent 
heterogeneity is due to the extremely slow diffusion of membrane proteins in the 




Dit proefschrift is niet alleen het resultaat van vier jaar onderzoek, maar ook de 
reflectie van mijn evolutie en groei als wetenschapper tijdens mijn doctoraat. Ik 
verdeel het proefschrift in vier delen, die overeenkomen met de verschillende 
onderwerpen waaraan ik heb gewerkt aan de interactie tussen cel membranen en 
andere biologische moleculen. 
Sinds de eerste dag dat ik in Groningen aankwam heb ik gewerkt aan amfipatische 
peptiden, in nauwe samenwerking met de groep van Siewert-Jan Marrink. Later 
verschoof mijn aandachtsgebied naar de synthetische biologie waarbij we artificiële 
membraan kanalen synthetiseerden opgebouwd uit amfipatische peptiden in 
samenwerking met de groep van Gerard Roelfes. Tegelijkertijd bestudeerde ik de 
interactie tussen suikers en lipiden membranen wederom, met de groep van Siewert-
Jan Marrink. Tot slot heb ik mijn vergaarde kennis in de membraan biologie toegepast 
op het bestuderen van de complezxe organisatie en dynamiek van aminozuur 
transporters in het plasma membraan van S. cerevisiae. Met elk hoofdstuk heb ik 
mijn kennis en expertise verbreed evenals de ervaring van het samenwerken met 
verschillende mensen, wat mijn promotie tot een zeer prettige en vruchtbare reis 
heeft gemaakt. 
Interactie van kleine moleculen met membranen: Amfipathische peptiden
In hoofdstukken 2-4, hebben we gekeken naar het mechanisme van anti-microbiële 
peptiden met het membraan. We hebben ons gericht op twee korte peptiden, 
de cyclische BPC194 en zijn lineaire analoog BPC193. Hoewel beide dezelfde 
aminozuursequentie bezitten, heeft alleen de  cyclische vorm een anti-microbiële 
werking. Met een combinatie van op fluorescentie-gebaseerde technieken en 
moleculaire dynamica simulaties, hebben we kunnen aantonen dat het cyclisch 
peptide de juiste conformatie aan neemt bij membraan binding. De daaropvolgende 
inerstie resulteert in de vorming van porien. Tegelijkertijd hebben we geconstateerd 
dat het peptide kan ook  membraan fusie faciliteert. We omschrijven hier een nieuwe 
twee component methode voor een antimicrobieel peptide, effectief tegen een groot 
scala aan prokaryoten.
Membraan kanalen: Toepassingen in de synthetische biologie
In hoofdstuk 5 ontwerpen en synthetiseren we een DNA-peptide hybride om 
oligomerisatie van een membraan kanaal te moduleren. Daartoe gebruiken we 
complementaire DNA strengen die resulteren in peptide dimerisatie evenals een 
G-quadruplex motief voor het vormen van tetrameren. In beide gevallen had het 
daaruit resulterende kanaal een voorkeur voor een specifieke oligomere toestand met 
een vaste grootte. Deze Initiële ontwerpen van hybride DNA-peptide suggereren een 
hoog potentieel voor de basis van membraan porien, gebaseerd op nucleïne zuren. 
Interactie van kleine moleculen met membranen: het verminderen versus niet-
reducerende suikers
In hoofdstuk 6 hebben we gekeken naar de effecten van koolhydraten op het 
membraan. We combineerden fluorescentie microscopie met moleculaire dynamica 
simulaties en ontdekte dat alleen de niet-reducerende koolhydraten, sucrose en 
trehalose een effect hebben op de organisatie van lipid rafts. Onze studie legt de 
mogelijke basis waarom deze disachariden door verschillende organismen worden 
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gesynthetiseerd  om te overleven in gevallen van extreme uitdroging.
Eiwitdynamica in het plasmamembraan van Saccharomyces cerevisiae
In hoofdstuk 7 bestudeerden we de lokalisatie, oligomerisatie en dynamiek van 
verschillende plasmamembraan aminozuur transporters van S. cerevisiae. De verdeling 
van deze eiwitten in het plasmamembraan bleek niet homogeen maar gepolariseerd. 
We hypotetiseren dat deze polarisatie een consequentie is van een extreem trage 






I am sitting in the darkness of the microscope room (yes, I am here again, myself and 
the silence) in the middle of the rainy, cloudy, foggy, cold October, in the Netherlands, 
where winter starts at the end of August, writing the last words of my thesis. I find 
these last words very hard to write (I am anxious to see the book finished, printed 
and unmodifiable, once and for all!) and at the same time extremely essential. One of 
the reasons is that in this bit of my thesis I can write whatever comes into my mind 
without caring about the scientific style of writing. Another reason, and the most 
important one, is the chance to capture in these words all my appreciation to all the 
people that made it possible for me to be here today writing these last words. It is 
hard to find a way to put all my thoughts into some lines with a meaningful order, so 
I decided to mention in a short story all the chronological (and geographical) events 
and people I encountered.
It all started in Girona (alias “the center of the world”), where my inner scientist, 
named “Menina”, was born in the year 2007. There I had my very first lab colleagues 
and I even supervised my first students (all of them ended up doing a PhD, at least I 
didn’t make them drop science).
Fel, you have always been “The Mentor”, initially for a week (what a supervisor, leaving me 
a week after my start to “do research” in Lisbon) but afterwards you have been always there, 
not just scientifically, but most importantly, as a friend. Marta, your positive energy and big 
heart stayed with me even when I left for the Netherlands. The “cats”, Tiffa, Imma and the 
rest of the UdG people, it was a pleasure spending time with you guys in and out of the lab. 
After a couple of years doing research in Girona (and a bit tired already of synthesizing 
antimicrobial peptides) I started what would be the beginning of a new and exciting 
period of my life (“The big change”). It was the 31st of January 2009 when Anna and I 
took the plane that would bring us to Amsterdam. After spending the whole night in 
the airport we finally arrived in Groningen (not before spending more than 2 hours 
in the train, though) and lucky for our stomachs and us it was koopzondag! (for the 
ones that don’t know, shops are generally closed on Sundays in the Netherlands, but 
the first Sunday of every month it is an exception and the shops and supermarkets 
are open).
Diaz, Diaz, Diaz, you have been the inflection point of my scientific career. Thanks to you 
I came for the first time to the “Poolman’s Lab”, where our work with Jacek, Durba and 
Siewert started. You know how enormously thankful I am to you for providing me with the 
opportunity to come to Groningen and have such a great time. I won’t forget our days in 
the lab, parties in the student house (JieMaaaaaaa, pe-pe-pe-pe-perrrrrrrrrrrrrrrooooo,...), 
discussing and getting excited about science all the time, meetings, writing together, etc. 
Thanks for being there. I wish you all the best in your future. 
The next day I was already following the lab’s rhythm: my first Monday morning 
group meeting (I still remember Armağan presenting a picture of her daughter, who 
is now a gorgeous girl, after maternity leave and saying: “this is my new project”) 
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and in the same day, subgroup meeting with Jacek and Bert (I think there I showed 
my first powerpoint presentation, something that would turn into a routine in our 
meetings). I was amazed at the way the Dutch do science, at least in my experience, 
in a very open and collaborative way (I even read once that this comes from the 
fact that the Dutch had to collaborate together to build the polders, to avoid future 
floods, all of them working together for a unique purpose). I have had the pleasure 
to establish lots of collaborations, working with inspiring people and learning a lot 
on the way.
Bert, you welcomed me in your lab, even though you knew I was from Spain and everybody 
thought I was drinking wine for breakfast and having “siesta” every day at the university 
(to make it clear, that is so not true). After one or two months, while you were trying to 
understand whether I was doing a Masters or a PhD in Girona, you asked me to join the lab 
to start another PhD, something that, to be honest, I accepted without the need of sleeping on 
it (well, I did consult with Edu, though). I am hartelijk thankful to you for appointing me (or 
as some others would say: “stealing me”), giving me the chance to enlist as a PhD student 
under your guidance, observing and learning from you, something that I will take with me 
once another bird (as myself) flies from the nest. I also want to express my gratitude to you 
for all the support that you have shown to Edu, which is also support for me.
Durba, my dear, you have been a role model to follow. You inspired me with your wisdom, 
experience, and knowledge and I am very thankful to you for that. I know you will become a 
very successful Professor, and you will give your mustached-students a hard time.
Jacek, with you I started my period in Bert’s lab, you taught me lots of things and in the end 
we had a very productive period working together (our already written chapters saved me so 
much writing time at the end of my PhD!).
Siewert, I am trying to think whether I have spent more time discussing science with you or 
preparing you coffee. However, I had a great time working with you during almost five years 
(we are not yet done with the work, but I hope we can finish our last project together soon). 
Thanks for being in my committee as well, and sorry for having the defense on Friday at 
nine, I know it’s way too early for you. I would also like to include here Alex, César, Clement, 
Djurre, Marcelo, Helgi, Tsjerk, Jaakko, Floris, Xavier and all the MD group members I 
shared some time with, especially having drinks and fun at conferences.
Manel, I didn’t know where to mention you since I met you, if I am not mistaken, at the 
end of 2007 when Marta Ribeiro was in Girona (Marta, eu ainda espero que um dia nossos 
caminhos se cruzam, em New York ou em outro lugar). Your curiosity and your thirst for 
knowledge have always amazed me. Thanks for all the help, always, in all areas. I hope to be 




Joining Bert made me share my days in the lab with a bunch of new colleagues (in 
“Poolman’s Lab” a bunch means around 40 new colleagues). It was the first time 
having so many workmates and I was a bit frustrated to see I couldn’t get close (on 
a personal level) with all of them, something easily achievable in Girona (in a group 
of not more than 10). So I had to accept it and keep on going. However, I met great 
friends and I hope to keep in touch with them.
Josy and Ronnie, you were some of the first I met. Soon we had great times together. Ronnie, 
thanks for all the cooking during dinners and for always proposing fun activities to do 
together. Josy, when you left, my cheerful dancing and sports partner was also leaving. 
However, I am very happy for you two and I wish you the best in this next exciting period 
of your lives.
JP, thanks for such a great 30-year-old birthday BBQ! Sorry this is what comes to my 
mind each time I think of you. However, I also remember great funny moments in the lab, 
especially when you were being annoying to poor Adeline. All the best in your future and I 
will be waiting for the second BBQ. 
I want to mention here other people that also left the group: Adeline (we never coincide 
in Paris, so sad…), Tejas (great night tour in Zurich, thanks), Inga (thanks for a couple 
of Feuerzangenbowlen), Andreja, Nadia, Anna Dimitrova (crazy!), Karlien (you were 
extremely helpful) and all the “ERIBA people”: Justyna, Astri, Petra, Anton, Anne, 
Annemarie, Georges and Liesbeth. To most of you I already told that the lab has never been 
the same since you left.
Fortunately, not everybody left and more fun was about to come. This was at the time 
I changed office and joined the “yeast team”, working on my last project in the lab 
together with Dušan, Frans, Stephanie and Joury.
Dušan, ¿qué pasa negro? Thanks to you I started working with yeast and I gained a lot of 
knowledge (still too much to learn, though) on molecular cell biology and other “angles” of 
life. All the best in your career and be patient if you end up supervising PhD’s.
Stephanie, you are currently having fun in some remote place in Australia while we are 
here enjoying the rain, but I won’t complain because you will be proof reading those lines 
very soon (maybe from a beach?). Thanks a million for that and for always helping me in 
anything I asked, in the lab and outside of it (thanks for letting me step on your dining table 
to fix my suit pants). I wish you all the best, I know your PhD will be a success and whatever 
you do afterwards you will nail it, as always. I hope you keep on cooking such delicious 
meals, you are the best!
Andrew, from you I have learnt a lot, you are a great scientist and for the sake of science I 
hope you never ever quit. Anybody working with you will have a fantastic character to get 
inspired from, laugh with and, according to my experience, get scared the hell out each time 
you want to talk to them (not because of your face, you know why…).
Dirk, thanks for all the pressure you put on me (and others) talking about finishing up theses 
in the coffee corner (always with a lot of humor, though). Thanks for being in my committee 
as well.
Gea and Ria, I owe you also my gratitude for all the help in the lab. Ria, I am kindly thankful 
for all the care you had towards me and also Edu. Thanks to you he found his own way in 
Nijenborgh 4, meeting friends and also clients.
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Rianne, bedankt voor het geduld om Nederlans met mij te spreken. Thanks for all the work 
with the sugars project. I have no doubt you will have a very successful PhD, all the best.
Joury “van het closet”, we all had so much fun since you joined the lab. Keep that priceless 
smile on your face man and all the best in your future. Topie, hoi hoi, mazzel, oing oing, 
buru buru!
Pranav and Nobina, my dear Indians, I will never ever forget the day we could hold a 
conversation for an hour (or even more) in Punjabi, Bengali and Catalan without English 
(especially Pranav that became “English-less”). We have had great times together and 
have shared lots of stress in the last months of our PhD’s but, eventually, we’ll all find our 
successful ways.
Marysia, my dear Maria, you started your PhD just a month before I came, I think, so we 
have shared lots of years together in the lab, but what I have enjoyed the most are your 
baking skills and your dinners! Thank you so much and keep on going. Maciek good luck 
with your “Klussenbedrijf”, as well.
Jeanette, initially my officemate and later on my friend, thanks for always being so helpful, 
such a good listener and a lovely person.
During my days in Groningen I also supervised a couple of students and had the 
chance to collaborate with great people.
Beata, it was very interesting working with someone that is both a biotechnologist and a 
psychologist. Łukasz, I really enjoyed the time you were in Groningen. You were (and are) 
a brilliant student/guy (besides, you handled Dušan’s comments very well). I also learned 
from both of you. All the best in your PhD’s!
Armağan, thanks to you I learnt about electrophysiology studies. It was a pleasure working 
with you. Thanks for always listening and for being always so cheerful (as Alberto once told 
me and I fully agree with him, you radiate optimism).
Marc Stuart, thanks for all the cryo-EM work. Jan Willem Veening, thanks for providing us 
with a few slides to perform one last experiment that the referees asked. Manuel Jäger, thanks 
for giving us one of your synthesized saccharides. Jianwei, it was nice performing with you 
the microscopy experiment you needed for your project, all the best with your defence.
Lorina, for how long did we work together? I think for about a couple of years. During this 
time, I must say it was great working with you (and having coffee breaks). I am sure you will 
find a fantastic job after your Ph.D. (otherwise a rich husband!)
Gerard, it was also very nice working with you, thanks for giving me the opportunity to 
work “upstairs”. I feel sorry for what happen to Beatrix (no, not the former queen, the 
peptide synthesizer), it was time for her to get retired. Thanks for being in my committee as 
well.
Tina, I have really enjoyed each time you have come to Groningen for experiments. I am not 
sure whether Edu thinks the same, though, since each time you were here we stayed in front 
of the microscope until…almost midnight. It was great working, listening to FFH.de and 
eating pizza with you!
Abhi, thanks for such a nice collaboration with the sugars. I had a great time visiting your 
lab. Marc, thank you for being in my committee. I hope our work will be out soon.





Michiel, alias Miguel, I am enormously thankful to you for all the plugins you have made for 
us, making our data analysis more straightforward.
Antoine, I am very thankful to you and your group in general, without it my last chapter 
wouldn’t exist. Thanks for being in my committee.
The final days in ¨ Poolman’s Lab” arrived (sooner that I realized, time flies!) and with 
the end of a PhD in the Netherlands arrives the time one has to choose two faithful, 
devoted, honorable guardians called “paranimfen” (in English, paranymphs). For 
those who don’t know, here is the explanation from our friend Wikipedia:
“In the Netherlands a pair of paranymphs (paranimfen) are present at the doctoral 
thesis defence. This ritual originates from the ancient concept where obtaining 
a doctorate was seen as a de facto marriage to the university. Furthermore the 
paranymphs would also act as a physical shield in case the debate became too 
heated, or as a backup for the doctoral candidate to ask for advice when answering 
questions. Today their role is symbolic and seen as a position of honor similar to a 
best man at a wedding.”
The chosen warriors were Duygu, alias paranymph number one, and Frans, alias 
paranymph number two (for the ones that are wondering, they were enumerated in 
height order, of course!).
Duygu, guapa, I am not able to write what I would like to tell you in just a few lines. We had 
great times together, sharing so many things (positive and negative) but everything can be 
solved (or forgotten) with a good glass of wine. You have been there, and I know you will be 
always there. We still have too many things to experience together, places to discover and for 
that we need (and have) a whole life up front. Thanks for everything. Of course with Duygu 
comes Kıvanç, my lovely piano teacher and friend, it was great meeting you and your sense 
of humor (I love it!). I hope to travel more with you (if you and I don’t plan a trip, who is 
going to do it? no one!) and have many more unforgettable moments the four of us together.
Frans, my dear lefty (colleague number…something, my blondie friend, Bert of the cake, 
etc.), there are so many things I also want to say to you. First of all, it has been an immense 
pleasure working with you. Even though my first impression towards you, when we shared 
our first office (ages ago…) was a bit, how to say it nicely…not so positive? Later on I 
discovered a very good friend in you. Despite all the stress around us, making me give talks 
instead of you with only one day notice, your unstoppable talking and gossiping, I really 
enjoyed all moments together (especially the sailing with Marijke and the trip to Girona 
with Marcel, those were the best). Just one last advice: don’t lose your optimism!
I wish all the best to the rest of the Enzymology members: Alicja, Faizah, Lotteke, 
Ruslan, Giorgios, Sonja, Dorith, Arnold, Jonas, Franz, Albert, Michael, Durkje, Katja, 
Raj, Boqun and Hallie.
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Outside I met my “Spanish community”, my second family.
Un abrazo enorme para todos, y en especial, a los que habéis compartido conmigo la mayor 
parte de mi estancia en Groningen: Alberto, Esther y Clara (mis queridos “putu peu”, el 
tío más cojonudo y la mamá más fuerte y guapa del mundo junto con su princesita). Es 
imposible olvidar a los primeros españoles que conocí en Groningen, no os puedo categorizar 
solo como amigos, porque os considero mi familia madrileña. ¡Muchas gracias por todos los 
momentos juntos! Lo mismo va para mi querida Noe, su muelle y su Jason. Cuántas alegrías, 
fiestas, marshmallows volando, tristezas, separaciones, reunificaciones, cenas, cenas y más 
cenas. Noe, muchas gracias por todos los ánimos, sobre todo en el final de esta etapa de 
mi vida. Jeanette, César, André y Tomás os deseo lo mejor en USA, ¡se os echa de menos! 
Maria, Frank y Tomàs, també us desitjo el millor a Groningen o allà on sigueu (Frank, 
quick translation: all the best!). Clau, muchos ánimos con tu pequeña, eres una mamá muy 
valiente.
In Girona I kept my real family and my best friends.
Papa i mama, es pot dir que si he arribat aquí, ha estat en gran part gràcies a vosaltres. Sempre 
m’heu proporcionat tot el que heu tingut a les mans per fer-me feliç i ho heu aconseguit. 
Moltes gràcies per tot!
Irene, Juanma i Cristina, sempre diuen que els amics de debò es poden comptar amb una sola 
mà. Doncs hi estic d’acord. Moltes gràcies per organitzar les vostres agendes i trobar sempre 
una estona per veure’ns quan l’Edu i jo hem baixat. Irene, moltes gràcies per tots els skype 
meetings i converses per whatsapp, encara que estiguéssim a gairebé 2000 km de distancia, 
era com tenir-te al meu costat sempre que t’he necessitat.
Luckily for me, my love decided to join me during this long journey.
Edu, moltes gràcies per venir amb mi a Groningen i fer possible el que, amb aquesta tesis, 
estic aconseguint. Hem passat quatre anys fantàstics, plens de bons moments i, mentrestant, 
t’has convertit en un gran dissenyador (i sé que això només és el principi d’una gran 
trajectòria professional, moltes gràcies per la portada!). Han sigut tantes les coses que hem 
après i són tantes les que ens queden per descobrir, que ja tinc ganes de saber el futur que ens 
espera, segurament, amb moments molt durs i difícils i d’altres, plens de felicitat i alegries, 
però no m’importa sempre i quan els passi amb tu.
It’s time to go and I want to finish those lines with the two words every PhD finishes 
with: 
Hora Finita,
Gemma Moiset.
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